[
  {
    "Generic Name": "Acyclovir Tablet",
    "Company Name": "Apotex Corp.",
    "Contact Info": "800-706-5575",
    "Presentation": "Tablet, 400 mg/1 (NDC 60505-5306-1)",
    "Type of Update": "New",
    "Date of Update": "04/26/2024",
    "Availability Information": "",
    "Related Information": "Business related decision to discontinue the product",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Antiviral",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/26/2024",
    "Initial Posting Date": "04/26/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Acyclovir Tablet",
    "Company Name": "Apotex Corp.",
    "Contact Info": "800-706-5575",
    "Presentation": "Tablet, 400 mg/1 (NDC 60505-5306-8)",
    "Type of Update": "New",
    "Date of Update": "04/26/2024",
    "Availability Information": "",
    "Related Information": "Business related decision to discontinue the product",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Antiviral",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/26/2024",
    "Initial Posting Date": "04/26/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Acyclovir Tablet",
    "Company Name": "Apotex Corp.",
    "Contact Info": "800-706-5575",
    "Presentation": "Tablet, 800 mg/1 (NDC 60505-5307-1)",
    "Type of Update": "New",
    "Date of Update": "04/26/2024",
    "Availability Information": "",
    "Related Information": "Business related decision to discontinue the product",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Antiviral",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/26/2024",
    "Initial Posting Date": "04/26/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Acyclovir Tablet",
    "Company Name": "Apotex Corp.",
    "Contact Info": "800-706-5575",
    "Presentation": "Tablet, 800 mg/1 (NDC 60505-5307-5)",
    "Type of Update": "New",
    "Date of Update": "04/26/2024",
    "Availability Information": "",
    "Related Information": "Business related decision to discontinue the product",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Antiviral",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/26/2024",
    "Initial Posting Date": "04/26/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Albuterol Sulfate Powder, Metered",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "ProAir Digihaler, Powder, Metered, 90 ug (NDC 59310-117-20)",
    "Type of Update": "New",
    "Date of Update": "04/30/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Pulmonary/Allergy",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/30/2024",
    "Initial Posting Date": "04/30/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Albuterol Sulfate Solution",
    "Company Name": "Nephron Pharmaceuticals Corporation",
    "Contact Info": "800-443-4313",
    "Presentation": "Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 0487-9901-30)",
    "Type of Update": "Revised",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Pulmonary/Allergy; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/25/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Alclometasone Dipropionate Cream",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Cream, .5 mg/1 g (NDC 0168-0263-60)",
    "Type of Update": "New",
    "Date of Update": "11/27/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Dermatology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "11/27/2023",
    "Initial Posting Date": "11/27/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Alclometasone Dipropionate Cream",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Cream, .5 mg/1 g (NDC 0168-0263-45)",
    "Type of Update": "New",
    "Date of Update": "11/27/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Dermatology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "11/27/2023",
    "Initial Posting Date": "11/27/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Alclometasone Dipropionate Cream",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Cream, .5 mg/1 g (NDC 0168-0263-15)",
    "Type of Update": "New",
    "Date of Update": "11/27/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Dermatology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "11/27/2023",
    "Initial Posting Date": "11/27/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Alprostadil Suppository",
    "Company Name": "Mylan Institutional, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Muse, Suppository, 250 ug (NDC 0037-8120-06)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Out of stock; Estimated release dates to be determined",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Urology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/18/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Alprostadil Suppository",
    "Company Name": "Mylan Institutional, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Muse, Suppository, 500 ug (NDC 0037-8130-06)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Out of stock; Estimated release dates to be determined",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Urology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/18/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Alprostadil Suppository",
    "Company Name": "Mylan Institutional, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Muse, Suppository, 1000 ug (NDC 0037-8140-06)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Out of stock; Estimated release dates to be determined",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Urology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/18/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amifostine Injection",
    "Company Name": "Clinigen, Inc.",
    "Contact Info": "877-776-5385",
    "Presentation": "Ethyol, Injection, 500 mg/10 mL (NDC 76310-017-50)",
    "Type of Update": "Revised",
    "Date of Update": "04/18/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Temporary discontinuation of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Oncology; Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/21/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amino Acid Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Plenamine, Injection, 0.15 (NDC 0264-4500-00)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/08/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amino Acid Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Aminosyn II 15% In Plastic Container, Injection, 0.15 (NDC 0990-7171-17)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7171-17",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/08/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amino Acid Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Aminosyn II 10% In Plastic Container, Injection, 0.1 (NDC 0990-7172-17)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7172-17",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/08/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amino Acid Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Aminosyn-PF 7%, Injection, 0.07 (NDC 0990-4178-03)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Unavailable",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-4178-03",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/08/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amino Acid Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Aminosyn-PF 10%, Injection, 0.1 (NDC 0990-4179-05)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Unavailable",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-4179-05",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/08/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amino Acid Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Clinisol 15% Sulfite Free In Plastic Container, Injection, 0.15 (NDC 0338-0502-06)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/08/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amino Acid Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Plenamine, Injection, 0.15 (NDC 0264-4500-05)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/08/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amino Acid Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Clinisol 15% Sulfite Free In Plastic Container, Injection, 0.15 (NDC 0338-0502-03)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/08/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxapine Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Amoxapine Tablets, USP, Tablet, 50 mg (NDC 0591-5714-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Estimated recovery September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/09/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxapine Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Amoxapine Tablets, USP, Tablet, 25 mg (NDC 0591-5713-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Estimated recovery September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/09/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxapine Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Amoxapine Tablets, USP, Tablet, 100 mg (NDC 0591-5715-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Estimated recovery September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/09/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxapine Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Amoxapine Tablets, USP, Tablet, 150 mg (NDC 0591-5716-30)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Estimated Recovery September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/09/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2876",
    "Presentation": "Powder, For Suspension, 125 mg/5 mL (NDC 65862-706-55)",
    "Type of Update": "Revised",
    "Date of Update": "05/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2876",
    "Presentation": "Powder, For Suspension, 125 mg/5 mL (NDC 65862-706-80)",
    "Type of Update": "Revised",
    "Date of Update": "05/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2876",
    "Presentation": "Powder, For Suspension, 200 mg/5 mL (NDC 65862-070-50)",
    "Type of Update": "Revised",
    "Date of Update": "05/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2876",
    "Presentation": "Powder, For Suspension, 200 mg/5 mL (NDC 65862-070-75)",
    "Type of Update": "Revised",
    "Date of Update": "05/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2876",
    "Presentation": "Powder, For Suspension, 250 mg/5 mL (NDC 65862-707-55)",
    "Type of Update": "Revised",
    "Date of Update": "05/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2876",
    "Presentation": "Powder, For Suspension, 250 mg/5 mL (NDC 65862-707-80)",
    "Type of Update": "Revised",
    "Date of Update": "05/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2876",
    "Presentation": "Powder, For Suspension, 400 mg/5 mL (NDC 65862-071-50)",
    "Type of Update": "Revised",
    "Date of Update": "05/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2876",
    "Presentation": "Powder, For Suspension, 400 mg/5 mL (NDC 65862-071-75)",
    "Type of Update": "Revised",
    "Date of Update": "05/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Powder, For Suspension, 125 mg/5 mL (NDC 0143-9888-15)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Powder, For Suspension, 125 mg/5 mL (NDC 0143-9888-80)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Powder, For Suspension, 200 mg/5 mL (NDC 0143-9886-50)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Powder, For Suspension, 200 mg/5 mL (NDC 0143-9886-75)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Amoxicillin, Powder, For Suspension, 250 mg/5 mL (NDC 0143-9889-15)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Powder, For Suspension, 250 mg/5 mL (NDC 0143-9889-80)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Powder, For Suspension, 400 mg/5 mL (NDC 0143-9887-50)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Powder, For Suspension, 400 mg/5 mL (NDC 0143-9887-75)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Amoxicillin for Oral Suspension, USP, Powder, For Suspension, 200 mg/5 mL (NDC 0093-4160-73)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "-",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Amoxicillin for Oral Suspension, USP, Powder, For Suspension, 200 mg/5 mL (NDC 0093-4160-76)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "-",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Amoxicillin for Oral Suspension, USP, Powder, For Suspension, 200 mg/5 mL (NDC 0093-4160-78)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "-",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Amoxicillin for Oral Suspension, USP, Powder, For Suspension, 400 mg/5 mL (NDC 0093-4161-73)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "-",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Amoxicillin for Oral Suspension, USP, Powder, For Suspension, 400 mg/5 mL (NDC 0093-4161-76)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "-",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Amoxicillin for Oral Suspension, USP, Powder, For Suspension, 400 mg/5 mL (NDC 0093-4161-78)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "-",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2876",
    "Presentation": "Powder, For Suspension, 125 mg/5 mL (NDC 65862-706-01)",
    "Type of Update": "Revised",
    "Date of Update": "05/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2876",
    "Presentation": "Powder, For Suspension, 200 mg/5 mL (NDC 65862-070-01)",
    "Type of Update": "Revised",
    "Date of Update": "05/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2876",
    "Presentation": "Powder, For Suspension, 250 mg/5 mL (NDC 65862-707-01)",
    "Type of Update": "Revised",
    "Date of Update": "05/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2876",
    "Presentation": "Powder, For Suspension, 400 mg/5 mL (NDC 65862-071-01)",
    "Type of Update": "Revised",
    "Date of Update": "05/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Powder, For Suspension, 125 mg/5 mL (NDC 0143-9888-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Powder, For Suspension, 200 mg/5 mL (NDC 0143-9886-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Powder, For Suspension, 250 mg/5 mL (NDC 0143-9889-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Powder, For Suspension, 400 mg/5 mL (NDC 0143-9887-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Powder, For Suspension, 125 mg/5 mL (NDC 0781-6039-46)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Powder, For Suspension, 125 mg/5 mL (NDC 0781-6039-55)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Powder, For Suspension, 125 mg/5 mL (NDC 0781-6039-58)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Powder, For Suspension, 200 mg/5 mL (NDC 0781-6156-46)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Powder, For Suspension, 200 mg/5 mL (NDC 0781-6156-52)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Powder, For Suspension, 200 mg/5 mL (NDC 0781-6156-57)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Powder, For Suspension, 400 mg/5 mL (NDC 0781-6157-46)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Powder, For Suspension, 400 mg/5 mL (NDC 0781-6157-52)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-545-8747",
    "Presentation": "Powder, For Suspension, 400 mg/5 mL (NDC 0781-6157-57)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Powder, For Suspension, 250 mg/5 mL (NDC 0781-6041-46)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Powder, For Suspension, 250 mg/5 mL (NDC 0781-6041-55)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Powder, For Suspension, 250 mg/5 mL (NDC 0781-6041-58)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Amoxicillin for Oral Suspension, USP, Powder, For Suspension, 250 mg/5 mL (NDC 0093-4155-73)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "-",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Amoxicillin for Oral Suspension, USP, Powder, For Suspension, 250 mg/5 mL (NDC 0093-4155-80)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "-",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amoxicillin Powder, For Suspension",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Amoxicillin for Oral Suspension, USP, Powder, For Suspension, 250 mg/5 mL (NDC 0093-4155-79)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "-",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "SpecGx LLC",
    "Contact Info": "800-325-8888",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0406-8884-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Available for primary customers",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "SpecGx LLC",
    "Contact Info": "800-325-8888",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0406-8885-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Available for primary customers only; Backorder expected in August 2024 with recovery late Sept.",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "SpecGx LLC",
    "Contact Info": "800-325-8888",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0406-8891-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Available to primary customers only.",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "SpecGx LLC",
    "Contact Info": "800-325-8888",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0406-8892-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Available for primary customers only. Backorder projected in November",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "SpecGx LLC",
    "Contact Info": "800-325-8888",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0406-8893-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Available for primary customers only. Backorder projected in November",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "SpecGx LLC",
    "Contact Info": "800-325-8888",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0406-8894-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Available to primary customers only. Backorder expected in July. Next release late Aug with intermittent backorder through Oct 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Epic Pharma, LLC",
    "Contact Info": "(718) 276-8600 ext. 3",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 42806-344-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Epic Pharma, LLC",
    "Contact Info": "(718) 276-8600 ext. 3",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 42806-341-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Epic Pharma, LLC",
    "Contact Info": "(718) 276-8600 ext. 3",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 42806-343-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Epic Pharma, LLC",
    "Contact Info": "(718) 276-8600 ext. 3",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 42806-345-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Epic Pharma, LLC",
    "Contact Info": "(718) 276-8600 ext. 3",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 42806-339-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Alvogen",
    "Contact Info": "844-842-8672 and email: CustomerService-US@alvogen.com",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 47781-174-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/02/2024",
    "Availability Information": "Available",
    "Related Information": "Supporting contracted business only",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Alvogen",
    "Contact Info": "844-842-8672 and email: CustomerService-US@alvogen.com",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 47781-176-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/02/2024",
    "Availability Information": "Available",
    "Related Information": "Supporting contracted business only",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Alvogen",
    "Contact Info": "844-842-8672 and email: CustomerService-US@alvogen.com",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 47781-178-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/02/2024",
    "Availability Information": "Available",
    "Related Information": "Supporting contracted business only",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Alvogen",
    "Contact Info": "844-842-8672 and email: CustomerService-US@alvogen.com",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 47781-179-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/02/2024",
    "Availability Information": "Available",
    "Related Information": "Supporting contracted business only",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Alvogen",
    "Contact Info": "844-842-8672 and email: CustomerService-US@alvogen.com",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 47781-180-01)",
    "Type of Update": "Reverified",
    "Date of Update": "05/18/2024",
    "Availability Information": "Available",
    "Related Information": "Supporting contracted business only",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Sunrise Pharmaceutical, Inc.",
    "Contact Info": "732-382-6085 Monday to Friday 9 am to 3:45 pm",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 11534-190-01)",
    "Type of Update": "Reverified",
    "Date of Update": "05/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Sunrise Pharmaceutical, Inc.",
    "Contact Info": "732-382-6085 Monday to Friday 9 am to 3:45 pm",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 11534-192-01)",
    "Type of Update": "Reverified",
    "Date of Update": "05/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Sunrise Pharmaceutical, Inc.",
    "Contact Info": "732-382-6085 Monday to Friday 9 am to 3:45 pm",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 11534-191-01)",
    "Type of Update": "Reverified",
    "Date of Update": "05/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Sunrise Pharmaceutical, Inc.",
    "Contact Info": "732-382-6085 Monday to Friday 9 am to 3:45 pm",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 11534-193-01)",
    "Type of Update": "Reverified",
    "Date of Update": "05/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Sunrise Pharmaceutical, Inc.",
    "Contact Info": "732-382-6085 Monday to Friday 9 am to 3:45 pm",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 11534-194-01)",
    "Type of Update": "Reverified",
    "Date of Update": "05/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Sunrise Pharmaceutical, Inc.",
    "Contact Info": "732-382-6085 Monday to Friday 9 am to 3:45 pm",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 11534-195-01)",
    "Type of Update": "Reverified",
    "Date of Update": "05/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Sunrise Pharmaceutical, Inc.",
    "Contact Info": "732-382-6085 Monday to Friday 9 am to 3:45 pm",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 11534-196-01)",
    "Type of Update": "Reverified",
    "Date of Update": "05/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Lannett Company, Inc.",
    "Contact Info": "844-834-0530",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0527-0760-37)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Lannett Company, Inc.",
    "Contact Info": "844-834-0530",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0527-0761-37)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Lannett Company, Inc.",
    "Contact Info": "844-834-0530",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0527-1502-37)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Lannett Company, Inc.",
    "Contact Info": "844-834-0530",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 0527-0763-37)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Lannett Company, Inc.",
    "Contact Info": "844-834-0530",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0527-0764-37)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Lannett Company, Inc.",
    "Contact Info": "844-834-0530",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0527-1505-37)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Lannett Company, Inc.",
    "Contact Info": "844-834-0530",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0527-0766-37)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "(866) 850-2876 or CustomerService@AurobindoUSA.com",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 13107-068-01)",
    "Type of Update": "Revised",
    "Date of Update": "01/31/2024",
    "Availability Information": "Estimated availability: September 2024",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "(866) 850-2876 or CustomerService@AurobindoUSA.com",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 13107-069-01)",
    "Type of Update": "Revised",
    "Date of Update": "01/31/2024",
    "Availability Information": "Estimated availability: September 2024",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "(866) 850-2876 or CustomerService@AurobindoUSA.com",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 13107-070-01)",
    "Type of Update": "Revised",
    "Date of Update": "01/31/2024",
    "Availability Information": "Estimated availability: September 2024",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "(866) 850-2876 OR CustomerService@AurobindoUSA.com",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 13107-072-01)",
    "Type of Update": "Revised",
    "Date of Update": "01/31/2024",
    "Availability Information": "Estimated availability: September 2024",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "(866) 850-2876 or CustomerService@AurobindoUSA.com",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 13107-073-01)",
    "Type of Update": "Revised",
    "Date of Update": "01/31/2024",
    "Availability Information": "Estimated availability: September 2024",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "(866) 850-2876 OR CustomerService@AurobindoUSA.com",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 13107-074-01)",
    "Type of Update": "Revised",
    "Date of Update": "01/31/2024",
    "Availability Information": "Estimated availability: September 2024",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Granules Pharmaceuticals Inc.",
    "Contact Info": "877-770-3183",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 70010-111-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/23/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Granules Pharmaceuticals Inc.",
    "Contact Info": "877-770-3183",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 70010-112-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Estimated availability: July 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Granules Pharmaceuticals Inc.",
    "Contact Info": "877-770-3183",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 70010-113-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/23/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Granules Pharmaceuticals Inc.",
    "Contact Info": "877-770-3183",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 70010-114-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Estimated availability: July 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Granules Pharmaceuticals Inc.",
    "Contact Info": "877-770-3183",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 70010-115-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/23/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Granules Pharmaceuticals Inc.",
    "Contact Info": "877-770-3183",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 70010-116-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/23/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Granules Pharmaceuticals Inc.",
    "Contact Info": "877-770-3183",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 70010-117-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/23/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "USPHARMA WINDLAS",
    "Contact Info": "855-257-0292",
    "Presentation": "Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 72516-016-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "USPHARMA WINDLAS",
    "Contact Info": "855-257-0292",
    "Presentation": "Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 72516-014-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "USPHARMA WINDLAS",
    "Contact Info": "855-257-0292",
    "Presentation": "Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 72516-013-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "USPHARMA WINDLAS",
    "Contact Info": "855-257-0292",
    "Presentation": "Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 72516-012-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "USPHARMA WINDLAS",
    "Contact Info": "855-257-0292",
    "Presentation": "Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 72516-011-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0185-2099-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0185-0853-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0185-0842-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0185-2098-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Adderall, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 57844-110-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "Teva is manufacturing and distributing consistent with historic levels. We continue to see unprecedented demand.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Adderall, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 57844-112-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "Estimated recovery September 2024\n\nTeva is manufacturing and distributing consistent with historic levels. We continue to see unprecedented demand.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Adderall, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 57844-115-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "Teva is manufacturing and distributing consistent with historic levels. We continue to see unprecedented demand.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Adderall, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 57844-120-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "Teva is manufacturing and distributing consistent with historic levels. We continue to see unprecedented demand.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Adderall, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 57844-130-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "Teva is manufacturing and distributing consistent with historic levels. We continue to see unprecedented demand.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Adderall, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 57844-105-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "Teva is manufacturing and distributing consistent with historic levels. We continue to see unprecedented demand.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Adderall, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 57844-117-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "Teva is manufacturing and distributing consistent with historic levels. We continue to see unprecedented demand.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 0555-0776-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "Teva is manufacturing and distributing consistent with historic levels. We continue to see unprecedented demand.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0555-0777-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Estimated Recovery August 2024\nTeva is manufacturing and distributing consistent with historic levels. We continue to see unprecedented demand.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0555-0775-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "Teva is manufacturing and distributing consistent with historic levels. We continue to see unprecedented demand.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0555-0972-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "-",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0555-0973-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "Teva is manufacturing and distributing consistent with historic levels. We continue to see unprecedented demand.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0555-0974-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "Teva is manufacturing and distributing consistent with historic levels. We continue to see unprecedented demand.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0555-0971-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "Teva is manufacturing and distributing consistent with historic levels. We continue to see unprecedented demand.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Elite Laboratories, Inc.",
    "Contact Info": "888-852-6657",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 64850-500-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Elite Laboratories, Inc.",
    "Contact Info": "888-852-6657",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 64850-501-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Elite Laboratories, Inc.",
    "Contact Info": "888-852-6657",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 64850-502-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Elite Laboratories, Inc.",
    "Contact Info": "888-852-6657",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 64850-503-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Elite Laboratories, Inc.",
    "Contact Info": "888-852-6657",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 64850-504-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Elite Laboratories, Inc.",
    "Contact Info": "888-852-6657",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 64850-505-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
    "Company Name": "Elite Laboratories, Inc.",
    "Contact Info": "888-852-6657",
    "Presentation": "Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 64850-506-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "08/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ampicillin Sodium Injection",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Injection, 125 mg (NDC 0781-3400-95)",
    "Type of Update": "New",
    "Date of Update": "03/04/2024",
    "Availability Information": "",
    "Related Information": "Other NDCs are available",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Antibiotic",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/04/2024",
    "Initial Posting Date": "03/04/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ampicillin Sodium Injection",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Injection, 250 mg (NDC 0781-9242-95)",
    "Type of Update": "New",
    "Date of Update": "03/04/2024",
    "Availability Information": "",
    "Related Information": "Other NDCs are available",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Antibiotic",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/04/2024",
    "Initial Posting Date": "03/04/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ampicillin Sodium Injection",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Injection, 500 mg (NDC 0781-9250-95)",
    "Type of Update": "New",
    "Date of Update": "03/04/2024",
    "Availability Information": "",
    "Related Information": "Other NDCs are available",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Antibiotic",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/04/2024",
    "Initial Posting Date": "03/04/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ampicillin Sodium Injection",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Injection, 125 mg (NDC 0781-9401-95)",
    "Type of Update": "New",
    "Date of Update": "03/04/2024",
    "Availability Information": "",
    "Related Information": "Other NDCs are available",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Antibiotic",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/04/2024",
    "Initial Posting Date": "03/04/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ampicillin Sodium Injection",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Injection, 250 mg (NDC 0781-9402-95)",
    "Type of Update": "New",
    "Date of Update": "03/04/2024",
    "Availability Information": "",
    "Related Information": "Other NDCs are available",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Antibiotic",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/04/2024",
    "Initial Posting Date": "03/04/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ampicillin Sodium Injection",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Injection, 500 mg (NDC 0781-9407-95)",
    "Type of Update": "New",
    "Date of Update": "03/04/2024",
    "Availability Information": "",
    "Related Information": "Other NDCs are available",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Antibiotic",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/04/2024",
    "Initial Posting Date": "03/04/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Atropa Belladonna, Opium Suppository",
    "Company Name": "Padagis US LLC",
    "Contact Info": "866-634-9120",
    "Presentation": "Belladonna And Opium, Suppository, 16.2 mg; 60 mg (NDC 0574-7040-12)",
    "Type of Update": "Revised",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Urology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "08/03/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Belladonna+and+Opium+Suppositories&st=d&tab=tabs-4&panels=0",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Atropa Belladonna, Opium Suppository",
    "Company Name": "Padagis US LLC",
    "Contact Info": "866-634-9120",
    "Presentation": "Belladonna And Opium, Suppository, 16.2 mg; 60 mg (NDC 0574-7040-04)",
    "Type of Update": "Revised",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Urology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "08/03/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Belladonna+and+Opium+Suppositories&st=d&tab=tabs-4&panels=0",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Atropine Sulfate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, .4 mg/1 mL (NDC 63323-580-20)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Atropine Sulfate Injection",
    "Company Name": "American Regent, Inc.",
    "Contact Info": "800-645-1706",
    "Presentation": "Injection, .4 mg/1 mL (NDC 0517-1004-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "old NDC 0517-0401-25",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Atropine Sulfate Injection",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Injection, .4 mg/1 mL (NDC 16729-525-08)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Requirements related to complying with good manufacturing practices",
    "Therapeutic Category": "Anesthesia; Neurology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Atropine Sulfate Injection",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Injection, .4 mg/1 mL (NDC 16729-512-43)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Requirements related to complying with good manufacturing practices",
    "Therapeutic Category": "Anesthesia; Neurology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Atropine Sulfate Injection",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Injection, 1 mg/1 mL (NDC 16729-526-08)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Requirements related to complying with good manufacturing practices",
    "Therapeutic Category": "Anesthesia; Neurology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Atropine Sulfate Injection",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Injection, .05 mg/1 mL (NDC 16729-483-03)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Temporarily discontinued",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Anesthesia; Neurology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Atropine Sulfate Injection",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Injection, .1 mg/1 mL (NDC 16729-484-45)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Requirements related to complying with good manufacturing practices",
    "Therapeutic Category": "Anesthesia; Neurology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Atropine Sulfate Injection",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Injection, .1 mg/1 mL (NDC 16729-484-90)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Temporarily discontinued",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Anesthesia; Neurology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Atropine Sulfate Injection",
    "Company Name": "Amphastar Pharmaceuticals, Inc.",
    "Contact Info": "800-423-4136",
    "Presentation": "Injection, .1 mg/1 mL (NDC 76329-3340-1)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Atropine Sulfate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 0409-1630-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Atropine Sulfate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (NDC 0409-9630-05)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Atropine Sulfate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Atropine Sulfate, Injection, 0.5 mg/5 mL (0.1 mg/mL) Syringes (NDC 0409-4910-34)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery and Estimated Recovery: April 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia; Neurology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Atropine Sulfate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 0409-4911-34)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: October 2024; Estimated Recovery: March 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia; Neurology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Atropine Sulfate Injection",
    "Company Name": "American Regent, Inc.",
    "Contact Info": "800-645-1706",
    "Presentation": "Injection, 1 mg/1 mL (NDC 0517-1001-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "old NDC 0517-1010-25",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Atropine Sulfate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Atropine Sulfate Injection, USP, Injection, 0.4 mg/1 mL (NDC 0641-6251-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/20/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Atropine Sulfate Injection",
    "Company Name": "Medefil, Inc.",
    "Contact Info": "630-682-4600",
    "Presentation": "Atropine Sulfate, Injection, .1 mg/1 mL (NDC 64253-400-91)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Atropine Sulfate Ointment",
    "Company Name": "Bausch & Lomb Incorporated",
    "Contact Info": "800-553-5340",
    "Presentation": "Ointment, 10 mg/1 g (NDC 24208-825-55)",
    "Type of Update": "New",
    "Date of Update": "12/06/2023",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Anesthesia; Neurology; Pediatric",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "12/06/2023",
    "Initial Posting Date": "12/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Azacitidine Injection",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Azacitidine for Injection, Injection, 100 mg (NDC 68001-313-56)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "Product is manufactured and labeled  for Blue Point Laboratories on a made to order basis",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/22/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Azacitidine Injection",
    "Company Name": "Celgene Corporation",
    "Contact Info": "1-888-423-5436",
    "Presentation": "Vidaza, Injection, 100 mg (NDC 0781-3253-94)",
    "Type of Update": "Revised",
    "Date of Update": "12/19/2023",
    "Availability Information": "Discontinuation",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Oncology",
    "Status": "To Be Discontinued",
    "Change Date": "12/19/2023",
    "Date Discontinued": "12/19/2023",
    "Initial Posting Date": "12/18/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Azacitidine Injection",
    "Company Name": "Celgene Corporation",
    "Contact Info": "1-888-423-5436",
    "Presentation": "Vidaza, Injection, 100 mg, Powder, Lyoph (NDC 0781-9253-94)",
    "Type of Update": "Revised",
    "Date of Update": "12/19/2023",
    "Availability Information": "Discontinuation",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Oncology",
    "Status": "To Be Discontinued",
    "Change Date": "12/19/2023",
    "Date Discontinued": "12/19/2023",
    "Initial Posting Date": "12/18/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Azacitidine%20for%20Injection&st=d",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Azacitidine Injection",
    "Company Name": "Celgene Corporation",
    "Contact Info": "1-888-423-5436",
    "Presentation": "Vidaza, Injection, 100 mg (NDC 59572-102-01)",
    "Type of Update": "Reverified",
    "Date of Update": "05/27/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/18/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Azacitidine Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "1-888-386-1300",
    "Presentation": "Injection, 100 mg/30 mL (NDC 63323-771-39)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/18/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Azacitidine Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "1-800-631-2174",
    "Presentation": "Azacitidine for Injection, Injection, 100 mg/ Vial (NDC 0143-9606-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/18/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Azacitidine Injection",
    "Company Name": "Dr. Reddy's Laboratories, Inc.",
    "Contact Info": "866-732-3952",
    "Presentation": "Injection, 100 mg (NDC 43598-305-62)",
    "Type of Update": "Reverified",
    "Date of Update": "07/23/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/18/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Azacitidine Injection",
    "Company Name": "Armas Pharmaceuticals Inc",
    "Contact Info": "1-732-637-1971",
    "Presentation": "Injection, 100 mg (NDC 72485-201-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/18/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Azacitidine Injection",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Injection, 100 mg (NDC 16729-306-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Shortage duration not available.",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/21/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Azacitidine Injection",
    "Company Name": "Cipla Limited",
    "Contact Info": "844-247-5287",
    "Presentation": "Injection, 100 mg (NDC 69097-805-40)",
    "Type of Update": "Reverified",
    "Date of Update": "03/05/2024",
    "Availability Information": "",
    "Related Information": "This presentation has been discontinued.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "To Be Discontinued",
    "Change Date": "03/05/2024",
    "Date Discontinued": "03/05/2024",
    "Initial Posting Date": "12/22/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Azacitidine%20Injection&st=d",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Azacitidine Injection",
    "Company Name": "Meitheal Pharmaceuticals, Inc.",
    "Contact Info": "844-824-8426",
    "Presentation": "Injection, 100 mg/30 mL (NDC 71288-115-30)",
    "Type of Update": "Reverified",
    "Date of Update": "07/03/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/18/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Azacitidine Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 100 mg/4 mL (NDC 55150-393-01)",
    "Type of Update": "Reverified",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/22/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Azithromycin for Suspension",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "for Suspension, 200 mg/5 mL (NDC 0069-3140-19)",
    "Type of Update": "New",
    "Date of Update": "09/28/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Antibiotic",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "02/28/2024",
    "Initial Posting Date": "09/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Azithromycin for Suspension",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "for Suspension, 300 mg/15mL (NDC 0069-3110-19)",
    "Type of Update": "New",
    "Date of Update": "09/28/2023",
    "Availability Information": "",
    "Related Information": "Discontinuation due to business reasons.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Antibiotic",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "09/28/2023",
    "Initial Posting Date": "09/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Azithromycin for Suspension",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Zithromax, for Suspension, 1 g (NDC 0069-3051-07)",
    "Type of Update": "New",
    "Date of Update": "09/28/2023",
    "Availability Information": "",
    "Related Information": "Discontinuation due to business reasons.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Antibiotic",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "09/28/2023",
    "Initial Posting Date": "09/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Azithromycin for Suspension",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Zithromax, for Suspension, 1 g (NDC 59762-3051-1)",
    "Type of Update": "New",
    "Date of Update": "05/17/2024",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Antiviral",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "05/17/2024",
    "Initial Posting Date": "05/17/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Azithromycin for Suspension",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Zithromax, for Suspension, 1 g (NDC 59762-3051-2)",
    "Type of Update": "New",
    "Date of Update": "05/17/2024",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Antiviral",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "05/17/2024",
    "Initial Posting Date": "05/17/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Azithromycin for Suspension",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Zithromax, for Suspension, 200 mg/5 mL (NDC 59762-3120-1)",
    "Type of Update": "New",
    "Date of Update": "05/17/2024",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Antiviral",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "05/17/2024",
    "Initial Posting Date": "05/17/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Azithromycin for Suspension",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Zithromax, for Suspension, 900 mg/22.5 mL (NDC 59762-3130-1)",
    "Type of Update": "New",
    "Date of Update": "05/17/2024",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Antiviral",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "05/17/2024",
    "Initial Posting Date": "05/17/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Azithromycin for Suspension",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Zithromax, for Suspension, 1200 mg/30 mL (NDC 59762-3140-1)",
    "Type of Update": "New",
    "Date of Update": "05/17/2024",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Antiviral",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "05/17/2024",
    "Initial Posting Date": "05/17/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Azithromycin for Suspension",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Zithromax, for Suspension, 1 g (NDC 0069-3051-75)",
    "Type of Update": "New",
    "Date of Update": "03/26/2024",
    "Availability Information": "",
    "Related Information": "Discontinuation due to business reasons.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/26/2024",
    "Initial Posting Date": "03/26/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Barium Sulfate Cream",
    "Company Name": "Bracco Diagnostics",
    "Contact Info": "800-631-5245",
    "Presentation": "E-Z-Paste, Cream, .6 g/1 g (NDC 32909-770-01)",
    "Type of Update": "New",
    "Date of Update": "03/26/2024",
    "Availability Information": "",
    "Related Information": "Discontinued due to business reasons.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Medical Imaging",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/26/2024",
    "Initial Posting Date": "03/26/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": "https://www.fda.gov/media/177304/download"
  },
  {
    "Generic Name": "Barium Sulfate Suspension",
    "Company Name": "Bracco Diagnostics",
    "Contact Info": "800-631-5245",
    "Presentation": "Liquid Polibar Plus, Suspension, 1.05 g/1 mL (NDC 32909-167-55)",
    "Type of Update": "New",
    "Date of Update": "05/02/2024",
    "Availability Information": "",
    "Related Information": "Discontinued due to business reasons.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Medical Imaging",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "05/02/2024",
    "Initial Posting Date": "05/02/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": "https://www.fda.gov/media/178274/download"
  },
  {
    "Generic Name": "Barium Sulfate Suspension",
    "Company Name": "Bracco Diagnostics",
    "Contact Info": "800-631-5245",
    "Presentation": "NeuLumEX, Suspension, 1 mg/1 mL (NDC 32909-927-03)",
    "Type of Update": "New",
    "Date of Update": "05/02/2024",
    "Availability Information": "",
    "Related Information": "Discontinued due to business reasons.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "05/02/2024",
    "Initial Posting Date": "05/02/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": "https://www.fda.gov/media/178274/download"
  },
  {
    "Generic Name": "Bazedoxifene Acetate, Estrogens, Conjugated Tablets",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Duavee, Tablets, 20 mg; .45 mg (NDC 0008-1123-12)",
    "Type of Update": "Revised",
    "Date of Update": "03/12/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Reproductive",
    "Status": "Resolved",
    "Change Date": "03/12/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "09/21/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Betaxolol Hydrochloride Ophthalmic Suspension",
    "Company Name": "Novartis Pharmaceuticals Corporation",
    "Contact Info": "888-669-6682",
    "Presentation": "Betoptic S, Ophthalmic Suspension, 2.8 mg/1 mL (NDC 0078-0729-10)",
    "Type of Update": "New",
    "Date of Update": "07/02/2024",
    "Availability Information": "",
    "Related Information": "Novartis has made a business decision to permanently discontinue BETOPTIC S (betaxolol hydrochloride ophthalmic suspension), 0.25% as base.\n\nDiscontinuation of the product is not due to manufacturing, product quality, safety, or efficacy concerns.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Ophthalmology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "07/02/2024",
    "Initial Posting Date": "07/02/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Betaxolol Hydrochloride Ophthalmic Suspension",
    "Company Name": "Novartis Pharmaceuticals Corporation",
    "Contact Info": "888-669-6682",
    "Presentation": "Betoptic S, Ophthalmic Suspension, 2.8 mg/1 mL (NDC 0078-0729-15)",
    "Type of Update": "New",
    "Date of Update": "07/02/2024",
    "Availability Information": "",
    "Related Information": "Novartis has made a business decision to permanently discontinue BETOPTIC S (betaxolol hydrochloride ophthalmic suspension), 0.25% as base.\n\nDiscontinuation of the product is not due to manufacturing, product quality, safety, or efficacy concerns.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Ophthalmology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "07/02/2024",
    "Initial Posting Date": "07/02/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bisoprolol Fumarate; Hydrochlorothiazide Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Ziac, Tablet, 10 mg; 6.25 mg (NDC 51285-040-01)",
    "Type of Update": "New",
    "Date of Update": "07/26/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "07/26/2024",
    "Initial Posting Date": "07/26/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bisoprolol Fumarate; Hydrochlorothiazide Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Ziac, Tablet, 2.5 mg; 6.25 mg (NDC 51285-047-02)",
    "Type of Update": "New",
    "Date of Update": "07/26/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "07/26/2024",
    "Initial Posting Date": "07/26/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bisoprolol Fumarate; Hydrochlorothiazide Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Ziac, Tablet, 5 mg; 6.25 mg (NDC 51285-050-02)",
    "Type of Update": "New",
    "Date of Update": "07/26/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "07/26/2024",
    "Initial Posting Date": "07/26/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "BOSENTAN TABLET",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "BOSENTAN, TABLET, 125 mg (NDC 0054-0521-22)",
    "Type of Update": "New",
    "Date of Update": "09/19/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "09/19/2023",
    "Initial Posting Date": "09/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "BOSENTAN TABLET",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "BOSENTAN, TABLET, 125 mg (NDC 0054-0521-21)",
    "Type of Update": "New",
    "Date of Update": "09/19/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "09/19/2023",
    "Initial Posting Date": "09/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "BOSENTAN TABLET",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "BOSENTAN, TABLET, 125 mg (NDC 0054-0521-18)",
    "Type of Update": "New",
    "Date of Update": "09/19/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "09/19/2023",
    "Initial Posting Date": "09/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "BOSENTAN TABLET",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "BOSENTAN, TABLET, 62.5 mg (NDC 0054-0520-21)",
    "Type of Update": "New",
    "Date of Update": "09/19/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "09/19/2023",
    "Initial Posting Date": "09/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "BOSENTAN TABLET",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "BOSENTAN, TABLET, 62.5 mg (NDC 0054-0520-18)",
    "Type of Update": "New",
    "Date of Update": "09/19/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "09/19/2023",
    "Initial Posting Date": "09/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bumetanide Injection",
    "Company Name": "MSN Laboratories Private Limited",
    "Contact Info": "Distributed by: Novadoz Pharmaceuticals LLC; Telephone: (855) 668-2369; customerservice@novadozpharma.com",
    "Presentation": "Bumetanide, Injection, 0.25 mg/mL, 4mL (NDC 72205-101-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/13/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bumetanide Injection",
    "Company Name": "MSN Laboratories Private Limited",
    "Contact Info": "Distributed by: Novadoz Pharmaceuticals LLC; Telephone: (855) 668-2369; customerservice@novadozpharma.com",
    "Presentation": "Bumetanide, Injection, .25 mg/1 mL (NDC 72205-101-07)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/13/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bumetanide Injection",
    "Company Name": "MSN Laboratories Private Limited",
    "Contact Info": "Distributed by: Novadoz Pharmaceuticals LLC; Telephone: (855) 668-2369; customerservice@novadozpharma.com",
    "Presentation": "Bumetanide, Injection, 0.25 mg/mL, 10 mL (NDC 72205-102-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/13/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bumetanide Injection",
    "Company Name": "MSN Laboratories Private Limited",
    "Contact Info": "Distributed by: Novadoz Pharmaceuticals LLC; Telephone: (855) 668-2369; customerservice@novadozpharma.com",
    "Presentation": "Bumetanide, Injection, .25 mg/1 mL (NDC 72205-102-07)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/13/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bumetanide Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Bumetanide, Injection, .25 mg/1 mL (NDC 70860-405-04)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/31/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bumetanide Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Bumetanide, Injection, .25 mg/1 mL (NDC 70860-406-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/31/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bumetanide Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, .25 mg/1 mL (NDC 65219-570-04)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/31/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bumetanide Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, .25 mg/1 mL (NDC 65219-572-10)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/31/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bumetanide Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, .25 mg/1 mL (NDC 0409-1412-04)",
    "Type of Update": "Revised",
    "Date of Update": "11/03/2023",
    "Availability Information": "",
    "Related Information": "Discontinued",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "12/01/2023",
    "Date Discontinued": "11/03/2023",
    "Initial Posting Date": "12/13/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bumetanide Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, .25 mg/1 mL (NDC 0409-1412-10)",
    "Type of Update": "Revised",
    "Date of Update": "11/03/2023",
    "Availability Information": "",
    "Related Information": "Discontinued",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "12/01/2023",
    "Date Discontinued": "11/03/2023",
    "Initial Posting Date": "12/13/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bumetanide Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Injection, .25 mg/1 mL (NDC 0641-6008-10)",
    "Type of Update": "Revised",
    "Date of Update": "05/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/31/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bumetanide Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Injection, .25 mg/1 mL (NDC 0641-6007-10)",
    "Type of Update": "Revised",
    "Date of Update": "05/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/31/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Bupivacaine Hydrochloride Preservative Free, Injection, 2.5 mg/1 mL (NDC 55150-167-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Bupivacaine Hydrochloride Preservative Free, Injection, 2.5 mg/1 mL (NDC 55150-168-30)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Bupivacaine Hydrochloride Preservative Free, Injection, 5 mg/1 mL (NDC 55150-169-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Bupivacaine Hydrochloride Preservative Free, Injection, 5 mg/1 mL (NDC 55150-170-30)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Unavailable",
    "Related Information": "On backorder. Recovery: TBD. Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Bupivacaine Hydrochloride Preservative Free, Injection, 7.5 mg/1 mL (NDC 55150-171-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Unavailable",
    "Related Information": "On backorder. Recovery: TBD. Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Bupivacaine Hydrochloride Preservative Free, Injection, 7.5 mg/1 mL (NDC 55150-172-30)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Unavailable",
    "Related Information": "On backorder. Recovery: TBD. Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-249-50)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-250-50)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Bupivacaine Hydrochloride, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1159-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Bupivacaine Hydrochloride, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1159-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Bupivacaine Hydrochloride, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Bupivacaine Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-1162-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Bupivacaine Hydrochloride, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-1162-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Bupivacaine Hydrochloride, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-1163-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 0409-1165-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Bupivacaine Hydrochloride, Injection, 225 mg/30 mL (7.5 mg/mL) (NDC 0409-1165-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Bupivacaine Hydrochloride, Injection, Bupivacaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25% dextrose) (NDC 0409-3613-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Marcaine, Injection, Marcaine 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1559-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Marcaine, Injection, Marcaine 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1559-30)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Marcaine, Injection, Marcaine 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1587-50)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Marcaine, Injection, Marcaine 50 mg/10 mL (5 mg/mL) (NDC 0409-1560-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Marcaine, Injection, Marcaine 150 mg/30 mL (5 mg/mL) (NDC 0409-1560-29)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Marcaine, Injection, Marcaine 250 mg/50 mL (5 mg/mL) (NDC 0409-1610-50)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Marcaine, Injection, Marcaine 75 mg/10 mL (7.5 mg/mL) (NDC 0409-1582-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Marcaine, Injection, Marcaine 225 mg/30 mL (7.5 mg/mL) (NDC 0409-1582-29)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-465-57)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-467-57)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-17)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-37)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-31)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Not available at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-17)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-37)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-31)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next release not available at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-17)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-37)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Huons Co., Ltd",
    "Contact Info": "+82-2-854-4700 or via email intbiz@huons.com",
    "Presentation": "Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 73293-0002-2)",
    "Type of Update": "Reverified",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Kindos Pharmaceuticals Co. Ltd.",
    "Contact Info": "844-824-8426",
    "Presentation": "Injection, 2.5 mg/1 mL (NDC 71288-723-52)",
    "Type of Update": "Reverified",
    "Date of Update": "07/11/2024",
    "Availability Information": "Available",
    "Related Information": "Meitheal Pharmaceuticals is distributor/labeler; product is available",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Kindos Pharmaceuticals Co. Ltd.",
    "Contact Info": "844-824-8426",
    "Presentation": "Injection, 5 mg/1 mL (NDC 71288-726-52)",
    "Type of Update": "Reverified",
    "Date of Update": "07/11/2024",
    "Availability Information": "Available",
    "Related Information": "Meitheal Pharmaceuticals is distributor/labeler; product is available",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Somerset Therapeutics, LLC",
    "Contact Info": "732-554-1037",
    "Presentation": "Injection, 2.5 mg/1 mL (NDC 70069-752-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/29/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Somerset Therapeutics, LLC",
    "Contact Info": "732-554-1037",
    "Presentation": "Injection, 5 mg/1 mL (NDC 70069-753-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/29/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Kindos Pharmaceuticals Co. Ltd.",
    "Contact Info": "844-824-8426",
    "Presentation": "Injection, 2.5 mg/1 mL (NDC 71288-722-32)",
    "Type of Update": "Reverified",
    "Date of Update": "07/11/2024",
    "Availability Information": "Available",
    "Related Information": "Meitheal Pharmaceuticals is distributor/labeler; product is available",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Kindos Pharmaceuticals Co. Ltd.",
    "Contact Info": "844-824-8426",
    "Presentation": "Injection, 5 mg/1 mL (NDC 71288-725-32)",
    "Type of Update": "Reverified",
    "Date of Update": "07/11/2024",
    "Availability Information": "Available",
    "Related Information": "Meitheal Pharmaceuticals is distributor/labeler; product is available",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride Injection",
    "Company Name": "Kindos Pharmaceuticals Co. Ltd.",
    "Contact Info": "844-824-8426",
    "Presentation": "Injection, 7.5 mg/1 mL (NDC 71288-728-32)",
    "Type of Update": "Reverified",
    "Date of Update": "07/11/2024",
    "Availability Information": "Available",
    "Related Information": "Meitheal Pharmaceuticals is distributor/labeler; product is available",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-461-57)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-463-57)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-468-17)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-468-37)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-17)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-37)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-31)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next release date not available at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sensorcaine, Injection, 7.5 mg/1 mL; .005 mg/1 mL (NDC 63323-460-37)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Bupivacaine Hydrochloride And Epinephrine, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-9042-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: June 2025; Estimated Recovery: December 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Bupivacaine Hydrochloride And Epinephrine, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-9042-17)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: June 2025; Estimated Recovery: December 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Bupivacaine Hydrochloride And Epinephrine, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-9043-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: June 2025; Estimated Recovery: December 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Bupivacaine Hydrochloride And Epinephrine, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-9045-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: June 2025; Estimated Recovery: December 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Bupivacaine Hydrochloride And Epinephrine, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-9045-17)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: June 2025; Estimated Recovery: December 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Bupivacaine Hydrochloride And Epinephrine, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-9046-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: April 2025; Estimated Recovery: September 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 25 mg/10 mL (2.5 mg/mL 1:200,000) (NDC 0409-1746-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: September 2024; Estimated Recovery: December 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 75 mg/30 mL (2.5 mg/mL 1:200,000) (NDC 0409-1746-30)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: July 2024; Estimated Recovery: December 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 50 mg/10 mL (5 mg/mL 1:200,000) (NDC 0409-1749-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: November 2024; Estimated Recovery: December 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 150 mg/30 mL (5 mg/mL 1:200,000) (NDC 0409-1749-29)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: July 2024; Estimated Recovery: December 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 125 mg/50 mL (2.5 mg/mL 1:200,000) (NDC 0409-1752-50)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: August 2024; Estimated Recovery: December 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 250 mg/50 mL (5 mg/mL 1:200,000) (NDC 0409-1755-50)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: July 2024; Estimated Recovery: December 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupropion Hydrochloride Tablet, Extended Release",
    "Company Name": "Endo Pharmaceuticals. Inc.",
    "Contact Info": "800-462-3636",
    "Presentation": "Tablet, Extended Release, 150 mg (NDC 10370-101-03)",
    "Type of Update": "New",
    "Date of Update": "10/02/2023",
    "Availability Information": "",
    "Related Information": "Discontinued due to business reasons",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/02/2023",
    "Initial Posting Date": "10/02/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupropion Hydrochloride Tablet, Extended Release",
    "Company Name": "Endo Pharmaceuticals. Inc.",
    "Contact Info": "800-462-3636",
    "Presentation": "Tablet, Extended Release, 150 mg (NDC 10370-101-50)",
    "Type of Update": "New",
    "Date of Update": "10/02/2023",
    "Availability Information": "",
    "Related Information": "Discontinued due to business reasons",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/02/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupropion Hydrochloride Tablet, Extended Release",
    "Company Name": "Endo Pharmaceuticals. Inc.",
    "Contact Info": "800-462-3636",
    "Presentation": "Tablet, Extended Release, 300 mg (NDC 10370-102-03)",
    "Type of Update": "New",
    "Date of Update": "12/28/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "12/28/2023",
    "Initial Posting Date": "12/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Bupropion Hydrochloride Tablet, Extended Release",
    "Company Name": "Endo Pharmaceuticals. Inc.",
    "Contact Info": "800-462-3636",
    "Presentation": "Tablet, Extended Release, 300 mg (NDC 10370-102-50)",
    "Type of Update": "New",
    "Date of Update": "12/28/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "12/28/2023",
    "Initial Posting Date": "12/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Peritoneal Dialysis Solution",
    "Company Name": "Fresenius Medical Care North America",
    "Contact Info": "800-323-5188",
    "Presentation": "Delflex, Peritoneal Dialysis Solution, 18.4 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 49230-206-20)",
    "Type of Update": "New",
    "Date of Update": "03/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Renal",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/21/2024",
    "Initial Posting Date": "03/21/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Peritoneal Dialysis Solution",
    "Company Name": "Fresenius Medical Care North America",
    "Contact Info": "800-323-5188",
    "Presentation": "Delflex, Peritoneal Dialysis Solution, 18.4 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 49230-209-23)",
    "Type of Update": "New",
    "Date of Update": "03/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Renal",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/21/2024",
    "Initial Posting Date": "03/21/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Peritoneal Dialysis Solution",
    "Company Name": "Fresenius Medical Care North America",
    "Contact Info": "800-323-5188",
    "Presentation": "Delflex, Peritoneal Dialysis Solution, 18.4 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 49230-212-23)",
    "Type of Update": "New",
    "Date of Update": "03/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Renal",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/21/2024",
    "Initial Posting Date": "03/21/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Solution",
    "Company Name": "Fresenius Medical Care North America",
    "Contact Info": "800-323-5188 (7:00 am  6:00 pm CST)",
    "Presentation": "Delflex, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 15.2 mg/100 mL; 567 mg/100 mL; 392 mg/100 mL (NDC 49230-188-50)",
    "Type of Update": "New",
    "Date of Update": "06/04/2024",
    "Availability Information": "",
    "Related Information": "As part of Fresenius Medical Care North Americas (FMCNA) overall strategy to replace DELFLEX PVC with Biofine, we are temporarily discontinuing the DELFLEX 5L product in a PVC Container.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Renal",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "06/04/2024",
    "Initial Posting Date": "06/04/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Solution",
    "Company Name": "Fresenius Medical Care North America",
    "Contact Info": "800-323-5188 (7:00 am  6:00 pm CST)",
    "Presentation": "Delflex, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 15.2 mg/100 mL; 567 mg/100 mL; 392 mg/100 mL (NDC 49230-191-50)",
    "Type of Update": "New",
    "Date of Update": "06/04/2024",
    "Availability Information": "",
    "Related Information": "As part of Fresenius Medical Care North Americas (FMCNA) overall strategy to replace DELFLEX PVC with Biofine, we are temporarily discontinuing the DELFLEX 5L product in a PVC Container.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Renal",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "06/04/2024",
    "Initial Posting Date": "06/04/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Solution",
    "Company Name": "Fresenius Medical Care North America",
    "Contact Info": "800-323-5188 (7:00 am  6:00 pm CST)",
    "Presentation": "Delflex, Solution, 18.4 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 49230-206-50)",
    "Type of Update": "New",
    "Date of Update": "06/04/2024",
    "Availability Information": "",
    "Related Information": "As part of Fresenius Medical Care North Americas (FMCNA) overall strategy to replace DELFLEX PVC with Biofine, we are temporarily discontinuing the DELFLEX 5L product in a PVC Container.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Renal",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "06/04/2024",
    "Initial Posting Date": "06/04/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Solution",
    "Company Name": "Fresenius Medical Care North America",
    "Contact Info": "800-323-5188 (7:00 am  6:00 pm CST)",
    "Presentation": "Delflex, Solution, 18.4 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 49230-209-50)",
    "Type of Update": "New",
    "Date of Update": "06/04/2024",
    "Availability Information": "",
    "Related Information": "As part of Fresenius Medical Care North Americas (FMCNA) overall strategy to replace DELFLEX PVC with Biofine, we are temporarily discontinuing the DELFLEX 5L product in a PVC Container.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Renal",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "06/04/2024",
    "Initial Posting Date": "06/04/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Solution",
    "Company Name": "Fresenius Medical Care North America",
    "Contact Info": "800-323-5188 (7:00 am  6:00 pm CST)",
    "Presentation": "Delflex, Solution, 18.4 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 49230-212-50)",
    "Type of Update": "New",
    "Date of Update": "06/04/2024",
    "Availability Information": "",
    "Related Information": "As part of Fresenius Medical Care North Americas (FMCNA) overall strategy to replace DELFLEX PVC with Biofine, we are temporarily discontinuing the DELFLEX 5L product in a PVC Container.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Renal",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "06/04/2024",
    "Initial Posting Date": "06/04/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Capecitabine Tablet",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Tablet, 150 mg (NDC 59651-204-60)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/09/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Capecitabine Tablet",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Tablet, 500 mg (NDC 59651-205-08)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/09/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Capecitabine Tablet",
    "Company Name": "Dr. Reddy's Laboratories, Inc.",
    "Contact Info": "866-732-3952",
    "Presentation": "Tablet, 150 mg (NDC 55111-496-60)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/09/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Capecitabine Tablet",
    "Company Name": "Dr. Reddy's Laboratories, Inc.",
    "Contact Info": "866-732-3952",
    "Presentation": "Tablet, 500 mg (NDC 55111-497-04)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/09/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Capecitabine Tablet",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Tablet, 500 mg (NDC 16729-073-29)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/09/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Capecitabine Tablet",
    "Company Name": "Genentech, Inc",
    "Contact Info": "800-551-2231",
    "Presentation": "Xeloda, Tablet, 150 mg (NDC 0004-1100-20)",
    "Type of Update": "Revised",
    "Date of Update": "01/23/2024",
    "Availability Information": "",
    "Related Information": "Product was discontinued in March 2023.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "To Be Discontinued",
    "Change Date": "01/23/2024",
    "Date Discontinued": "01/23/2024",
    "Initial Posting Date": "02/09/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Capecitabine Tablet",
    "Company Name": "Genentech, Inc",
    "Contact Info": "800-551-2231",
    "Presentation": "Xeloda, Tablet, 500 mg (NDC 0004-1101-50)",
    "Type of Update": "Revised",
    "Date of Update": "01/23/2024",
    "Availability Information": "",
    "Related Information": "Product was discontinued in March 2023.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "To Be Discontinued",
    "Change Date": "01/23/2024",
    "Date Discontinued": "01/23/2024",
    "Initial Posting Date": "02/09/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Capecitabine Tablet",
    "Company Name": "Novadoz Pharmaceuticals LLC",
    "Contact Info": "848-200-1906",
    "Presentation": "Capecitabine, Tablet, 500 mg (NDC 72205-007-92)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Manufactured by MSN Laboratories Private Limited (Formulation Division)",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/09/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Capecitabine Tablet",
    "Company Name": "Novadoz Pharmaceuticals LLC",
    "Contact Info": "848-200-1906",
    "Presentation": "Capecitabine, Tablet, 150 mg (NDC 72205-006-60)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Manufactured by MSN Laboratories Private Limited (Formulation Division)",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/09/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Capecitabine Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Capecitabine Tablets USP, Tablet, 150 mg (NDC 0093-7473-06)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/09/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Capecitabine Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Capecitabine Tablets USP, Tablet, 500 mg (NDC 0093-7474-89)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/09/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carbamazepine Capsule, Extended Release",
    "Company Name": "Takeda Pharmaceuticals USA Inc.",
    "Contact Info": "866-861-1750",
    "Presentation": "Capsule, Extended Release, 100 mg (NDC 66993-407-32)",
    "Type of Update": "New",
    "Date of Update": "02/06/2024",
    "Availability Information": "",
    "Related Information": "The brand Carbatrol will continue to be available.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "02/06/2024",
    "Initial Posting Date": "02/06/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carbamazepine Capsule, Extended Release",
    "Company Name": "Takeda Pharmaceuticals USA Inc.",
    "Contact Info": "866-861-1750",
    "Presentation": "Capsule, Extended Release, 200 mg (NDC 66993-408-32)",
    "Type of Update": "New",
    "Date of Update": "02/06/2024",
    "Availability Information": "",
    "Related Information": "The brand Carbatrol will continue to be available.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "02/06/2024",
    "Initial Posting Date": "02/06/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carbamazepine Capsule, Extended Release",
    "Company Name": "Takeda Pharmaceuticals USA Inc.",
    "Contact Info": "866-861-1750",
    "Presentation": "Capsule, Extended Release, 300 mg (NDC 66993-409-32)",
    "Type of Update": "New",
    "Date of Update": "02/06/2024",
    "Availability Information": "",
    "Related Information": "The brand Carbatrol will continue to be available.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "02/06/2024",
    "Initial Posting Date": "02/06/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carbamazepine Tablet, Extended Release",
    "Company Name": "Novartis Pharmaceuticals Corporation",
    "Contact Info": "888-669-6682",
    "Presentation": "Tablet, Extended Release, 100 mg (NDC 0781-8016-01)",
    "Type of Update": "New",
    "Date of Update": "10/23/2023",
    "Availability Information": "",
    "Related Information": "Novartis Pharmaceuticals brand product, Tegretol XR 100 mg (NDC 0078-0510-05), will continue to be manufactured and available.",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/23/2023",
    "Initial Posting Date": "10/23/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carbamazepine Tablet, Extended Release",
    "Company Name": "Novartis Pharmaceuticals Corporation",
    "Contact Info": "888-669-6682",
    "Presentation": "Tablet, Extended Release, 200 mg (NDC 0781-5987-01)",
    "Type of Update": "New",
    "Date of Update": "10/23/2023",
    "Availability Information": "",
    "Related Information": "Novartis Pharmaceuticals brand product, Tegretol XR, 200 mg (NDC 0078-0511-05), will continue to be manufactured and available.",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/23/2023",
    "Initial Posting Date": "10/23/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carbamazepine Tablet, Extended Release",
    "Company Name": "Novartis Pharmaceuticals Corporation",
    "Contact Info": "888-669-6682",
    "Presentation": "Tablet, Extended Release, 400 mg (NDC 0781-5988-01)",
    "Type of Update": "New",
    "Date of Update": "10/23/2023",
    "Availability Information": "",
    "Related Information": "Novartis Pharmaceuticals brand product, Tegretol XR, 400 mg, (NDC 0078-0512-05), will continue to be manufactured and available.",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/23/2023",
    "Initial Posting Date": "10/23/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carbidopa and Levodopa Tablet",
    "Company Name": "Mylan Pharmaceuticals Inc., a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Tablet, 10/100 mg (NDC 0378-0078-01)",
    "Type of Update": "New",
    "Date of Update": "03/26/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/26/2024",
    "Initial Posting Date": "03/26/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carbidopa and Levodopa Tablet",
    "Company Name": "Mylan Pharmaceuticals Inc., a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Tablet, 25/100 mg (NDC 0378-0085-01)",
    "Type of Update": "New",
    "Date of Update": "03/26/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/26/2024",
    "Initial Posting Date": "03/26/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carbidopa and Levodopa Tablet",
    "Company Name": "Mylan Pharmaceuticals Inc., a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Tablet, 25/250 mg (NDC 0378-1133-01)",
    "Type of Update": "New",
    "Date of Update": "03/26/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/26/2024",
    "Initial Posting Date": "03/26/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Injection, 10 mg/1 mL (NDC 16729-295-33)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Resupply TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Requirements related to complying with good manufacturing practices",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Injection, 10 mg/1 mL (NDC 16729-295-31)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Teyro Labs",
    "Contact Info": "Apotex Inc.: 800-706-5575",
    "Presentation": "Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-7)",
    "Type of Update": "Revised",
    "Date of Update": "08/06/2024",
    "Availability Information": "Available",
    "Related Information": "Wholesaler & Distributor through Marketing partner (Apotex Inc.)",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Ingenus Pharmaceuticals LLC",
    "Contact Info": "866-321-5031",
    "Presentation": "Injection, 600 mg/60 mL (NDC 50742-448-60)",
    "Type of Update": "Reverified",
    "Date of Update": "06/24/2024",
    "Availability Information": "Available",
    "Related Information": "For any other information, please contact the Ingenus Customer Service team at 866-321-5031.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "Distributed by BPI Labs, LLC;  Customer service number:  (727) 471-0850 Ext 270",
    "Presentation": "Carboplatin, Injection, 50mg/5mL (NDC 54288-164-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Distributed by BPI Labs, LLC",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270",
    "Presentation": "Carboplatin, Injection, 150mg/15mL (NDC 54288-165-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Distributed by BPI Labs, LLC",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/18/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270",
    "Presentation": "Carboplatin, Injection, 450mg/45mL (NDC 54288-166-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Distributed by BPI Labs, LLC",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270",
    "Presentation": "Carboplatin, Injection, 600 mg/65 mL (NDC 54288-167-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Distributed by BPI Labs, LLC",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Teyro Labs",
    "Contact Info": "Apotex Inc.: 800-706-5575",
    "Presentation": "Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-1)",
    "Type of Update": "Revised",
    "Date of Update": "08/06/2024",
    "Availability Information": "Available",
    "Related Information": "Wholesaler & Distributor through Marketing partner (Apotex Inc.)",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Teyro Labs",
    "Contact Info": "Apotex Inc.: 800-706-5575",
    "Presentation": "Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3)",
    "Type of Update": "Revised",
    "Date of Update": "08/06/2024",
    "Availability Information": "Available",
    "Related Information": "Wholesaler & Distributor through Marketing partner (Apotex Inc.)",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Teyro Labs",
    "Contact Info": "Apotex Inc.: 800-706-5575",
    "Presentation": "Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-6)",
    "Type of Update": "Revised",
    "Date of Update": "08/06/2024",
    "Availability Information": "Available",
    "Related Information": "Wholesaler & Distributor through Marketing partner (Apotex Inc.)",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Ingenus Pharmaceuticals LLC",
    "Contact Info": "866-321-5031",
    "Presentation": "Injection, 450 mg/45 mL (NDC 50742-447-45)",
    "Type of Update": "Reverified",
    "Date of Update": "06/24/2024",
    "Availability Information": "Available",
    "Related Information": "For any other information, please contact the Ingenus Customer Service team at 866-321-5031.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Carboplatin, Injection, 450 mg/45 mL (NDC 55150-335-01)",
    "Type of Update": "Reverified",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Carboplatin, Injection, 600 mg/60 mL (NDC 55150-386-01)",
    "Type of Update": "Reverified",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Injection, 10 mg/1 mL (NDC 16729-295-34)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Injection, 10 mg/1 mL (NDC 16729-295-12)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 10 mg/1 mL (NDC 63323-172-60)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Injection, 10 mg/1 mL (NDC 0703-4239-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 50 mg/5 mL (10 mg/mL)  (NDC 61703-339-18)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-360-18)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: July 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 150 mg/15 mL (10 mg/mL)  (NDC 61703-339-22)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-150-05)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-339-50)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 450 mg/45 mL (10 mg/mL)  (NDC 61703-262-05)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: October 2024; Estimated Recovery: December 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 600 mg/60 mL (10 mg/mL)  (NDC 61703-339-56)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 600 mg/60 mL (10 mg/mL)  (NDC 61703-600-05)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery and Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Injection, 10 mg/1 mL (NDC 0703-4244-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Injection, 10 mg/1 mL (NDC 0703-4246-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Carboplatin Injection",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Injection, 10 mg/1 mL (NDC 0703-4248-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Caspofungin Acetate Injection",
    "Company Name": "Merck Sharp & Dohme Corp.",
    "Contact Info": "800-672-6372",
    "Presentation": "Cancidas, Injection, 7 mg/1 mL (NDC 0006-3823-10)",
    "Type of Update": "New",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "06/27/2024",
    "Initial Posting Date": "06/27/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cefixime Capsule",
    "Company Name": "Ascend Laboratories, LLC",
    "Contact Info": "201-326-9004",
    "Presentation": "Capsule, 400 mg (NDC 67877-584-50)",
    "Type of Update": "Revised",
    "Date of Update": "03/19/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Resolved",
    "Change Date": "03/19/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "01/21/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cefixime Capsule",
    "Company Name": "Lupin Pharmaceuticals, Inc.",
    "Contact Info": "866-587-4617",
    "Presentation": "Suprax, Capsule, 400 mg (NDC 68180-423-08)",
    "Type of Update": "Revised",
    "Date of Update": "03/19/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Resolved",
    "Change Date": "03/19/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "01/21/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cefixime Capsule",
    "Company Name": "Lupin Pharmaceuticals, Inc.",
    "Contact Info": "866-587-4617",
    "Presentation": "Suprax, Capsule, 400 mg (NDC 68180-423-11)",
    "Type of Update": "Revised",
    "Date of Update": "03/19/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Resolved",
    "Change Date": "03/19/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "01/21/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cefotaxime Sodium Injection",
    "Company Name": "SteriMax, Inc.",
    "Contact Info": "800-881-3550",
    "Presentation": "Cefotaxime, Injection, 2 g (NDC 21586-012-02)",
    "Type of Update": "Revised",
    "Date of Update": "03/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/17/2015",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/152896/download",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cefotaxime Sodium Injection",
    "Company Name": "SteriMax, Inc.",
    "Contact Info": "800-881-3550",
    "Presentation": "Injection, 1 g (NDC 21586-011-02)",
    "Type of Update": "Reverified",
    "Date of Update": "03/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/17/2015",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/152896/download",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cefotaxime Sodium Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Cefotaxime for Injection, USP, Injection, 500 mg (NDC 0143-9930-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Shortage duration is unknown at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/17/2015",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cefotaxime Sodium Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Cefotaxime for Injection, USP, Injection, 1 g (NDC 0143-9931-25)",
    "Type of Update": "Revised",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Shortage duration is unknown at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/17/2015",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cefotaxime Sodium Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Cefotaxime for Injection, USP, Injection, 2 g (NDC 0143-9933-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Shortage duration is unknown at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/17/2015",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cefotaxime Sodium Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Cefotaxime for Injection, USP, Injection, 10 g (NDC 0143-9935-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Shortage duration is unknown at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anti-Infective; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/17/2015",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cefotetan Disodium Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 1 g/10 mL (NDC 63323-385-10)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "08/14/2014",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cefotetan Disodium Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 2 g/20 mL (NDC 63323-386-20)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "08/14/2014",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cefotetan Disodium Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 10 g (NDC 63323-396-61)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "No release date available at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "08/14/2014",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cefotetan Disodium Injection",
    "Company Name": "Teligent Pharma, Inc.",
    "Contact Info": "856-697-1441",
    "Presentation": "Cefotan, Injection, 2 g/20 mL (NDC 52565-053-10)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Discontinued",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/17/2015",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Cefotetan+Disodium+Injection&st=d&tab=tabs-2",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cefotetan Disodium Injection",
    "Company Name": "PAI Pharma",
    "Contact Info": "800-845-8210",
    "Presentation": "Cefotan, Injection, 2 g/20 mL (NDC 0121-0977-10)",
    "Type of Update": "New",
    "Date of Update": "05/14/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "08/14/2014",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cefotetan Disodium Injection",
    "Company Name": "PAI Pharma",
    "Contact Info": "800-845-8210",
    "Presentation": "Cefotan, Injection, 1 g/10 mL (NDC 0121-0976-10)",
    "Type of Update": "New",
    "Date of Update": "05/14/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "08/14/2014",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Chloramphenicol Sodium Succinate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 1 g/10 mL (NDC 63323-011-15)",
    "Type of Update": "Revised",
    "Date of Update": "12/11/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Anti-Infective",
    "Status": "To Be Discontinued",
    "Change Date": "12/11/2023",
    "Date Discontinued": "12/11/2023",
    "Initial Posting Date": "04/05/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Chloroprocaine Hydrochloride Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Clorotekal, Injection, 10 mg/mL (NDC 0264-7055-05)",
    "Type of Update": "Revised",
    "Date of Update": "11/02/2023",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "To Be Discontinued",
    "Change Date": "11/02/2023",
    "Date Discontinued": "11/02/2023",
    "Initial Posting Date": "05/17/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Chloroprocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Nesacaine, Injection, 10 mg/1 mL (NDC 63323-475-37)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/17/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Chloroprocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Nesacaine, Injection, 20 mg/1 mL (NDC 63323-476-37)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/17/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Chloroprocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Nesacaine, Injection, 20 mg/1 mL (NDC 63323-477-27)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/17/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Chloroprocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Nesacaine, Injection, 30 mg/1 mL (NDC 63323-478-27)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/17/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Chloroprocaine Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Chloroprocaine HCl Injection, USP, Injection, 20 mg/1 mL (NDC 0143-9209-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Additional lots will be available in the September - October 2024 timeframe.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/17/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Chloroprocaine Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Chloroprocaine HCl Injection, USP, Injection, 30 mg/1 mL (NDC 0143-9210-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Additional lots will be available in the September - October 2024 timeframe.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/17/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cinacalcet Hydrochloride Tablet",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2976",
    "Presentation": "Tablet, 30 mg (NDC 65862-831-05)",
    "Type of Update": "New",
    "Date of Update": "04/29/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/29/2024",
    "Initial Posting Date": "04/29/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cinacalcet Hydrochloride Tablet",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2976",
    "Presentation": "Tablet, 30 mg (NDC 65862-831-30)",
    "Type of Update": "New",
    "Date of Update": "04/29/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/29/2024",
    "Initial Posting Date": "04/29/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cinacalcet Hydrochloride Tablet",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2976",
    "Presentation": "Tablet, 60 mg (NDC 65862-832-05)",
    "Type of Update": "New",
    "Date of Update": "04/29/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/29/2024",
    "Initial Posting Date": "04/29/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cinacalcet Hydrochloride Tablet",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2976",
    "Presentation": "Tablet, 60 mg (NDC 65862-832-30)",
    "Type of Update": "New",
    "Date of Update": "04/29/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/29/2024",
    "Initial Posting Date": "04/29/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cinacalcet Hydrochloride Tablet",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2976",
    "Presentation": "Tablet, 90 mg (NDC 65862-833-05)",
    "Type of Update": "New",
    "Date of Update": "04/29/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/29/2024",
    "Initial Posting Date": "04/29/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cinacalcet Hydrochloride Tablet",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2976",
    "Presentation": "Tablet, 90 mg (NDC 65862-833-30)",
    "Type of Update": "New",
    "Date of Update": "04/29/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/29/2024",
    "Initial Posting Date": "04/29/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cisatracurium Besylate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 10 mg/1 mL (NDC 0409-3670-10)",
    "Type of Update": "New",
    "Date of Update": "04/15/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/15/2024",
    "Initial Posting Date": "04/15/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cisatracurium Besylate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 10 mg/5ml (2 mg/mL) Single Dose Vial PREMIERProRx (NDC 0409-5547-10)",
    "Type of Update": "New",
    "Date of Update": "04/15/2024",
    "Availability Information": "",
    "Related Information": "Supply expected to exhaust July 2024",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/15/2024",
    "Initial Posting Date": "04/15/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cisatracurium Besylate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 2 mg/1 mL (NDC 0409-7083-10)",
    "Type of Update": "New",
    "Date of Update": "04/15/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/15/2024",
    "Initial Posting Date": "04/15/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cisatracurium Besylate Injection",
    "Company Name": "AbbVie Inc.",
    "Contact Info": "800-633-9110",
    "Presentation": "Nimbex, Injection, 2 mg/1 mL (NDC 0074-4378-05)",
    "Type of Update": "New",
    "Date of Update": "09/11/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "To Be Discontinued",
    "Change Date": "09/11/2023",
    "Date Discontinued": "09/11/2023",
    "Initial Posting Date": "09/11/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cisatracurium Besylate Injection",
    "Company Name": "AbbVie Inc.",
    "Contact Info": "800-633-9110",
    "Presentation": "Nimbex, Injection, 2 mg/1 mL (NDC 0074-4380-10)",
    "Type of Update": "New",
    "Date of Update": "09/11/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "To Be Discontinued",
    "Change Date": "09/11/2023",
    "Date Discontinued": "09/11/2023",
    "Initial Posting Date": "09/11/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cisatracurium Besylate Injection",
    "Company Name": "AbbVie Inc.",
    "Contact Info": "800-633-9110",
    "Presentation": "Nimbex, Injection, 10 mg/1 mL (NDC 0074-4382-20)",
    "Type of Update": "New",
    "Date of Update": "09/11/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "To Be Discontinued",
    "Change Date": "09/11/2023",
    "Date Discontinued": "09/11/2023",
    "Initial Posting Date": "09/11/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cisplatin Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "Sagent Pharmaceuticals: 866-625-1618; Fosun Pharma USA Inc.: 855-282-4882",
    "Presentation": "Injection, 50 mL vial, 1 mg/mL (NDC 25021-253-50)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available.  NDC 25021-253-50 and NDC 25021-253-51 marketed by Sagent Pharmaceuticals.  NDC 72266-252-01 and NDC 72266-253-01) marketed by Fosun Pharma USA Inc.",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cisplatin Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "Sagent Pharmaceuticals: 866-625-1618; Fosun Pharma USA Inc.: 855-282-4882",
    "Presentation": "Injection, 100 mL vial, 1 mg/mL (NDC 25021-253-51)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available.  NDC 25021-253-50 and NDC 25021-253-51 marketed by Sagent Pharmaceuticals.  NDC 72266-252-01 and NDC 72266-253-01) marketed by Fosun Pharma USA Inc.",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cisplatin Injection",
    "Company Name": "Qilu Pharmaceutical Co., Ltd.",
    "Contact Info": "Apotex Corp.: 800-706-5575",
    "Presentation": "Injection, 50 mL vial, 1 mg/mL (NDC 60505-6279-0)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Estimated availability August 2024. Marketed by Apotex Corp.",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Resolved",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cisplatin Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "Sagent Pharmaceuticals: 866-625-1618; Fosun Pharma USA Inc.: 855-282-4882",
    "Presentation": "Injection, 50 mL vial, 1 mg/mL (NDC 72266-252-01)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available. NDC 25021-253-50 and NDC 25021-253-51 marketed by Sagent Pharmaceuticals. NDC 72266-252-01 and NDC 72266-253-01) marketed by Fosun Pharma USA Inc.",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Resolved",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cisplatin Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "Sagent Pharmaceuticals: 866-625-1618; Fosun Pharma USA Inc.: 855-282-4882",
    "Presentation": "Injection, 100 mL vial, 1 mg/mL (NDC 72266-253-01)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available. NDC 25021-253-50 and NDC 25021-253-51 marketed by Sagent Pharmaceuticals. NDC 72266-252-01 and NDC 72266-253-01) marketed by Fosun Pharma USA Inc.",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Resolved",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cisplatin Injection",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Injection, 50 mL vial, 1 mg/mL (NDC 16729-288-11)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cisplatin Injection",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Injection, 100 mL vial, 1 mg/mL (NDC 16729-288-38)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cisplatin Injection",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Injection, 50 mL vial, 1 mg/mL (NDC 68001-283-27)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "Marketed by BluePoint Laboratories",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "To Be Discontinued",
    "Change Date": "06/27/2024",
    "Date Discontinued": "06/27/2024",
    "Initial Posting Date": "02/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cisplatin Injection",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Injection, 100 mL vial, 1 mg/mL (NDC 68001-283-32)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "Marketed by BluePoint Laboratories",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "To Be Discontinued",
    "Change Date": "06/27/2024",
    "Date Discontinued": "06/27/2024",
    "Initial Posting Date": "02/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cisplatin Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 50 mL vial, 1 mg/mL (NDC 63323-103-51)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cisplatin Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 100 mL vial, 1 mg/mL (NDC 63323-103-65)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cisplatin Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 200 mL vial, 1 mg/mL (NDC 63323-103-64)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cisplatin Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Injection, 50 mL vial, 1 mg/mL (NDC 0143-9504-01)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cisplatin Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Injection, 100 mL vial, 1 mg/mL (NDC 0143-9505-01)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cisplatin Injection",
    "Company Name": "HQ Specialty Pharma",
    "Contact Info": "WG Critical Care 888-493-0861",
    "Presentation": "Injection, 200 mL vial, 1 mg/mL (NDC 44567-511-01)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available. Marketed by WG Critical Care.",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cisplatin Injection",
    "Company Name": "HQ Specialty Pharma",
    "Contact Info": "WG Critical Care 888-493-0861",
    "Presentation": "Injection, 50 mg (NDC 44567-530-01)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available. Marketed by WG Critical Care.",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cisplatin Injection",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Injection, 50 mL vial, 1 mg/mL (NDC 0703-5747-11)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cisplatin Injection",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Injection, 100 mL vial, 1 mg/mL (NDC 0703-5748-11)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clindamycin Phosphate Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Cleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) (NDC 0009-0870-26)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clindamycin Phosphate Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Cleocin Phosphate, Injection, Cleocin Phosphate 600 mg/4 mL (150 mg/mL) (NDC 0009-0775-26)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Next Delivery: August 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clindamycin Phosphate Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Cleocin Phosphate, Injection, Cleocin Phosphate 9 g/60 mL (150 mg/mL) (NDC 0009-0728-09)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clindamycin Phosphate Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Cleocin Phosphate, Injection, Cleocin Phosphate 900 mg/6 mL (150 mg/mL) (NDC 0009-0902-18)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clindamycin Phosphate Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 150 mg/1 mL (NDC 25021-115-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Backorder. Estimated availability TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clindamycin Phosphate Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 150 mg/1 mL (NDC 25021-115-04)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Backorder. Estimated availability TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clindamycin Phosphate Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 150 mg/1 mL (NDC 25021-115-06)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Backorder. Estimated availability TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clindamycin Phosphate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9545-50)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clindamycin Phosphate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9549-50)",
    "Type of Update": "Revised",
    "Date of Update": "05/13/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clindamycin Phosphate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-9553-50)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clindamycin Phosphate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-3410-50)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clindamycin Phosphate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Clindamycin Phosphate, Injection, 600 mg/50 mL (NDC 0338-3612-50)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clindamycin Phosphate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-3814-50)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clindamycin Phosphate Injection",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL (NDC 0781-3288-09)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clindamycin Phosphate Injection",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 0781-3289-09)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clindamycin Phosphate Injection",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 0781-3290-09)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clindamycin Phosphate Injection",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 72572-074-24)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "Civica Label",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clindamycin Phosphate Injection",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 72572-076-24)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "Civica Label",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clindamycin Phosphate Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL) (NDC 0009-3051-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: August 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clindamycin Phosphate Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL) (NDC 0009-5095-06)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clindamycin Phosphate Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL) (NDC 0009-4073-04)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: July 2024; Estimated Recovery: September 2024; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clobetasol Propionate Cream",
    "Company Name": "Fougera (a Sandoz company)",
    "Contact Info": "800-525-8747",
    "Presentation": "Cream, .5 mg/1 g (NDC 0168-0163-15)",
    "Type of Update": "New",
    "Date of Update": "04/03/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/03/2024",
    "Initial Posting Date": "04/03/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clobetasol Propionate Cream",
    "Company Name": "Fougera (a Sandoz company)",
    "Contact Info": "800-525-8747",
    "Presentation": "Cream, .5 mg/1 g (NDC 0168-0163-30)",
    "Type of Update": "New",
    "Date of Update": "04/03/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/03/2024",
    "Initial Posting Date": "04/03/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clobetasol Propionate Cream",
    "Company Name": "Fougera (a Sandoz company)",
    "Contact Info": "800-525-8747",
    "Presentation": "Cream, .5 mg/1 g (NDC 0168-0163-46)",
    "Type of Update": "New",
    "Date of Update": "04/03/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/03/2024",
    "Initial Posting Date": "04/03/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clobetasol Propionate Cream",
    "Company Name": "Fougera (a Sandoz company)",
    "Contact Info": "800-525-8747",
    "Presentation": "Cream, .5 mg/1 g (NDC 0168-0163-60)",
    "Type of Update": "New",
    "Date of Update": "04/03/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/03/2024",
    "Initial Posting Date": "04/03/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clobetasol Propionate Cream",
    "Company Name": "Fougera (a Sandoz company)",
    "Contact Info": "800-525-8747",
    "Presentation": "Cream, .5 mg/1 g (NDC 0168-0293-15)",
    "Type of Update": "New",
    "Date of Update": "04/03/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/03/2024",
    "Initial Posting Date": "04/03/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clobetasol Propionate Cream",
    "Company Name": "Fougera (a Sandoz company)",
    "Contact Info": "800-525-8747",
    "Presentation": "Cream, .5 mg/1 g (NDC 0168-0293-30)",
    "Type of Update": "New",
    "Date of Update": "04/03/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/03/2024",
    "Initial Posting Date": "04/03/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clobetasol Propionate Cream",
    "Company Name": "Fougera (a Sandoz company)",
    "Contact Info": "800-525-8747",
    "Presentation": "Cream, .5 mg/1 g (NDC 0168-0293-60)",
    "Type of Update": "New",
    "Date of Update": "04/03/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/03/2024",
    "Initial Posting Date": "04/03/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clobetasol Propionate Cream",
    "Company Name": "Fougera (a Sandoz company)",
    "Contact Info": "800-525-8747",
    "Presentation": "Clobetasol Propionate (Emollient), Cream, .5 mg/1 g (NDC 0168-0301-30)",
    "Type of Update": "New",
    "Date of Update": "04/03/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/03/2024",
    "Initial Posting Date": "04/03/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clobetasol Propionate Cream",
    "Company Name": "Fougera (a Sandoz company)",
    "Contact Info": "800-525-8747",
    "Presentation": "Clobetasol Propionate (Emollient), Cream, .5 mg/1 g (NDC 0168-0301-60)",
    "Type of Update": "New",
    "Date of Update": "04/03/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/03/2024",
    "Initial Posting Date": "04/03/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clocortolone Pivalate Cream",
    "Company Name": "EPI Health",
    "Contact Info": "843-965-8333",
    "Presentation": "Cream, 1 mg/g (NDC 71403-804-93)",
    "Type of Update": "New",
    "Date of Update": "10/18/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Dermatology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/18/2023",
    "Initial Posting Date": "10/18/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clocortolone Pivalate Cream",
    "Company Name": "EPI Health",
    "Contact Info": "843-965-8333",
    "Presentation": "Cream, 1 mg/g (NDC 71403-804-75)",
    "Type of Update": "New",
    "Date of Update": "10/18/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Dermatology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/18/2023",
    "Initial Posting Date": "10/18/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clocortolone Pivalate Cream",
    "Company Name": "EPI Health",
    "Contact Info": "843-965-8333",
    "Presentation": "Cream, 1 mg/g (NDC 71403-804-45)",
    "Type of Update": "New",
    "Date of Update": "10/18/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Dermatology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/18/2023",
    "Initial Posting Date": "10/18/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clofarabine Injection",
    "Company Name": "Apotex Corp.",
    "Contact Info": "800-706-5575",
    "Presentation": "Injection, 20 mg/20 ml (1mg/ml) (NDC 60505-6166-0)",
    "Type of Update": "New",
    "Date of Update": "10/26/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Oncology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/26/2023",
    "Initial Posting Date": "10/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clomipramine Hydrochloride Capsule",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Capsule, 50 mg (NDC 69238-1109-9)",
    "Type of Update": "New",
    "Date of Update": "04/30/2024",
    "Availability Information": "",
    "Related Information": "Business-related decision to discontinue the product.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/30/2024",
    "Initial Posting Date": "04/30/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Rubicon Research Private Limited",
    "Contact Info": "sales@advagenpharma.com",
    "Presentation": "Clonazepam, Tablet, .5 mg (NDC 72888-152-30)",
    "Type of Update": "Reverified",
    "Date of Update": "06/18/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Advagen Pharma Ltd.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Rubicon Research Private Limited",
    "Contact Info": "sales@advagenpharma.com",
    "Presentation": "Clonazepam, Tablet, .5 mg (NDC 72888-152-01)",
    "Type of Update": "Reverified",
    "Date of Update": "06/18/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Advagen Pharma Ltd.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Rubicon Research Private Limited",
    "Contact Info": "sales@advagenpharma.com",
    "Presentation": "Clonazepam, Tablet, .5 mg (NDC 72888-152-05)",
    "Type of Update": "Reverified",
    "Date of Update": "06/18/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Advagen Pharma Ltd.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Rubicon Research Private Limited",
    "Contact Info": "sales@advagenpharma.com",
    "Presentation": "Clonazepam, Tablet, 1 mg (NDC 72888-153-30)",
    "Type of Update": "Reverified",
    "Date of Update": "06/18/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Advagen Pharma Ltd.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Rubicon Research Private Limited",
    "Contact Info": "sales@advagenpharma.com",
    "Presentation": "Clonazepam, Tablet, 1 mg (NDC 72888-153-01)",
    "Type of Update": "Reverified",
    "Date of Update": "06/18/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Advagen Pharma Ltd.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/27/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Rubicon Research Private Limited",
    "Contact Info": "sales@advagenpharma.com",
    "Presentation": "Clonazepam, Tablet, 1 mg (NDC 72888-153-05)",
    "Type of Update": "Reverified",
    "Date of Update": "06/18/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Advagen Pharma Ltd.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Rubicon Research Private Limited",
    "Contact Info": "sales@advagenpharma.com",
    "Presentation": "Clonazepam, Tablet, 2 mg (NDC 72888-154-30)",
    "Type of Update": "Reverified",
    "Date of Update": "06/18/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Advagen Pharma Ltd.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Rubicon Research Private Limited",
    "Contact Info": "sales@advagenpharma.com",
    "Presentation": "Clonazepam, Tablet, 2 mg (NDC 72888-154-01)",
    "Type of Update": "Reverified",
    "Date of Update": "06/18/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Advagen Pharma Ltd.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Rubicon Research Private Limited",
    "Contact Info": "sales@advagenpharma.com",
    "Presentation": "Clonazepam, Tablet, 2 mg (NDC 72888-154-05)",
    "Type of Update": "Reverified",
    "Date of Update": "06/18/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Advagen Pharma Ltd.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Tablet, .5 mg (NDC 16729-136-00)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Requirements related to complying with good manufacturing practices",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Tablet, .5 mg (NDC 16729-136-16)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Tablet, 1 mg (NDC 16729-137-00)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Tablet, 1 mg (NDC 16729-137-16)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Tablet, 2 mg (NDC 16729-138-00)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Requirements related to complying with good manufacturing practices",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Tablet, 2 mg (NDC 16729-138-16)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Requirements related to complying with good manufacturing practices",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Cheplapharm Arzneimittel GmbH",
    "Contact Info": "orders@h2-pharma.com",
    "Presentation": "Klonopin, Tablet, .5 mg (NDC 61269-605-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by H2-Pharma",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Cheplapharm Arzneimittel GmbH",
    "Contact Info": "orders@h2-pharma.com",
    "Presentation": "Klonopin, Tablet, 1 mg (NDC 61269-610-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by H2-Pharma",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Cheplapharm Arzneimittel GmbH",
    "Contact Info": "orders@h2-pharma.com",
    "Presentation": "Klonopin, Tablet, 2 mg (NDC 61269-620-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by H2-Pharma",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Prinston Pharmaceutical, Inc.",
    "Contact Info": "For orders, Solco Healthcare 866-931-9829",
    "Presentation": "Clonazepam, Tablet, .5 mg (NDC 43547-406-10)",
    "Type of Update": "Reverified",
    "Date of Update": "06/18/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Solco Healthcare",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Prinston Pharmaceutical, Inc.",
    "Contact Info": "For orders, Solco Healthcare 866-931-9829",
    "Presentation": "Clonazepam, Tablet, .5 mg (NDC 43547-406-11)",
    "Type of Update": "Reverified",
    "Date of Update": "06/18/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Solco Healthcare",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Prinston Pharmaceutical, Inc.",
    "Contact Info": "For orders, Solco Healthcare 866-931-9829",
    "Presentation": "Clonazepam, Tablet, .5 mg (NDC 43547-406-50)",
    "Type of Update": "Reverified",
    "Date of Update": "06/18/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Solco Healthcare",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Prinston Pharmaceutical, Inc.",
    "Contact Info": "For orders, Solco Healthcare 866-931-9829",
    "Presentation": "Clonazepam, Tablet, 1 mg (NDC 43547-407-10)",
    "Type of Update": "Reverified",
    "Date of Update": "06/18/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Solco Healthcare",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Prinston Pharmaceutical, Inc.",
    "Contact Info": "For orders, Solco Healthcare 866-931-9829",
    "Presentation": "Clonazepam, Tablet, 1 mg (NDC 43547-407-11)",
    "Type of Update": "Reverified",
    "Date of Update": "06/18/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Solco Healthcare",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Prinston Pharmaceutical, Inc.",
    "Contact Info": "For orders, Solco Healthcare 866-931-9829",
    "Presentation": "Clonazepam, Tablet, 1 mg (NDC 43547-407-50)",
    "Type of Update": "Reverified",
    "Date of Update": "06/18/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Solco Healthcare",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Prinston Pharmaceutical, Inc.",
    "Contact Info": "For orders, Solco Healthcare 866-931-9829",
    "Presentation": "Clonazepam, Tablet, 2 mg (NDC 43547-408-10)",
    "Type of Update": "Reverified",
    "Date of Update": "06/18/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Solco Healthcare",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Prinston Pharmaceutical, Inc.",
    "Contact Info": "For orders, Solco Healthcare 866-931-9829",
    "Presentation": "Clonazepam, Tablet, 2 mg (NDC 43547-408-50)",
    "Type of Update": "Reverified",
    "Date of Update": "06/18/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Solco Healthcare",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Clonazepam Tablets, USP CIV, Tablet, .5 mg (NDC 0093-0832-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/19/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Estimated recovery October 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Clonazepam Tablets, USP CIV, Tablet, .5 mg (NDC 0093-0832-05)",
    "Type of Update": "Revised",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Estimated recovery November 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Clonazepam Tablets, USP CIV, Tablet, 1 mg (NDC 0093-3212-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Estimated recovery November 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Clonazepam Tablets, USP CIV, Tablet, 1 mg (NDC 0093-3212-05)",
    "Type of Update": "Revised",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Estimated recovery November 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Clonazepam Tablets, USP CIV, Tablet, 2 mg (NDC 0093-3213-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Estimated recovery November 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Clonazepam Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Clonazepam Tablets, USP CIV, Tablet, 2 mg (NDC 0093-3213-05)",
    "Type of Update": "Revised",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Estimated recovery November 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Neurology; Pediatric; Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/10/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Colestipol Hydrochloride Granule",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Granule, 5 g/5 g (NDC 59762-0260-1)",
    "Type of Update": "New",
    "Date of Update": "10/17/2023",
    "Availability Information": "",
    "Related Information": "Supply expected to exhaust early November 2023. Discontinuation of the manufacture of the drug. This product distributed by Viatris.",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/30/2023",
    "Initial Posting Date": "03/30/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Colestipol Hydrochloride Granule",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Colestid, Granule, 5 g/5 g (NDC 0009-0260-04)",
    "Type of Update": "New",
    "Date of Update": "11/09/2023",
    "Availability Information": "",
    "Related Information": "Supply expected to exhaust December 2023",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/30/2023",
    "Initial Posting Date": "03/30/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Collagenase Clostridium Histolyticum Ointment",
    "Company Name": "Smith & Nephew, Inc.",
    "Contact Info": "800-876-1261",
    "Presentation": "Santyl, Ointment, 250 [arb'U]/1 g (NDC 50484-010-30)",
    "Type of Update": "Revised",
    "Date of Update": "04/08/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology",
    "Status": "Resolved",
    "Change Date": "04/08/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/21/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Collagenase Clostridium Histolyticum Ointment",
    "Company Name": "Smith & Nephew, Inc.",
    "Contact Info": "800-876-1261",
    "Presentation": "Santyl, Ointment, 250 [arb'U]/1 g (NDC 50484-010-90)",
    "Type of Update": "Revised",
    "Date of Update": "04/08/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology",
    "Status": "Resolved",
    "Change Date": "04/08/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/21/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Conivaptan Hydrochloride Injection",
    "Company Name": "Cumberland Pharmaceuticals Inc.",
    "Contact Info": "615-255-0068",
    "Presentation": "Vaprisol Dextrose In Plastic Container, Injection, 20 mg/100 mL (NDC 66220-160-10)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cromolyn Sodium Concentrate",
    "Company Name": "Ailex Pharmaceuticals",
    "Contact Info": "Distributed by Ritedose (855) 806 3300 and Woodward (248) 308-1120 extension 2",
    "Presentation": "Concentrate, 100 mg/5 mL (NDC 69784-200-96)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Distributed by Woodward Pharma Services LLC (248) 308-1120 Ext 2",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Pulmonary/Allergy",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/03/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cromolyn Sodium Concentrate",
    "Company Name": "Ailex Pharmaceuticals",
    "Contact Info": "Distributed by Ritedose (855) 806 3300 and Woodward (248) 308-1120 extension 2",
    "Presentation": "Concentrate, 100 mg/5 mL (NDC 76204-025-96)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Distributed by Ritedose Pharmaceuticals, LLC (855) 806 3300",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Pulmonary/Allergy",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/03/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cromolyn Sodium Concentrate",
    "Company Name": "Rising Pharma Holdings, Inc.",
    "Contact Info": "(201) 961-9000 or contact@risingpharma.com",
    "Presentation": "Concentrate, 100 mg/5 mL (NDC 16571-600-96)",
    "Type of Update": "Revised",
    "Date of Update": "07/02/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Shipping limited quantities.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Pulmonary/Allergy",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/03/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cromolyn Sodium Concentrate",
    "Company Name": "Micro Labs LTD",
    "Contact Info": "(908) 484-7410",
    "Presentation": "Concentrate, 100 mg/5 mL (NDC 42571-132-52)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Pulmonary/Allergy",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/03/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cromolyn Sodium Concentrate",
    "Company Name": "Mylan Specialty, a Viatris Company",
    "Contact Info": "(800) 796-9526",
    "Presentation": "Gastrocrom, Concentrate, 20 mg/1 mL (NDC 0037-0678-96)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Pulmonary/Allergy",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/03/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cromolyn Sodium Oral Solution",
    "Company Name": "Mylan Institutional, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Oral Solution, 100mg/5mL (NDC 51525-0470-9)",
    "Type of Update": "New",
    "Date of Update": "11/01/2023",
    "Availability Information": "",
    "Related Information": "Gastrocrom 100mg/5mL Oral Concentrate 96s (NDC: 0037-0678-96) will remain available",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Pulmonary/Allergy",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "11/01/2023",
    "Initial Posting Date": "11/01/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cyanocobalamin Spray",
    "Company Name": "Endo Pharmaceuticals, Inc.",
    "Contact Info": "Par Pharmaceutical, Inc. customer service number: 800-828-9393",
    "Presentation": "Nascobal, Spray, 500 ug (NDC 49884-270-82)",
    "Type of Update": "New",
    "Date of Update": "07/12/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Hematology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "07/12/2024",
    "Initial Posting Date": "07/12/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cyclopentolate Hydrochloride Ophthalmic Solution",
    "Company Name": "Bausch & Lomb Incorporated",
    "Contact Info": "800-553-5340",
    "Presentation": "Pentolair, Ophthalmic Solution, 10 mg/1 mL (NDC 24208-735-06)",
    "Type of Update": "Revised",
    "Date of Update": "07/22/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Ophthalmology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/09/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cyclopentolate Hydrochloride Ophthalmic Solution",
    "Company Name": "Alcon",
    "Contact Info": "800-862-5266",
    "Presentation": "Cyclogyl, Ophthalmic Solution, 5 mg/1 mL (NDC 0065-0395-15)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Ophthalmology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/09/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cyclopentolate Hydrochloride Ophthalmic Solution",
    "Company Name": "Alcon",
    "Contact Info": "800-862-5266",
    "Presentation": "Cyclogyl, Ophthalmic Solution, 10 mg/1 mL (NDC 0065-0396-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/18/2024",
    "Availability Information": "",
    "Related Information": "Estimated availability End of July 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Ophthalmology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/09/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cyclopentolate Hydrochloride Ophthalmic Solution",
    "Company Name": "Alcon",
    "Contact Info": "800-862-5266",
    "Presentation": "Cyclogyl, Ophthalmic Solution, 10 mg/1 mL (NDC 0065-0396-05)",
    "Type of Update": "Revised",
    "Date of Update": "07/18/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Ophthalmology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/09/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cyclopentolate Hydrochloride Ophthalmic Solution",
    "Company Name": "Alcon",
    "Contact Info": "800-862-5266",
    "Presentation": "Cyclogyl, Ophthalmic Solution, 20 mg/1 mL (NDC 0065-0397-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Ophthalmology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/09/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cyclopentolate Hydrochloride Ophthalmic Solution",
    "Company Name": "Alcon",
    "Contact Info": "800-862-5266",
    "Presentation": "Cyclogyl, Ophthalmic Solution, 20 mg/1 mL (NDC 0065-0397-05)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Ophthalmology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/09/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cyclopentolate Hydrochloride Ophthalmic Solution",
    "Company Name": "Alcon",
    "Contact Info": "800-862-5266",
    "Presentation": "Cyclogyl, Ophthalmic Solution, 20 mg/1 mL (NDC 0065-0397-15)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Ophthalmology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/09/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cyclopentolate Hydrochloride Ophthalmic Solution",
    "Company Name": "Alcon",
    "Contact Info": "800-862-5266",
    "Presentation": "Cyclopentolate Hydrochloride Ophthalmic Solution, USP 1%, Ophthalmic Solution, 10 mg/1 mL (NDC 61314-396-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Ophthalmology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/09/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cyclopentolate Hydrochloride Ophthalmic Solution",
    "Company Name": "Alcon",
    "Contact Info": "800-862-5266",
    "Presentation": "Cyclopentolate Hydrochloride Ophthalmic Solution, USP 1%, Ophthalmic Solution, 10 mg/1 mL (NDC 61314-396-03)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Ophthalmology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/09/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cyclopentolate Hydrochloride Ophthalmic Solution",
    "Company Name": "Bausch & Lomb Incorporated",
    "Contact Info": "800-553-5340",
    "Presentation": "Pentolair, Ophthalmic Solution, 10 mg/1 mL (NDC 24208-735-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/22/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Ophthalmology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/09/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cyclopentolate Hydrochloride, Phenylephrine Hydrochloride Ophthalmic Solution",
    "Company Name": "Alcon",
    "Contact Info": "800-862-5266",
    "Presentation": "Cyclomydril, Ophthalmic Solution, 2 mg/1 mL; 10 mg/1 mL (NDC 0065-0359-02)",
    "Type of Update": "Revised",
    "Date of Update": "03/12/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Ophthalmology",
    "Status": "Resolved",
    "Change Date": "03/12/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/09/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cyclopentolate Hydrochloride, Phenylephrine Hydrochloride Ophthalmic Solution",
    "Company Name": "Alcon",
    "Contact Info": "800-862-5266",
    "Presentation": "Cyclomydril, Ophthalmic Solution, 2 mg/1 mL; 10 mg/1 mL (NDC 0065-0359-05)",
    "Type of Update": "Revised",
    "Date of Update": "03/12/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Ophthalmology",
    "Status": "Resolved",
    "Change Date": "03/12/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/09/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cyclosporine Injection",
    "Company Name": "Padagis US LLC",
    "Contact Info": "800-328-5113",
    "Presentation": "Injection, 250 mg/5 mL (50 mg/mL) in 5 mL Ampule (NDC 0574-0866-10)",
    "Type of Update": "New",
    "Date of Update": "09/29/2023",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the product.",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Transplant",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "09/29/2023",
    "Initial Posting Date": "09/29/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cytarabine Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "866-733-3952",
    "Presentation": "Injection, 5 mL vial, 20 mg/mL (NDC 25021-229-05)",
    "Type of Update": "Revised",
    "Date of Update": "07/12/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available. Marketed by Sagent Pharmaceuticals.",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Resolved",
    "Change Date": "07/12/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "09/24/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cytarabine Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "866-733-3952",
    "Presentation": "Injection, 20 mL vial, 100 mg/mL (NDC 25021-223-20)",
    "Type of Update": "Revised",
    "Date of Update": "07/12/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available. Marketed by Sagent Pharmaceuticals.",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Resolved",
    "Change Date": "07/12/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "09/24/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cytarabine Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 20 mL vial, 100 mg/mL (NDC 63323-120-20)",
    "Type of Update": "Revised",
    "Date of Update": "07/12/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Resolved",
    "Change Date": "07/12/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "09/24/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cytarabine Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Cytarabine, Injection, 5 mL vial, 20 mg/mL (NDC 61703-305-38)",
    "Type of Update": "Revised",
    "Date of Update": "07/12/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Resolved",
    "Change Date": "07/12/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "09/24/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cytarabine Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Cytarabine, Injection, 20 mL vial, 100 mg/mL (NDC 61703-319-22)",
    "Type of Update": "Revised",
    "Date of Update": "07/12/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Resolved",
    "Change Date": "07/12/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "09/24/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cytarabine Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Cytarabine, Injection, 25 mL vial, 20 mg/mL (NDC 61703-304-36)",
    "Type of Update": "Revised",
    "Date of Update": "07/12/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Resolved",
    "Change Date": "07/12/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "09/24/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cytarabine Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Cytarabine, Injection, 50 mL vial, 20 mg/mL (NDC 61703-303-46)",
    "Type of Update": "Revised",
    "Date of Update": "07/12/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Resolved",
    "Change Date": "07/12/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "09/24/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Cytarabine Injection",
    "Company Name": "Meitheal Pharmaceuticals, Inc.",
    "Contact Info": "844-824-8426",
    "Presentation": "Injection, 2 g/20 mL (NDC 71288-109-20)",
    "Type of Update": "Revised",
    "Date of Update": "07/12/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Resolved",
    "Change Date": "07/12/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "09/24/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dacarbazine Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 10 mg/1 mL (NDC 63323-127-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/20/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dacarbazine Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 10 mg/1 mL (NDC 63323-128-20)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/20/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dacarbazine Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Dacarbazine for Injection, USP, Injection, 200 mg per Vial (NDC 0143-9245-10)",
    "Type of Update": "Reverified",
    "Date of Update": "05/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Additional lots will be available in the June 2024 timeframe. Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/20/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dacarbazine Injection",
    "Company Name": "Meitheal Pharmaceuticals, Inc.",
    "Contact Info": "844-824-8426",
    "Presentation": "Injection, 200 mg/20 mL (NDC 71288-174-21)",
    "Type of Update": "New",
    "Date of Update": "07/22/2024",
    "Availability Information": "Available",
    "Related Information": "New launch",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/20/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dactinomycin Injection",
    "Company Name": "Recordati Rare Diseases Inc.",
    "Contact Info": "866-209-7604",
    "Presentation": "Cosmegen, Injection, .5 mg/1 mL (NDC 55292-811-55)",
    "Type of Update": "New",
    "Date of Update": "10/16/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/16/2023",
    "Initial Posting Date": "10/16/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dactinomycin Injection",
    "Company Name": "Recordati Rare Diseases Inc.",
    "Contact Info": "866-209-7604",
    "Presentation": "Injection, .5 mg/1 mL (NDC 66993-489-35)",
    "Type of Update": "New",
    "Date of Update": "10/16/2023",
    "Availability Information": "",
    "Related Information": "Authorized generic distributed by Prasco Laboratories",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Oncology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/16/2023",
    "Initial Posting Date": "10/16/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dactinomycin Injection",
    "Company Name": "Recordati Rare Diseases Inc.",
    "Contact Info": "866-209-7604",
    "Presentation": "Injection, .5 mg/1 mL (NDC 66993-489-83)",
    "Type of Update": "New",
    "Date of Update": "10/16/2023",
    "Availability Information": "",
    "Related Information": "Authorized generic distributed by Prasco Laboratories",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Oncology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/16/2023",
    "Initial Posting Date": "10/16/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Desmopressin Acetate Spray",
    "Company Name": "Apotex Corp.",
    "Contact Info": "800-706-5575",
    "Presentation": "Desmopressin Acetate (needs No Refrigeration), Spray, 10 ug (NDC 60505-0815-0)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Hematology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/12/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Desmopressin Acetate Spray",
    "Company Name": "Ferring",
    "Contact Info": "888-337-7464",
    "Presentation": "Stimate, Spray, 1.5 mg/1 mL (NDC 0053-6871-00)",
    "Type of Update": "Reverified",
    "Date of Update": "03/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Hematology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/12/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Desmopressin Acetate Spray",
    "Company Name": "Ferring",
    "Contact Info": "888-337-7464",
    "Presentation": "Desmopressin Acetate, Spray, 10 ug/.1 mL (NDC 69918-501-05)",
    "Type of Update": "Reverified",
    "Date of Update": "03/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Hematology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/12/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Desmopressin Acetate Spray",
    "Company Name": "Ferring",
    "Contact Info": "888-337-7464",
    "Presentation": "Ddavp, Spray, .1 ug/1 mL (NDC 55566-2500-0)",
    "Type of Update": "Reverified",
    "Date of Update": "03/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Hematology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/12/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Desvenlafaxine Succinate Tablet, Extended Release",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Pristiq, Tablet, Extended Release, 25 mg (NDC 59762-1210-3)",
    "Type of Update": "New",
    "Date of Update": "09/11/2023",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug; Supply expected to exhaust November 2023",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "09/11/2023",
    "Date Discontinued": "09/11/2023",
    "Initial Posting Date": "09/11/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexamethasone Sodium Phosphate Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 10 mg/1 mL (NDC 55150-304-25)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Unavailable",
    "Related Information": "On backorder. Recovery: TBD. Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/08/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexamethasone Sodium Phosphate Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 100 mg/10 mL (NDC 55150-305-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Unavailable",
    "Related Information": "On backorder. Recovery: TBD. Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/08/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexamethasone Sodium Phosphate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 4 mg/1 mL (NDC 76045-106-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "5 month expiry available upon request.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/08/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexamethasone Sodium Phosphate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 10 mg/1 mL (NDC 76045-109-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/08/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexamethasone Sodium Phosphate Injection",
    "Company Name": "Mylan Institutional, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Injection, 4 mg/1 mL (NDC 67457-423-12)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/08/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexamethasone Sodium Phosphate Injection",
    "Company Name": "Mylan Institutional, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Injection, 4 mg/1 mL (NDC 67457-422-54)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/08/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexamethasone Sodium Phosphate Injection",
    "Company Name": "Mylan Institutional, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Injection, 4 mg/1 mL (NDC 67457-421-30)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/08/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexamethasone Sodium Phosphate Injection",
    "Company Name": "Mylan Institutional, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Injection, 10 mg/1 mL (NDC 67457-420-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/08/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexamethasone Sodium Phosphate Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 4 mg/1 mL (NDC 55150-237-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Intermittent availability expected",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/08/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexamethasone Sodium Phosphate Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 4 mg/1 mL (NDC 55150-238-05)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Intermittent availability expected",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/08/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexamethasone Sodium Phosphate Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 4 mg/1 mL (NDC 55150-239-30)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Unavailable",
    "Related Information": "On backorder. Recovery: TBD. Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/08/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexamethasone Sodium Phosphate Injection",
    "Company Name": "Somerset Therapeutics, LLC",
    "Contact Info": "732-554-1019",
    "Presentation": "Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 70069-021-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/29/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/08/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexamethasone Sodium Phosphate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 4 mg/1 mL (NDC 63323-165-05)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/08/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexamethasone Sodium Phosphate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 10 mg/1 mL (NDC 63323-516-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/08/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexamethasone Sodium Phosphate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 4 mg/1 mL (NDC 63323-165-30)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/08/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexamethasone Sodium Phosphate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 4 mg/1 mL (NDC 63323-165-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/08/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexamethasone Sodium Phosphate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 63323-506-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/08/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexamethasone Sodium Phosphate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Dexamethasone Sodium Phosphate Injection, USP, Injection, 4 mg/1 mL (NDC 0641-6145-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Currently available.  Additional product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/08/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexamethasone Sodium Phosphate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Dexamethasone Sodium Phosphate Injection, USP, Injection, 4 mg/1 mL (NDC 0641-6146-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Currently available.  Additional product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/08/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexamethasone Sodium Phosphate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Dexamethasone Sodium Phosphate Injection, USP, Injection, 10 mg/1 mL (NDC 0641-0367-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots will be scheduled for manufacturing.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/08/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Par Pharmaceutical, Inc.",
    "Contact Info": "800-828-9393",
    "Presentation": "Injection, 4 ug/1 mL (NDC 42023-186-20)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Please check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Par Pharmaceutical, Inc.",
    "Contact Info": "800-828-9393",
    "Presentation": "Injection, 4 ug/1 mL (NDC 42023-187-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Please check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Mylan Institutional, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 67457-924-50)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Mylan Institutional, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 67457-925-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-296-10)",
    "Type of Update": "Reverified",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-297-10)",
    "Type of Update": "Reverified",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Injection, 4 ug/1 mL (NDC 70121-1388-8)",
    "Type of Update": "Reverified",
    "Date of Update": "07/09/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Injection, 4 ug/1 mL (NDC 70121-1389-7)",
    "Type of Update": "Reverified",
    "Date of Update": "07/09/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "866-733-3952",
    "Presentation": "Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-976-58)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "866-733-3952",
    "Presentation": "Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-975-58)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Injection, 100 ug/1 mL (NDC 16729-239-93)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Resupply TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Requirements related to complying with good manufacturing practices",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Injection, 100 ug/1 mL (NDC 16729-432-93)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Discontinuation of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 55150-209-02)",
    "Type of Update": "Reverified",
    "Date of Update": "08/05/2024",
    "Availability Information": "Unavailable",
    "Related Information": "On backorder. Recovery: TBD. Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 0338-9555-24)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 0338-9557-12)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 43066-555-24)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 43066-557-12)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 4 ug/1 mL (NDC 63323-671-20)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next release not available at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 4 ug/1 mL (NDC 63323-671-50)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Not available at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 4 ug/1 mL (NDC 63323-671-00)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Not available at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 100 ug/1 mL (NDC 63323-421-02)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Backordered. Next release not available at this time; Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "HQ Specialty Pharma",
    "Contact Info": "WG Critical Care 888-493-0861",
    "Presentation": "Injection, 100 ug/1 mL (NDC 44567-600-04)",
    "Type of Update": "Reverified",
    "Date of Update": "05/18/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by WG Critical Care",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "HQ Specialty Pharma",
    "Contact Info": "WG Critical Care 888-493-0861",
    "Presentation": "Injection, 100 ug/1 mL (NDC 44567-601-04)",
    "Type of Update": "Reverified",
    "Date of Update": "05/18/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by WG Critical Care",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "HQ Specialty Pharma",
    "Contact Info": "WG Critical Care 888-493-0861",
    "Presentation": "Injection, 4 ug/1 mL (NDC 44567-602-24)",
    "Type of Update": "Reverified",
    "Date of Update": "05/18/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by WG Critical Care",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "HQ Specialty Pharma",
    "Contact Info": "WG Critical Care 888-493-0861",
    "Presentation": "Injection, 4 ug/1 mL (NDC 44567-603-24)",
    "Type of Update": "Reverified",
    "Date of Update": "05/18/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by WG Critical Care",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Mylan Institutional, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 67457-251-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Par Pharmaceutical, Inc.",
    "Contact Info": "800-828-9393",
    "Presentation": "Injection, 100 ug/1 mL (NDC 42023-146-25)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Recovery: TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-1660-20)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Next Delivery: August 2024; Estimated Recovery: June 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1660-50)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Precedex, Injection, 400 mcg/100 mL (4 mcg/mL)  (NDC 0409-1596-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Precedex, Injection, 200 mcg/2 mL (100 mcg/mL) (NDC 0409-1638-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Slayback Pharma",
    "Contact Info": "844-566-2505",
    "Presentation": "Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 71225-126-05)",
    "Type of Update": "Revised",
    "Date of Update": "01/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Slayback Pharma",
    "Contact Info": "844-566-2505",
    "Presentation": "Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 71225-126-06)",
    "Type of Update": "Revised",
    "Date of Update": "01/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 0143-9532-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Meitheal Pharmaceuticals, Inc.",
    "Contact Info": "844-824-8426",
    "Presentation": "Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 71288-505-03)",
    "Type of Update": "Revised",
    "Date of Update": "07/03/2024",
    "Availability Information": "Available",
    "Related Information": "Estimated recovery end of August 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "877-835-5472",
    "Presentation": "Injection, 4 mcg/mL, 50 mL (NDC 70121-1388-1)",
    "Type of Update": "Revised",
    "Date of Update": "07/09/2024",
    "Availability Information": "Available",
    "Related Information": "Sufficient Inventory available (16 to 20 wk) as per current demand",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Injection, 4 mcg/mL, 100 mL (NDC 70121-1389-1)",
    "Type of Update": "Revised",
    "Date of Update": "07/09/2024",
    "Availability Information": "Available",
    "Related Information": "Sufficient Inventory available (20 to 25 wk) as per current demand",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Jiangsu Hengrui Pharmaceuticals Co., Ltd.",
    "Contact Info": "See Related Information section below for customer service information",
    "Presentation": "Injection, 80 mcg/20 mL  (NDC 0781-3493-95)",
    "Type of Update": "Revised",
    "Date of Update": "07/11/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Sandoz Inc.; Customer service: 800-525-8747",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Jiangsu Hengrui Pharmaceuticals Co., Ltd.",
    "Contact Info": "See Related Information section below for customer service information",
    "Presentation": "Injection, 200 mcg/50 mL  (NDC 0781-3494-95)",
    "Type of Update": "Revised",
    "Date of Update": "07/11/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Sandoz Inc.; Customer service: 800-525-8747",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Jiangsu Hengrui Pharmaceuticals Co., Ltd.",
    "Contact Info": "See Related Information section below for customer service information",
    "Presentation": "Injection, 400 mcg/100 mL (NDC 0781-3495-95)",
    "Type of Update": "Revised",
    "Date of Update": "07/11/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Sandoz Inc.; Customer service: 800-525-8747",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-3301-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-4596-20)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-0155-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1174-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Precedex, Injection, 1000 mcg/250 mL Single Dose Glass Bottle (NDC 0409-1434-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Precedex, Injection, 1000 mcg/250 mL Glass Bottle NovaPlus (NDC 0409-2815-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1454-20)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dexmedetomidine Hydrochloride Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "855-273-0154",
    "Presentation": "Injection, 200 ug/2 mL (NDC 66794-230-42)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Piramal Critical Care Inc.: 800-414-1901",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/10/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Amphastar Pharmaceuticals, Inc.",
    "Contact Info": "800-423-4136",
    "Presentation": "Dextrose 50%, Injection, 25 g/50 mL (NDC 76329-3302-1)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/13/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Dextrose, Injection, 25 g/50 mL (50%, 0.5 g/mL) Syringes (NDC 0409-7517-16)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: July 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/13/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Dextrose, Injection, 25 g/50 mL (50%, 0.5 g/mL) Syringes (NDC 0409-4902-34)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: October 2024; Estimated Recovery: March 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/13/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Dextrose, Injection, 25 g/50 mL (50%, 0.5 g/mL) (NDC 0409-6648-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: July 2024; Estimated Recovery: December 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/13/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Dextrose, Injection, 2.5 g/10mL (25%, 250 mg/ mL) Syringes (NDC 0409-1775-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: July 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/07/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 2.5 g/50mL (5%, 50mg/mL) (NDC 0409-7100-66)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 5 g/100mL (5%) Plastic (NDC 0409-7100-67)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 12.5 g/250mL (5%) (NDC 0409-7100-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 63323-624-61)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 63323-624-74)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 63323-624-75)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 63323-624-10)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 63323-624-50)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7922-02",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-61)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7922-61",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-13)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7923-13",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-20)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7923-20",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-23)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7923-23",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-36)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7923-36",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-37)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7923-37",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-41)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-11)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-31)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-48)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-18)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-38)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0551-11)",
    "Type of Update": "Reverified",
    "Date of Update": "06/21/2024",
    "Availability Information": "Available",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 2.5 g/50 mL (NDC 0338-9143-30)",
    "Type of Update": "Reverified",
    "Date of Update": "06/21/2024",
    "Availability Information": "Available",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-9147-30)",
    "Type of Update": "Reverified",
    "Date of Update": "06/21/2024",
    "Availability Information": "Available",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0551-18)",
    "Type of Update": "Reverified",
    "Date of Update": "06/21/2024",
    "Availability Information": "Available",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0070-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0062-30)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-03)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0066-20)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Injection, 5 g/100 mL (NDC 0264-7510-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Injection, 5 g/100 mL (NDC 0264-7510-00)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Injection, 5 g/100 mL (NDC 0264-7510-20)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 0264-1510-32)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 0264-1510-31)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Injection, 10 g/100 mL (NDC 0264-7520-00)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Injection, 10 g/100 mL (NDC 0264-7520-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Injection, 10 g/100 mL (NDC 0264-7520-20)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-03)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7922-03",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-55)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7922-55",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-09)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7922-09",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/14/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-03)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-04)",
    "Type of Update": "Revised",
    "Date of Update": "06/21/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Injection, 10 g/100 mL (NDC 0264-7520-00)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Injection, 10 g/100 mL (NDC 0264-7520-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Injection, 10 g/100 mL (NDC 0264-7520-20)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-74)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-75)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-76)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7930-02)",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-03)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7930-03",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-09)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7930-09",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7938-19)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7938-19",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate, Lidocaine Hydrochloride Anhydrous Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .8 g/100 mL (NDC 0264-9598-20)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/25/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate, Lidocaine Hydrochloride Anhydrous Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-20)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/25/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dextrose Monohydrate, Lidocaine Hydrochloride Anhydrous Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/25/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Diazepam Gel",
    "Company Name": "Bausch Health Americas, Inc.",
    "Contact Info": "908-927-1400",
    "Presentation": "Gel, 10 mg/2 mL (NDC 68682-652-20)",
    "Type of Update": "Revised",
    "Date of Update": "04/19/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "Resolved",
    "Change Date": "04/19/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "06/15/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Diazepam Gel",
    "Company Name": "Bausch Health Americas, Inc.",
    "Contact Info": "908-927-1400",
    "Presentation": "Gel, 2.5 mg/.5 mL (NDC 68682-650-20)",
    "Type of Update": "Revised",
    "Date of Update": "04/19/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "Resolved",
    "Change Date": "04/19/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "06/15/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Diazepam Gel",
    "Company Name": "Bausch Health Americas, Inc.",
    "Contact Info": "908-927-1400",
    "Presentation": "Gel, 20 mg/4 mL (NDC 68682-655-20)",
    "Type of Update": "Revised",
    "Date of Update": "04/19/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "Resolved",
    "Change Date": "04/19/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "06/15/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Diazepam Gel",
    "Company Name": "Lupin Pharmaceuticals, Inc.",
    "Contact Info": "908-603-6000",
    "Presentation": "Gel, 10 mg/2 g (NDC 43386-280-01)",
    "Type of Update": "Revised",
    "Date of Update": "04/19/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "Resolved",
    "Change Date": "04/19/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Diazepam Gel",
    "Company Name": "Lupin Pharmaceuticals, Inc.",
    "Contact Info": "908-603-6000",
    "Presentation": "Gel, 20 mg/4 g (NDC 43386-281-01)",
    "Type of Update": "Revised",
    "Date of Update": "04/19/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "Resolved",
    "Change Date": "04/19/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Difluprednate Emulsion",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Difluprednate Ophthalmic Emulsion, Emulsion, .5 mg/1 mL (NDC 69238-1380-3)",
    "Type of Update": "Revised",
    "Date of Update": "04/24/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Ophthalmology",
    "Status": "Resolved",
    "Change Date": "04/24/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "12/21/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Difluprednate Emulsion",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Durezol, Emulsion, .5 mg/1 mL (NDC 0078-0862-25)",
    "Type of Update": "Revised",
    "Date of Update": "04/24/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Ophthalmology",
    "Status": "Resolved",
    "Change Date": "04/24/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "12/21/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Difluprednate Emulsion",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Durezol, Emulsion, .5 mg/1 mL (NDC 0781-6000-78)",
    "Type of Update": "Revised",
    "Date of Update": "04/24/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Ophthalmology",
    "Status": "Resolved",
    "Change Date": "04/24/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "12/21/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Difluprednate Emulsion",
    "Company Name": "Cipla Limited",
    "Contact Info": "844-247-5287",
    "Presentation": "Emulsion, .5 mg/1 mL (NDC 69097-341-35)",
    "Type of Update": "Revised",
    "Date of Update": "04/24/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Ophthalmology",
    "Status": "Resolved",
    "Change Date": "04/24/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "12/21/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Digoxin Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Digoxin Injection, USP, Injection, .25 mg/1 mL (NDC 0641-1410-35)",
    "Type of Update": "Revised",
    "Date of Update": "05/02/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "05/02/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "06/04/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Digoxin Injection",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Injection, 250 ug/1 mL (NDC 0781-3059-95)",
    "Type of Update": "Revised",
    "Date of Update": "05/02/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "05/02/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "06/04/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Digoxin Injection",
    "Company Name": "Covis Pharma",
    "Contact Info": "913-661-3814",
    "Presentation": "Lanoxin, Injection, 250 ug/1 mL (NDC 70515-260-10)",
    "Type of Update": "Revised",
    "Date of Update": "05/02/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "05/02/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "06/04/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Digoxin Injection",
    "Company Name": "Covis Pharma",
    "Contact Info": "913-661-3814",
    "Presentation": "Lanoxin, Injection, 250 ug/1 mL (NDC 70515-261-10)",
    "Type of Update": "Revised",
    "Date of Update": "05/02/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "05/02/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "06/04/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Digoxin Injection",
    "Company Name": "Covis Pharma",
    "Contact Info": "913-661-3814",
    "Presentation": "Lanoxin, Injection, 100 ug/1 mL (NDC 70515-262-10)",
    "Type of Update": "Revised",
    "Date of Update": "05/02/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "05/02/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "06/04/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Digoxin Injection",
    "Company Name": "Covis Pharma",
    "Contact Info": "913-661-3814",
    "Presentation": "Lanoxin, Injection, 100 ug/1 mL (NDC 70515-263-10)",
    "Type of Update": "Revised",
    "Date of Update": "05/02/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "05/02/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "06/04/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Diltiazem Hydrochloride Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 5 mg/1 mL (NDC 70860-301-05)",
    "Type of Update": "Reverified",
    "Date of Update": "05/22/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "05/22/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/21/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Diltiazem Hydrochloride Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 5 mg/1 mL (NDC 70860-301-10)",
    "Type of Update": "Reverified",
    "Date of Update": "05/22/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "05/22/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/21/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Diltiazem Hydrochloride Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 5 mg/1 mL (NDC 70860-301-25)",
    "Type of Update": "Reverified",
    "Date of Update": "05/22/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "05/22/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/21/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Diltiazem Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Diltiazem Hydrochloride, Injection, 100 mg (NDC 0409-4350-03)",
    "Type of Update": "Revised",
    "Date of Update": "05/22/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "05/22/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "02/21/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Diltiazem Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Injection, 5 mg/1 mL (NDC 0641-6013-10)",
    "Type of Update": "Revised",
    "Date of Update": "05/22/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "05/22/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Diltiazem Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Injection, 5 mg/1 mL (NDC 0641-6014-10)",
    "Type of Update": "Revised",
    "Date of Update": "05/22/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "05/22/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Diltiazem Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Injection, 5 mg/1 mL (NDC 0641-6015-10)",
    "Type of Update": "Revised",
    "Date of Update": "05/22/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "05/22/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Diltiazem Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 125mg/ 25mL (NDC 55150-427-10)",
    "Type of Update": "Reverified",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/21/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Diltiazem Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 25mg/ 5mL (NDC 55150-425-10)",
    "Type of Update": "Reverified",
    "Date of Update": "08/05/2024",
    "Availability Information": "Unavailable",
    "Related Information": "On backorder. Recovery: TBD. Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/21/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Diltiazem Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 50mg/10mL (NDC 55150-426-10)",
    "Type of Update": "Reverified",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/21/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Disopyramide Phosphate Capsule",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Capsule, Norpace CR, 100 mg Extended Release (NDC 0025-2732-31)",
    "Type of Update": "Revised",
    "Date of Update": "06/04/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available; Greenstone brand (NDC 59762-0386-1 and NDC 59762-0400-1) marketed by Viatris",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "06/04/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "03/19/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Disopyramide Phosphate Capsule",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Capsule, Norpace CR, 150 mg Extended Release (NDC 0025-2742-31)",
    "Type of Update": "Revised",
    "Date of Update": "06/04/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available; Greenstone brand (NDC 59762-0386-1 and NDC 59762-0400-1) marketed by Viatris",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "06/04/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "03/19/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Disopyramide Phosphate Capsule",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Capsule, Norpace IR, 100 mg (NDC 0025-2752-31)",
    "Type of Update": "Revised",
    "Date of Update": "06/04/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available; Greenstone brand (NDC 59762-0386-1 and NDC 59762-0400-1) marketed by Viatris",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "06/04/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "03/19/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Disopyramide Phosphate Capsule",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Capsule, Norpace IR, 150 mg  (NDC 0025-2762-31)",
    "Type of Update": "Revised",
    "Date of Update": "06/04/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available; Greenstone brand (NDC 59762-0386-1 and NDC 59762-0400-1) marketed by Viatris",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "06/04/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "03/19/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Disopyramide Phosphate Capsule",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Capsule, 100 mg (NDC 59762-0386-1)",
    "Type of Update": "Revised",
    "Date of Update": "06/04/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available; Greenstone brand (NDC 59762-0386-1 and NDC 59762-0400-1) marketed by Viatris",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "06/04/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "03/19/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Disopyramide Phosphate Capsule",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Capsule, 150 mg (NDC 59762-0400-1)",
    "Type of Update": "Revised",
    "Date of Update": "06/04/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available; Greenstone brand (NDC 59762-0386-1 and NDC 59762-0400-1) marketed by Viatris",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "06/04/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "03/19/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Disopyramide Phosphate Capsule",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Capsule, 100 mg (NDC 0093-3127-01)",
    "Type of Update": "Revised",
    "Date of Update": "06/04/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "06/04/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "03/19/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Disopyramide Phosphate Capsule",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Capsule, 150 mg (NDC 0093-3129-01)",
    "Type of Update": "Revised",
    "Date of Update": "06/04/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "06/04/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "03/19/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Disopyramide Phosphate Capsule",
    "Company Name": "Dr. Reddy's Laboratories, Inc.",
    "Contact Info": "866-732-3952",
    "Presentation": "Capsule, 100 mg (NDC 51862-095-01)",
    "Type of Update": "Revised",
    "Date of Update": "06/04/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available. Marketed by Mayne Pharmaceuticals.",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/19/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Disopyramide Phosphate Capsule",
    "Company Name": "Dr. Reddy's Laboratories, Inc.",
    "Contact Info": "866-732-3952",
    "Presentation": "Capsule, 150 mg (NDC 51862-096-01)",
    "Type of Update": "Revised",
    "Date of Update": "06/04/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available. Marketed by Mayne Pharmaceuticals.",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/19/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Disulfiram Tablet",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Tablet, 500 mg (NDC 0054-0357-25)",
    "Type of Update": "New",
    "Date of Update": "11/02/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "11/02/2023",
    "Initial Posting Date": "11/02/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Disulfiram Tablet",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Tablet, 500 mg (NDC 0054-0357-13)",
    "Type of Update": "New",
    "Date of Update": "11/02/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "11/02/2023",
    "Initial Posting Date": "11/02/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Disulfiram Tablet",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Tablet, 250 mg (NDC 0054-0356-25)",
    "Type of Update": "New",
    "Date of Update": "11/02/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "11/02/2023",
    "Initial Posting Date": "11/02/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Disulfiram Tablet",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Tablet, 250 mg (NDC 0054-0356-13)",
    "Type of Update": "New",
    "Date of Update": "11/02/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "11/02/2023",
    "Initial Posting Date": "11/02/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dobutamine Hydrochloride Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 100 mg/100 mL (NDC 0338-1073-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular; Pediatric; Renal",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/06/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dobutamine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 250 mg/250mL (100 mg/mL) (NDC 0409-2346-32)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery and Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Cardiovascular; Pediatric; Renal",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/06/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dobutamine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 500 mg/250mL (200 mg/mL) (NDC 0409-2347-32)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: July 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Cardiovascular; Pediatric; Renal",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/06/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dobutamine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 1,000 mg/250mL (400 mg/mL) (NDC 0409-3724-32)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: July 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Cardiovascular; Pediatric; Renal",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/06/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dobutamine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular; Pediatric; Renal",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/06/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dobutamine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular; Pediatric; Renal",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/06/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dobutamine Hydrochloride Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 200 mg/100 mL (NDC 0338-1075-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular; Pediatric; Renal",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/06/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dobutamine Hydrochloride Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/100 mL (NDC 0338-1077-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular; Pediatric; Renal",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/06/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dobutamine Hydrochloride Injection",
    "Company Name": "Hainan Poly Pharm. Co., Ltd.",
    "Contact Info": "Slate Run Pharmaceuticals, LLC: 844-529-8988",
    "Presentation": "Dobutamine Hydrochloride, Injection, 250 mg/20 mL (NDC 70436-203-80)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available, not applicable",
    "Related Information": "Distributed by Slate Run Pharmaceuticals, LLC, 1-844-529-8988",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular; Pediatric; Renal",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/06/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dobutamine Hydrochloride Injection",
    "Company Name": "Hainan Poly Pharm. Co., Ltd.",
    "Contact Info": -7752,
    "Presentation": "Injection, 500 mg/40 mL (NDC 70436-204-80)",
    "Type of Update": "Revised",
    "Date of Update": "11/01/2023",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Cardiovascular; Pediatric; Renal",
    "Status": "To Be Discontinued",
    "Change Date": "11/01/2023",
    "Date Discontinued": "11/01/2023",
    "Initial Posting Date": "11/06/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dobutamine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-88)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular; Pediatric; Renal",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/06/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dofetilide Capsule",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Tikosyn, Capsule, .125 mg (NDC 0069-5800-43)",
    "Type of Update": "New",
    "Date of Update": "04/23/2024",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/23/2024",
    "Initial Posting Date": "04/23/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dofetilide Capsule",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Tikosyn, Capsule, .25 mg (NDC 0069-5810-43)",
    "Type of Update": "New",
    "Date of Update": "04/23/2024",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/23/2024",
    "Initial Posting Date": "04/23/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dofetilide Capsule",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Tikosyn, Capsule, .5 mg (NDC 0069-5820-43)",
    "Type of Update": "New",
    "Date of Update": "04/23/2024",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/23/2024",
    "Initial Posting Date": "04/23/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dopamine Hydrochloride Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-03)",
    "Type of Update": "Reverified",
    "Date of Update": "06/21/2024",
    "Availability Information": "Available",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/06/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dopamine Hydrochloride Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-02)",
    "Type of Update": "Revised",
    "Date of Update": "05/13/2024",
    "Availability Information": "Available",
    "Related Information": "Available on allocation; Recovery June 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/06/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dopamine Hydrochloride Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-03)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/06/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dopamine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/250 mL (1.6 mg/1 mL) (NDC 0409-7809-22)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: July 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/06/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dopamine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/500 mL (1.6 mg/1 mL) (NDC 0409-7809-24)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery and Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/06/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dopamine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/250 mL (3.2 mg/1 mL) (NDC 0409-7810-22)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: July 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/06/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dopamine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Dopamine Hydrochloride, Injection, 200 mg/5mL (40 mg/1 mL) (NDC 0409-5820-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/06/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dopamine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Dopamine Hydrochloride, Injection, 400 mg/10mL (40 mg/1 mL) (NDC 0409-9104-20)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/06/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dopamine Hydrochloride Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-02)",
    "Type of Update": "Reverified",
    "Date of Update": "06/21/2024",
    "Availability Information": "Available",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/06/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dopamine Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Injection, 40 mg/1 mL (NDC 0143-9252-25)",
    "Type of Update": "Reverified",
    "Date of Update": "05/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/06/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dopamine Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Injection, 40 mg/1 mL (NDC 0143-9254-25)",
    "Type of Update": "Revised",
    "Date of Update": "05/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/06/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Doxycycline Hyclate Capsule",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Vibramycin, Capsule, 100 mg (NDC 0069-0950-50)",
    "Type of Update": "New",
    "Date of Update": "02/01/2024",
    "Availability Information": "",
    "Related Information": "Supply expected to exhaust early April 2024",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/01/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Doxycycline Hyclate Tablet",
    "Company Name": "Apotex Corp.",
    "Contact Info": "800-706-5575",
    "Presentation": "Tablet, 75 mg (NDC 60505-4382-6)",
    "Type of Update": "New",
    "Date of Update": "04/30/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/30/2024",
    "Initial Posting Date": "04/30/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Doxycycline Hyclate Tablet",
    "Company Name": "Apotex Corp.",
    "Contact Info": "800-706-5575",
    "Presentation": "Tablet, 150 mg (NDC 60505-4384-6)",
    "Type of Update": "New",
    "Date of Update": "04/30/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/30/2024",
    "Initial Posting Date": "04/30/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dulaglutide Injection",
    "Company Name": "Eli Lilly and Co.",
    "Contact Info": "800-545-5979",
    "Presentation": "Trulicity, Injection, .75 mg/.5 mL (NDC 0002-1433-80)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dulaglutide Injection",
    "Company Name": "Eli Lilly and Co.",
    "Contact Info": "800-545-5979",
    "Presentation": "Trulicity, Injection, 1.5 mg/.5 mL (NDC 0002-1434-80)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dulaglutide Injection",
    "Company Name": "Eli Lilly and Co.",
    "Contact Info": "800-545-5979",
    "Presentation": "Trulicity, Injection, 3 mg/.5 mL (NDC 0002-2236-80)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited availability through Q3 2024.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Dulaglutide Injection",
    "Company Name": "Eli Lilly and Co.",
    "Contact Info": "800-545-5979",
    "Presentation": "Trulicity, Injection, 4.5 mg/.5 mL (NDC 0002-3182-80)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited availability through Q3 2024.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Echothiophate Iodide Ophthalmic Solution",
    "Company Name": "Fera Pharmaceuticals",
    "Contact Info": "516-277-1448",
    "Presentation": "Phospholine Iodide, Ophthalmic Solution, 0.125% (NDC 48102-053-05)",
    "Type of Update": "Reverified",
    "Date of Update": "01/15/2024",
    "Availability Information": "Available through limited distribution by AllianceRx Walgreens Specialty Pharmacy.",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Ophthalmology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "09/24/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Enalaprilat Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Injection, 2.5 mg/2 mL (NDC 0143-9786-10)",
    "Type of Update": "Revised",
    "Date of Update": "06/26/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "06/26/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "03/29/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Enalaprilat Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Injection, 1.25 mg/1 mL (NDC 0143-9787-10)",
    "Type of Update": "Revised",
    "Date of Update": "06/26/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Resolved",
    "Change Date": "06/26/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "03/29/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-17)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/14/2016",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-17)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/14/2016",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-17)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/14/2016",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-17)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/14/2016",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 2.5 g/50 mL (0.5%; 1:200,000) (NDC 0409-3177-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: April 2025; Estimated Recovery: September 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 200 mg/20 mL (1%; 1:100,000) (NDC 0409-3178-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: August 2024; Estimated Recovery: September 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC 0409-3178-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: November 2024; Estimated Recovery: March 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 500 mg/50 mL (1%; 1:100,000) (NDC 0409-3178-03)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: February 2025; Estimated Recovery: September 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 75 mg/5 mL (1.5%; 1:200,000) (NDC 0409-1209-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 450 mg/30 mL (1.5%; 1:200,000) (NDC 0409-3181-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery and Estimated Recovery: March 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:100,000) (NDC 0409-3182-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: July 2025; Estimated Recovery: September 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 600 mg/30 mL (2%; 1:100,000) (NDC 0409-3182-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: July 2025; Estimated Recovery: September 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 1 g/50 mL (2%; 1:100,000) (NDC 0409-3182-03)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: July 2025; Estimated Recovery: September 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:200,000) (NDC 0409-3183-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: February 2025; Estimated Recovery: March 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/14/2016",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-27)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/14/2016",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-57)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/14/2016",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-27)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/14/2016",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-57)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/14/2016",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-37)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/14/2016",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-37)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/14/2016",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-27)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/14/2016",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Injection, Syringes",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, Syringes, 1 mg/10 mL (0.1 mg/1 mL) (NDC 0409-4933-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: November 2024; Estimated Recovery: March 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Cardiovascular; Pulmonary/Allergy",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/27/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Injection, Syringes",
    "Company Name": "Amphastar Pharmaceuticals, Inc.",
    "Contact Info": "800-423-4136",
    "Presentation": "Injection, Syringes, 0.1 mg/mL (NDC 76329-3318-1)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Available on allocation",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Cardiovascular; Pulmonary/Allergy",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/27/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Epinephrine Solution",
    "Company Name": "Adamis Pharmaceuticals Corporation",
    "Contact Info": "800-230-3935",
    "Presentation": "Symjepi, Solution, 0.15 mg/0.3 mL  (NDC 78670-131-02)",
    "Type of Update": "New",
    "Date of Update": "09/18/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Pulmonary/Allergy",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "09/18/2023",
    "Initial Posting Date": "09/18/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Erythromycin Ointment",
    "Company Name": "Armas Pharmaceuticals Inc",
    "Contact Info": "732-637-1971",
    "Presentation": "Ointment, 0.5% 3.5-gram tubes (NDC 72485067035)",
    "Type of Update": "Revised",
    "Date of Update": "07/02/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Ophthalmology; Pediatric",
    "Status": "Resolved",
    "Change Date": "07/02/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/06/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Erythromycin Ointment",
    "Company Name": "Armas Pharmaceuticals Inc",
    "Contact Info": "732-637-1971",
    "Presentation": "Ointment, 0.5% 1 -gram tube (NDC 72485067031)",
    "Type of Update": "Revised",
    "Date of Update": "07/02/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Ophthalmology; Pediatric",
    "Status": "Resolved",
    "Change Date": "07/02/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/06/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Erythromycin Ointment",
    "Company Name": "Bausch & Lomb Incorporated",
    "Contact Info": "800-553-5340",
    "Presentation": "Erythromycin, Ointment, 5 mg/1 g (NDC 24208-910-55)",
    "Type of Update": "Revised",
    "Date of Update": "07/02/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Ophthalmology; Pediatric",
    "Status": "Resolved",
    "Change Date": "07/02/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/06/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Erythromycin Ointment",
    "Company Name": "Bausch & Lomb Incorporated",
    "Contact Info": "800-553-5340",
    "Presentation": "Erythromycin, Ointment, 5 mg/1 g (NDC 24208-910-19)",
    "Type of Update": "Revised",
    "Date of Update": "07/02/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Ophthalmology; Pediatric",
    "Status": "Resolved",
    "Change Date": "07/02/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/06/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Estradiol Valerate Injection",
    "Company Name": "Par Pharmaceutical, Inc.",
    "Contact Info": "800-828-9393",
    "Presentation": "Delestrogen, Injection, 40 mg/1 mL (NDC 42023-112-01)",
    "Type of Update": "New",
    "Date of Update": "06/04/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Reproductive",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "06/04/2024",
    "Initial Posting Date": "06/04/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Etomidate Injection",
    "Company Name": "Caplin Steriles, Ltd.",
    "Contact Info": "Check Marketing Partner",
    "Presentation": "Injection, 2 mg/1 mL (NDC 65219-445-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory; Marketed by Fresenius Kabi",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/05/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Etomidate Injection",
    "Company Name": "Caplin Steriles, Ltd.",
    "Contact Info": "Check Marketing Partner",
    "Presentation": "Injection, 40 mg/20 mL (NDC 65219-445-20)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory; Marketed by Fresenius Kabi",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/05/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Etomidate Injection",
    "Company Name": "Caplin Steriles, Ltd.",
    "Contact Info": "Check Marketing Partner",
    "Presentation": "Injection, 2 mg/1 mL (NDC 25021-674-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Sagent",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/05/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Etomidate Injection",
    "Company Name": "Caplin Steriles, Ltd.",
    "Contact Info": "Check Marketing Partner",
    "Presentation": "Injection, 2 mg/1 mL (NDC 25021-674-20)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Sagent",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/05/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Etomidate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Etomidate, Injection, 2 mg/1 mL (NDC 72572-160-10)",
    "Type of Update": "Revised",
    "Date of Update": "05/17/2024",
    "Availability Information": "Pending information",
    "Related Information": "Distributed by Civica",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/05/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Etomidate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Etomidate, Injection, 2 mg/1 mL (NDC 72572-161-10)",
    "Type of Update": "Revised",
    "Date of Update": "05/17/2024",
    "Availability Information": "Pending information",
    "Related Information": "Distributed by Civica",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/05/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Etomidate Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 20 mg/10 mL (NDC 55150-221-10)",
    "Type of Update": "Reverified",
    "Date of Update": "08/05/2024",
    "Availability Information": "Unavailable",
    "Related Information": "On backorder. Recovery: TBD. Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/05/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Etomidate Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 40 mg/20 mL (NDC 55150-222-20)",
    "Type of Update": "Reverified",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/05/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Etomidate Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "866-733-3952",
    "Presentation": "Etomidate, Injection, 2 mg/1 mL (NDC 72266-146-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/05/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Etomidate Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "866-733-3952",
    "Presentation": "Etomidate, Injection, 2 mg/1 mL (NDC 72266-147-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/05/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Etomidate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Etomidate Injection, USP, Injection, 2 mg/1 mL (NDC 0143-9506-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots are scheduled to be manufactured.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/05/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Etomidate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Etomidate Injection, USP, Injection, 2 mg/1 mL (NDC 0143-9507-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots will be available.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/05/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Etomidate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Etomidate, Injection, 2 mg/1 mL (NDC 0143-9310-10)",
    "Type of Update": "Reverified",
    "Date of Update": "05/17/2024",
    "Availability Information": "Pending information",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/05/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Etomidate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Etomidate, Injection, 2 mg/1 mL (NDC 0143-9311-10)",
    "Type of Update": "Reverified",
    "Date of Update": "05/17/2024",
    "Availability Information": "Pending information",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/05/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Etomidate Injection",
    "Company Name": "Mylan Institutional, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Etomidate, Injection, 2 mg/1 mL (NDC 67457-902-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/05/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Etomidate Injection",
    "Company Name": "Mylan Institutional, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Etomidate, Injection, 2 mg/1 mL (NDC 67457-903-20)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/05/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Etomidate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Amidate, Injection, 2 mg/1 mL (NDC 0409-6695-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/05/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Etomidate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Amidate, Injection, 2 mg/mL (NDC 0409-6695-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/05/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Evolocumab Injection",
    "Company Name": "Amgen Inc.",
    "Contact Info": "1-844-REPATHA (1-844-737-2842), Option 2",
    "Presentation": "Repatha, Injection, 1 KIT in 1 CARTON (55513-770-01) * 1 CARTRIDGE in 1 TRAY / 3.5 mL in 1 CARTRIDGE (NDC 55513-770-01)",
    "Type of Update": "New",
    "Date of Update": "04/12/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/12/2024",
    "Initial Posting Date": "04/12/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Evolocumab Injection",
    "Company Name": "Amgen Inc.",
    "Contact Info": "1-844-REPATHA (1-844-737-2842), Option 2",
    "Presentation": "Repatha, Injection, 1 KIT in 1 CARTON (72511-770-01) * 1 CARTRIDGE in 1 TRAY / 3.5 mL in 1 CARTRIDGE (NDC 72511-770-01)",
    "Type of Update": "New",
    "Date of Update": "04/12/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/12/2024",
    "Initial Posting Date": "04/12/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Famotidine, Ibuprofen Tablet, Coated",
    "Company Name": "Horizon Therapeutics",
    "Contact Info": "224-383-3000",
    "Presentation": "Duexis, Tablet, Coated, 26.6 mg; 800 mg (NDC 70748-312-09)",
    "Type of Update": "New",
    "Date of Update": "08/17/2023",
    "Availability Information": "",
    "Related Information": "Business decision to discontinue manufacture of the drug product",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "To Be Discontinued",
    "Change Date": "08/17/2023",
    "Date Discontinued": "08/17/2023",
    "Initial Posting Date": "08/17/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Famotidine, Ibuprofen Tablet, Coated",
    "Company Name": "Horizon Therapeutics",
    "Contact Info": "224-383-3000",
    "Presentation": "Duexis, Tablet, Coated, 26.6 mg; 800 mg (NDC 75987-010-03)",
    "Type of Update": "New",
    "Date of Update": "08/17/2023",
    "Availability Information": "",
    "Related Information": "Business decision to discontinue manufacture of the drug product",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "To Be Discontinued",
    "Change Date": "08/17/2023",
    "Date Discontinued": "08/17/2023",
    "Initial Posting Date": "08/17/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Felbamate Oral Suspension",
    "Company Name": "Mylan Specialty, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Felbatol , Oral Suspension, 8 oz Each 5 mL contains 600 mg felbamate (NDC 0037-0442-67)",
    "Type of Update": "New",
    "Date of Update": "11/27/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "11/27/2023",
    "Initial Posting Date": "11/27/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Felbamate Oral Suspension",
    "Company Name": "Mylan Specialty, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Felbatol, Oral Suspension, 32 oz Each 5 mL contains 600 mg felbamate (NDC 0037-0442-17)",
    "Type of Update": "New",
    "Date of Update": "11/27/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "11/27/2023",
    "Initial Posting Date": "11/27/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fenofibrate Tablet",
    "Company Name": "Viatris",
    "Contact Info": "viatrisusdrugshortage@viatris.com",
    "Presentation": "Tablet, 160 mg (NDC 0378-7101-77)",
    "Type of Update": "New",
    "Date of Update": "10/16/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/16/2023",
    "Initial Posting Date": "10/16/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fenofibrate Tablet",
    "Company Name": "Viatris",
    "Contact Info": "viatrisusdrugshortage@viatris.com",
    "Presentation": "Tablet, 54 mg (NDC 0378-7100-77)",
    "Type of Update": "New",
    "Date of Update": "10/16/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/16/2023",
    "Initial Posting Date": "10/16/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fenofibrate Tablet",
    "Company Name": "AbbVie Inc.",
    "Contact Info": "800-633-9110",
    "Presentation": "Tricor, Tablet, 145 mg (NDC 0074-3189-90)",
    "Type of Update": "New",
    "Date of Update": "10/16/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/16/2023",
    "Initial Posting Date": "10/16/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fenofibrate Tablet",
    "Company Name": "AbbVie Inc.",
    "Contact Info": "800-633-9110",
    "Presentation": "Tricor, Tablet, 48 mg (NDC 0074-3173-90)",
    "Type of Update": "New",
    "Date of Update": "10/16/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "10/16/2023",
    "Date Discontinued": "10/16/2023",
    "Initial Posting Date": "10/16/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fentanyl Citrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-20)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fentanyl Citrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-50)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fentanyl Citrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fentanyl Citrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-02)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fentanyl Citrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-05)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fentanyl Citrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Fentanyl Citrate, Injection, 100 mcg/2 mL (50 ug/1 mL) (NDC 0409-9094-22)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/179002/download",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fentanyl Citrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/179002/download",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fentanyl Citrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Fentanyl Citrate, Injection, 500 mcg/10 mL (50 ug/1 mL) (NDC 0409-9094-28)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/179002/download",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fentanyl Citrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Fentanyl Citrate, Injection, 1000 mcg/20 mL (50 ug/1 mL) (NDC 0409-9094-31)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/179002/download",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fentanyl Citrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Fentanyl Citrate, Injection, 2500 mcg/50 mL (50 ug/1 mL) (NDC 0409-9094-61)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/179002/download",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fentanyl Citrate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Fentanyl Citrate Injection, USP, Injection, 50 ug/1 mL (NDC 0641-6024-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Inventory available in vial presentations.",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Analgesia/Addiction; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/20/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fentanyl Citrate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Fentanyl Citrate Injection, USP, Injection, 50 ug/1 mL (NDC 0641-6025-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Inventory available in vial presentations.",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Analgesia/Addiction; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/20/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fentanyl Citrate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Fentanyl Citrate Injection, USP, Injection, 50 ug/1 mL (NDC 0641-6026-05)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Inventory available in vial presentations.",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Analgesia/Addiction; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/20/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fentanyl Citrate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Fentanyl Citrate Injection, USP, Injection, 50 mcg/1 mL (NDC 0641-6027-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/20/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fentanyl Citrate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Fentanyl Citrate Injection, USP, Injection, 50 mcg/1 mL (NDC 0641-6028-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/20/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fentanyl Citrate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Fentanyl Citrate Injection, USP, Injection, 50 mcg/1 mL (NDC 0641-6029-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/20/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fentanyl Citrate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Fentanyl Citrate Injection, USP, Injection, 50 mcg/1 mL (NDC 0641-6030-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/20/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fentanyl Citrate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Fentanyl Citrate Injection, USP, Injection, 50 mcg/1 mL (NDC 0641-6247-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/20/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fentanyl Citrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 50 ug/1 mL (NDC 63323-808-11)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Backordered. Next releast August 2024. Check wholesalers for inventory.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fesoterodine Fumarate  Tablet, Extended Release",
    "Company Name": "ANI Pharmaceuticals",
    "Contact Info": "800-434-1121",
    "Presentation": "Tablet, Extended Release, 8 mg (NDC 62559-376-30)",
    "Type of Update": "New",
    "Date of Update": "04/30/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Urology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/30/2024",
    "Initial Posting Date": "04/30/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fesoterodine Fumarate  Tablet, Extended Release",
    "Company Name": "ANI Pharmaceuticals",
    "Contact Info": "800-434-1121",
    "Presentation": "Tablet, Extended Release, 4 mg (NDC 62559-375-30)",
    "Type of Update": "New",
    "Date of Update": "04/30/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Urology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/30/2024",
    "Initial Posting Date": "04/30/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fesoterodine Fumarate  Tablet, Extended Release",
    "Company Name": "ANI Pharmaceuticals",
    "Contact Info": "800-434-1121",
    "Presentation": "Tablet, Extended Release, 4 mg (NDC 62559-375-90)",
    "Type of Update": "New",
    "Date of Update": "04/30/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Urology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/30/2024",
    "Initial Posting Date": "04/30/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fesoterodine Fumarate  Tablet, Extended Release",
    "Company Name": "ANI Pharmaceuticals",
    "Contact Info": "800-434-1121",
    "Presentation": "Tablet, Extended Release, 8 mg (NDC 62559-376-90)",
    "Type of Update": "New",
    "Date of Update": "04/30/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Urology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/30/2024",
    "Initial Posting Date": "04/30/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fluconazole Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Fluconazole In Sodium Chloride 0.9% In Plastic Container, Injection, 2 mg/1 mL (NDC 25021-184-82)",
    "Type of Update": "Reverified",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "01/13/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fluconazole Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Diflucan, Tablet, 200 mf (NDC 0049-3430-41)",
    "Type of Update": "New",
    "Date of Update": "03/28/2024",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/28/2024",
    "Initial Posting Date": "03/28/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fluconazole Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Diflucan, Tablet, 100 mg (NDC 0049-3420-41)",
    "Type of Update": "New",
    "Date of Update": "06/14/2024",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "06/14/2024",
    "Initial Posting Date": "06/14/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fluconazole Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Diflucan, Tablet, 50 mg  (NDC 0049-3410-30)",
    "Type of Update": "Revised",
    "Date of Update": "10/24/2023",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/24/2023",
    "Initial Posting Date": "10/24/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fluconazole Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Diflucan, Tablet, 200 mg (NDC 59762-5018-1)",
    "Type of Update": "New",
    "Date of Update": "08/31/2023",
    "Availability Information": "",
    "Related Information": "Supply expected to exhaust September 2023; Discontinuation of the manufacture of the drug.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "To Be Discontinued",
    "Change Date": "08/31/2023",
    "Date Discontinued": "08/31/2023",
    "Initial Posting Date": "08/31/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fludarabine Phosphate Injection",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "CYTOSTATIKUM Fludarabin Actavis 25 mg/ml, Injection, 25 mg/1 mL (NDC 0480-9772-01)",
    "Type of Update": "Revised",
    "Date of Update": "04/17/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Resolved",
    "Change Date": "04/17/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "05/06/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/171781/download?attachment",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fludarabine Phosphate Injection",
    "Company Name": "Areva Pharmaceuticals, Inc.",
    "Contact Info": "812-399-0479",
    "Presentation": "Injection, 25 mg/1 mL (NDC 59923-604-02)",
    "Type of Update": "Revised",
    "Date of Update": "04/17/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Resolved",
    "Change Date": "04/17/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "05/09/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fludarabine Phosphate Injection",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Fludarabine Phosphate for Injection, USP (Lyophilized), Injection, 50 mg/2 mL (NDC 45963-609-55)",
    "Type of Update": "Revised",
    "Date of Update": "04/17/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Resolved",
    "Change Date": "04/17/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "05/06/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fludarabine Phosphate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 25 mg/1 mL (NDC 63323-192-02)",
    "Type of Update": "Revised",
    "Date of Update": "04/17/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Resolved",
    "Change Date": "04/17/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "05/06/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fludarabine Phosphate Injection",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Fludarabine Phosphate for Injection, USP (Lyophilized), Injection, 25 mg/1 mL (NDC 45963-621-51)",
    "Type of Update": "Revised",
    "Date of Update": "04/17/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Resolved",
    "Change Date": "04/17/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "05/06/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Flurazepam Hydrochloride Capsule",
    "Company Name": "Rising Pharma Holdings, Inc.",
    "Contact Info": "1-844-874-7464",
    "Presentation": "Capsule, 15 mg (NDC 0378-4415-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Anticipated availability: Q1 2025; Delay is due to manufacturing delays at the contract manufacturing facility.",
    "Resolved Note": "",
    "Reason for Shortage": "Regulatory delay",
    "Therapeutic Category": "Neurology; Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "08/03/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Flurazepam Hydrochloride Capsule",
    "Company Name": "Rising Pharma Holdings, Inc.",
    "Contact Info": "1-844-874-7464",
    "Presentation": "Capsule, 30 mg (NDC 0378-4430-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Anticipated availability: Q1 2025; Delay is due to manufacturing delays at the contract manufacturing facility.",
    "Resolved Note": "",
    "Reason for Shortage": "Regulatory delay",
    "Therapeutic Category": "Neurology; Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "08/03/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Flurazepam Hydrochloride Capsule",
    "Company Name": "Chartwell Molecular Holdings LLC",
    "Contact Info": "845-268-5000 Ext. 510",
    "Presentation": "Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-90)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Flurazepam Hydrochloride Capsule",
    "Company Name": "Chartwell Molecular Holdings LLC",
    "Contact Info": "845-268-5000 Ext. 510",
    "Presentation": "Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-90)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Flurazepam Hydrochloride Capsule",
    "Company Name": "Chartwell Molecular Holdings LLC",
    "Contact Info": "845-268-5000 Ext. 510",
    "Presentation": "Capsule, 15 mg (NDC 62135-736-30)",
    "Type of Update": "Revised",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "08/03/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Flurazepam Hydrochloride Capsule",
    "Company Name": "Chartwell Molecular Holdings LLC",
    "Contact Info": "845-268-5000 Ext. 510",
    "Presentation": "Capsule, 30 mg (NDC 62135-737-30)",
    "Type of Update": "Revised",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology; Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "08/03/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fluticasone Propionate Powder, Metered",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-525-8800",
    "Presentation": "ArmonAir Digihaler, Powder, Metered, 55 ug (NDC 59310-114-06)",
    "Type of Update": "New",
    "Date of Update": "04/30/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Pulmonary/Allergy",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/30/2024",
    "Initial Posting Date": "04/30/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fluticasone Propionate Powder, Metered",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-525-8800",
    "Presentation": "ArmonAir Digihaler, Powder, Metered, 113 ug/1 (NDC 59310-200-06)",
    "Type of Update": "New",
    "Date of Update": "04/30/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Pulmonary/Allergy",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/30/2024",
    "Initial Posting Date": "04/30/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fluticasone Propionate Powder, Metered",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-525-8800",
    "Presentation": "ArmonAir Digihaler, Powder, Metered, 232 ug/1 (NDC 59310-311-06)",
    "Type of Update": "New",
    "Date of Update": "04/30/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Pulmonary/Allergy",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/30/2024",
    "Initial Posting Date": "04/30/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fluticasone Propionate; Salmeterol Xinafoate Powder, Metered",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "AirDuo Digihaler, Powder, Metered, 55 ug; 14 ug (NDC 59310-111-06)",
    "Type of Update": "New",
    "Date of Update": "04/30/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Pulmonary/Allergy",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/30/2024",
    "Initial Posting Date": "04/30/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fluticasone Propionate; Salmeterol Xinafoate Powder, Metered",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "AirDuo Digihaler, Powder, Metered, 113 ug; 14 ug (NDC 59310-129-06)",
    "Type of Update": "New",
    "Date of Update": "04/30/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Pulmonary/Allergy",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/30/2024",
    "Initial Posting Date": "04/30/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fluticasone Propionate; Salmeterol Xinafoate Powder, Metered",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "AirDuo Digihaler, Powder, Metered, 232 ug; 14 ug (NDC 59310-136-06)",
    "Type of Update": "New",
    "Date of Update": "04/30/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Pulmonary/Allergy",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/30/2024",
    "Initial Posting Date": "04/30/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Fulvestrant Solution",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Solution, 250 mg/5 mL (NDC 0591-5019-02)",
    "Type of Update": "New",
    "Date of Update": "10/26/2023",
    "Availability Information": "",
    "Related Information": "Business Decision to Discontinue.",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Oncology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/26/2023",
    "Initial Posting Date": "10/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Avet Pharmaceuticals, Inc.",
    "Contact Info": "855-228-9470",
    "Presentation": "Injection, 10 mg/1 mL (NDC 83634-302-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "Distributed by Avenacy; Contact information: 877-283-6229",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 10 mg/mL, 2 mL (NDC 70860-302-41)",
    "Type of Update": "Revised",
    "Date of Update": "03/06/2024",
    "Availability Information": "",
    "Related Information": "This presentation has been discontinued",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "03/06/2024",
    "Date Discontinued": "03/06/2024",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 10 mg/mL, 4 mL (NDC 70860-302-42)",
    "Type of Update": "Revised",
    "Date of Update": "03/06/2024",
    "Availability Information": "",
    "Related Information": "This presentation has been discontinued",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "03/06/2024",
    "Date Discontinued": "03/06/2024",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 10 mg/mL, 10 mL (NDC 70860-302-43)",
    "Type of Update": "Revised",
    "Date of Update": "03/06/2024",
    "Availability Information": "",
    "Related Information": "This presentation has been discontinued",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "03/06/2024",
    "Date Discontinued": "03/06/2024",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Meitheal Pharmaceuticals, Inc.",
    "Contact Info": "844-824-8426",
    "Presentation": "Injection, 10 mg/mL, 2 mL (NDC 71288-205-03)",
    "Type of Update": "Reverified",
    "Date of Update": "07/03/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Meitheal Pharmaceuticals, Inc.",
    "Contact Info": "844-824-8426",
    "Presentation": "Injection, 10 mg/1 mL (NDC 71288-203-05)",
    "Type of Update": "Reverified",
    "Date of Update": "07/03/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Meitheal Pharmaceuticals, Inc.",
    "Contact Info": "844-824-8426",
    "Presentation": "Injection, 10 mg/1 mL (NDC 71288-203-11)",
    "Type of Update": "Reverified",
    "Date of Update": "07/03/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 10 mg/1 mL (NDC 70860-302-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Use Sagent NDC 25021-311-02",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 10 mg/1 mL (NDC 70860-302-04)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Use Sagent NDC 25021-311-04",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 10 mg/1 mL (NDC 70860-302-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Use Sagent NDC 25021-311-10",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875",
    "Presentation": "Injection, 10 mg/1 mL (NDC 16729-500-08)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Requirements related to complying with good manufacturing practices",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875",
    "Presentation": "Injection, 10 mg/1 mL (NDC 16729-501-43)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875",
    "Presentation": "Injection, 10 mg/1 mL (NDC 16729-502-43)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Requirements related to complying with good manufacturing practices",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-27)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 10 mg/1 mL (NDC 63323-280-02)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 10 mg/1 mL (NDC 63323-280-04)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 10 mg/1 mL (NDC 63323-280-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 20 mg/2 mL (NDC 55150-322-25)",
    "Type of Update": "Reverified",
    "Date of Update": "08/05/2024",
    "Availability Information": "Unavailable",
    "Related Information": "On backorder. Recovery: TBD. Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 40 mg/4 mL (NDC 55150-323-25)",
    "Type of Update": "Reverified",
    "Date of Update": "08/05/2024",
    "Availability Information": "Unavailable",
    "Related Information": "On backorder. Recovery: TBD. Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 100 mg/10 mL (NDC 55150-324-25)",
    "Type of Update": "Reverified",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Furosemide, Injection, 10 mg/1 mL (NDC 36000-284-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Furosemide, Injection, 10 mg/1 mL (NDC 36000-282-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Furosemide, Injection, 10 mg/1 mL (NDC 36000-283-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Avet Pharmaceuticals, Inc.",
    "Contact Info": "855-228-9470",
    "Presentation": "Injection, 10 mg/1 mL (NDC 23155-473-41)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Avet Pharmaceuticals, Inc.",
    "Contact Info": "855-228-9470",
    "Presentation": "Injection, 10 mg/1 mL (NDC 23155-473-42)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Avet Pharmaceuticals, Inc.",
    "Contact Info": "855-228-9470",
    "Presentation": "Injection, 10 mg/1 mL (NDC 23155-473-44)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-04)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Furosemide, Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Furosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-25)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-26)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 10 mg/1 mL (NDC 25021-311-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 10 mg/1 mL (NDC 25021-311-04)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 10 mg/1 mL (NDC 25021-311-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "866-625-1618",
    "Presentation": "Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "866-625-1618",
    "Presentation": "Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-04)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Furosemide Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "866-625-1918",
    "Presentation": "Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/07/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Gentamicin Sulfate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 40 mg/1 mL (NDC 63323-010-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/24/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Resolved",
    "Change Date": "07/24/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Gentamicin Sulfate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 40 mg/1 mL (NDC 63323-010-20)",
    "Type of Update": "Revised",
    "Date of Update": "07/24/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Resolved",
    "Change Date": "07/24/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Gentamicin Sulfate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 10 mg/1 mL (NDC 63323-173-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/24/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Resolved",
    "Change Date": "07/24/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Gentamicin Sulfate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 80 mg/2 mL (40 mg/mL) (NDC 0409-1207-03)",
    "Type of Update": "Revised",
    "Date of Update": "07/24/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Resolved",
    "Change Date": "07/24/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Gentamicin Sulfate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Gentamicin Sulfate, Injection, 40 mg/1 mL (NDC 0409-1207-25)",
    "Type of Update": "Revised",
    "Date of Update": "03/29/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "To Be Discontinued",
    "Change Date": "03/29/2024",
    "Date Discontinued": "03/29/2024",
    "Initial Posting Date": "07/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Gentamicin Sulfate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Injection, 40 mg/1 mL (NDC 0143-9128-25)",
    "Type of Update": "Revised",
    "Date of Update": "07/24/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Resolved",
    "Change Date": "07/24/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Gentamicin Sulfate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Gentamicin Sulfate In Sodium Chloride 0.9% In Plastic Container, Injection, 60 mg/50 mL (NDC 0338-0507-41)",
    "Type of Update": "Revised",
    "Date of Update": "07/24/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Resolved",
    "Change Date": "07/24/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Gentamicin Sulfate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Gentamicin Sulfate In Sodium Chloride 0.9% In Plastic Container, Injection, 80 mg/50 mL (NDC 0338-0509-41)",
    "Type of Update": "Revised",
    "Date of Update": "07/24/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Resolved",
    "Change Date": "07/24/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Gentamicin Sulfate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Gentamicin Sulfate In Sodium Chloride 0.9% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-0503-48)",
    "Type of Update": "Revised",
    "Date of Update": "07/24/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Resolved",
    "Change Date": "07/24/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Gentamicin Sulfate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Gentamicin Sulfate In Sodium Chloride 0.9% In Plastic Container, Injection, 100 mg/50 mL (NDC 0338-0511-41)",
    "Type of Update": "Revised",
    "Date of Update": "07/24/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Resolved",
    "Change Date": "07/24/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Gentamicin Sulfate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Gentamicin Sulfate In Sodium Chloride 0.9% In Plastic Container, Injection, 100 mg/100 mL (NDC 0338-0505-48)",
    "Type of Update": "Revised",
    "Date of Update": "07/24/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Resolved",
    "Change Date": "07/24/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Gentamicin Sulfate Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Gentamicin Sulfate In Sodium Chloride 0.9% In Plastic Container, Injection, 60 mg/50 mL (NDC 0338-0507-48)",
    "Type of Update": "Revised",
    "Date of Update": "07/24/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Resolved",
    "Change Date": "07/24/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Glipizide Tablet, Extended Release",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Glipizide XL, Tablet, Extended Release, 5 mg (NDC 59762-0541-2)",
    "Type of Update": "New",
    "Date of Update": "08/09/2023",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "To Be Discontinued",
    "Change Date": "08/09/2023",
    "Date Discontinued": "08/09/2023",
    "Initial Posting Date": "08/09/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Glipizide Tablet, Extended Release",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Glipizide XL, Tablet, Extended Release, 10 mg (NDC 59762-0542-2)",
    "Type of Update": "New",
    "Date of Update": "08/09/2023",
    "Availability Information": "",
    "Related Information": "Supply expected to exhaust October 2023",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "To Be Discontinued",
    "Change Date": "08/09/2023",
    "Date Discontinued": "08/09/2023",
    "Initial Posting Date": "08/09/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Glipizide Tablet, Extended Release",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Glucotrol XL, Tablet, Extended Release, 5 mg (NDC 0049-0174-02)",
    "Type of Update": "New",
    "Date of Update": "08/05/2024",
    "Availability Information": "",
    "Related Information": "Supply expected to exhaust mid September 2024; Discontinuation of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "08/05/2024",
    "Initial Posting Date": "08/05/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Glipizide Tablet, Extended Release",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Glipizide XL, Tablet, Extended Release, 5 mg (NDC 59762-0541-1)",
    "Type of Update": "New",
    "Date of Update": "08/09/2023",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "To Be Discontinued",
    "Change Date": "08/09/2023",
    "Date Discontinued": "08/09/2023",
    "Initial Posting Date": "06/20/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Glipizide Tablet, Extended Release",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Glipizide XL, Tablet, Extended Release, 10 mg (NDC 59762-0542-1)",
    "Type of Update": "New",
    "Date of Update": "08/09/2023",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "To Be Discontinued",
    "Change Date": "08/09/2023",
    "Date Discontinued": "08/09/2023",
    "Initial Posting Date": "08/09/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Glipizide Tablet, Extended Release",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Glucotrol XL, Tablet, Extended Release, 10 mg (NDC 0049-0178-07)",
    "Type of Update": "New",
    "Date of Update": "08/09/2023",
    "Availability Information": "",
    "Related Information": "Supply expected to exhaust November 2023",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "To Be Discontinued",
    "Change Date": "08/09/2023",
    "Date Discontinued": "08/09/2023",
    "Initial Posting Date": "06/20/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Glipizide Tablet, Extended Release",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Glipizide XL, Tablet, Extended Release, 2.5 mg (NDC 59762-0540-1)",
    "Type of Update": "New",
    "Date of Update": "08/09/2023",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "To Be Discontinued",
    "Change Date": "08/09/2023",
    "Date Discontinued": "08/09/2023",
    "Initial Posting Date": "08/09/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Glucagon Hydrochloride Injection",
    "Company Name": "Novo Nordisk",
    "Contact Info": "609-987-5800",
    "Presentation": "Glucagen, Injection, 1 mg/1 mL (NDC 0169-7065-15)",
    "Type of Update": "New",
    "Date of Update": "11/15/2023",
    "Availability Information": "",
    "Related Information": "Will be unavailable after July 1, 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "11/18/2022",
    "Initial Posting Date": "11/18/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Heparin Sodium Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Heparin Sodium 1,000 Units In Sodium Chloride 0.9% In Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Hematology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/14/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Heparin Sodium Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 200 [USP'U]/100 mL (NDC 63323-519-77)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Hematology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/14/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Heparin Sodium Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 200 [USP'U]/100 mL (NDC 63323-519-10)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Hematology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/14/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Heparin Sodium Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0424-18)",
    "Type of Update": "Reverified",
    "Date of Update": "06/21/2024",
    "Availability Information": "Available",
    "Related Information": "On allocation; Product code AHB0953U replaces code 2B0953",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Hematology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/14/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Heparin Sodium Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04)",
    "Type of Update": "Revised",
    "Date of Update": "05/13/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "On Allocation; Recovery June 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Hematology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/14/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Heparin Sodium Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0431-03)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Hematology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/14/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Heparin Sodium Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-7620-03)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Hematology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/14/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Heparin Sodium Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Heparin Sodium, Injection, 2,000 Units/1,000 mL (2 Units/mL) (NDC 0409-7620-59)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Hematology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/14/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hyaluronidase, Ovine Injection",
    "Company Name": "Bausch & Lomb Incorporated",
    "Contact Info": "800-321-4576",
    "Presentation": "Vitrase, Injection, 200 USP U/mL (NDC 24208-002-02)",
    "Type of Update": "New",
    "Date of Update": "08/28/2023",
    "Availability Information": "",
    "Related Information": "Discontinuing manufacture of the product.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Ophthalmology; Other",
    "Status": "To Be Discontinued",
    "Change Date": "08/28/2023",
    "Date Discontinued": "08/28/2023",
    "Initial Posting Date": "08/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hyaluronidase, Ovine Injection",
    "Company Name": "Bausch & Lomb Incorporated",
    "Contact Info": "800-321-4576",
    "Presentation": "Vitrase, Injection, 200USP U/ml  (NDC 24208-002-03)",
    "Type of Update": "New",
    "Date of Update": "08/28/2023",
    "Availability Information": "",
    "Related Information": "Discontinuing manufacture of the product.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Ophthalmology; Other",
    "Status": "To Be Discontinued",
    "Change Date": "08/28/2023",
    "Date Discontinued": "08/28/2023",
    "Initial Posting Date": "08/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydrochlorothiazide; Quinapril Hydrochloride Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Accuretic, Tablet, 12.5 mg; 20 mg (NDC 59762-0220-1)",
    "Type of Update": "New",
    "Date of Update": "10/02/2023",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/02/2023",
    "Initial Posting Date": "10/02/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydrochlorothiazide; Quinapril Hydrochloride Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Accuretic, Tablet, 12.5 mg; 10 mg (NDC 59762-0222-1)",
    "Type of Update": "New",
    "Date of Update": "10/02/2023",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/02/2023",
    "Initial Posting Date": "10/02/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE TABLET",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "ACCURETIC, TABLET, 25 mg; 20 mg (NDC 59762-0223-1)",
    "Type of Update": "New",
    "Date of Update": "10/02/2023",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Antibiotic; Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/02/2023",
    "Initial Posting Date": "10/02/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydrocortisone Sodium Succinate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Solu-cortef, Injection, 1000 mg/vial (NDC 0009-0005-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Pulmonary/Allergy; Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Renal; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/24/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydrocortisone Sodium Succinate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Solu-cortef, Injection, 100 mg/vial (NDC 0009-0825-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: August 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Pulmonary/Allergy; Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Renal; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/24/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydrocortisone Sodium Succinate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Solu-cortef, Injection, 100 mg/vial (NDC 0009-0011-04)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Pulmonary/Allergy; Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Renal; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/24/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydrocortisone Sodium Succinate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Solu-Cortef, Injection, 100 mg/vial (NDC 0009-0011-03)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Pulmonary/Allergy; Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Renal; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/24/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydrocortisone Sodium Succinate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Solu-cortef, Injection, 250 mg/vial (NDC 0009-0013-06)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Pulmonary/Allergy; Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Renal; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/24/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydrocortisone Sodium Succinate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Solu-cortef, Injection, 250 mg/vial (NDC 0009-0013-05)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Pulmonary/Allergy; Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Renal; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/24/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydrocortisone Sodium Succinate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Solu-cortef, Injection, 500 mg/vial (NDC 0009-0016-12)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Pulmonary/Allergy; Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Renal; Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/24/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydromorphone Hydrochloride Injection",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Hydromorphone Hydrochloride Injection, USP CII, Injection, 10 mg/1 mL (NDC 0703-0110-03)",
    "Type of Update": "Revised",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Estimated recovery September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/01/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydromorphone Hydrochloride Injection",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Hydromorphone Hydrochloride Injection, USP CII, Injection, 10 mg/1 mL (NDC 0703-0113-03)",
    "Type of Update": "Revised",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Estimated recovery July 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/01/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydromorphone Hydrochloride Injection",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Hydromorphone Hydrochloride Injection, USP CII, Injection, 10 mg/1 mL (NDC 0703-0018-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Estimated recovery July 2024",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/01/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydromorphone Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Hydromorphone HCl Injection, USP, Injection, 2 mg/1 mL (NDC 0641-0121-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/03/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydromorphone Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Hydromorphone HCl Injection, USP, Injection, 2 mg/1 mL (NDC 0641-2341-41)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/03/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydromorphone Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Hydromorphone Hydrochloride, Injection, 1 mg/1 mL Syringes (NDC 0409-1283-31)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: July 2024; Estimated Recovery: December 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/179002/download",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydromorphone Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Hydromorphone Hydrochloride, Injection, 2 mg/1 mL Syringes (NDC 0409-1312-30)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: August 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/179002/download",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydromorphone Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Hydromorphone Hydrochloride, Injection, 4 mg/1 mL Syringes (NDC 0409-1304-31)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/179002/download",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydromorphone Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 0409-2552-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery and Estimated Recovery: June 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydromorphone Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-2634-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: January 2025; Estimated Recovery: March 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/179002/download",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydromorphone Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Hydromorphone Hydrochloride, Injection, 50 mg/5 mL (10 mg/mL)  (NDC 0409-2634-05)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: January 2025; Estimated Recovery: March 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/179002/download",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydromorphone Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Hydromorphone Hydrochloride, Injection, 500 mg/50 mL (10 mg/mL)  (NDC 0409-2634-50)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: January 2025; Estimated Recovery: March 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/179002/download",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydromorphone Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 1 mg/1 mL (NDC 63323-852-25)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydromorphone Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 2 mg/1 mL (NDC 63323-853-25)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Backordered. Next release September 2024;  Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydromorphone Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 4 mg/1 mL (NDC 63323-854-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydromorphone Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 10 mg/1 mL (NDC 63323-851-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Backordered. Next release August 2024. Check wholesalers for inventory.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydromorphone Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 10 mg/1 mL (NDC 63323-851-15)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Backordered. Next release August 2024; Check wholesalers for inventory.",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydromorphone Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 10 mg/1 mL (NDC 63323-851-50)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydromorphone Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-11)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydromorphone Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydromorphone Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Dilaudid, Injection, 2 mg/1 mL (NDC 76045-010-11)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydroxocobalamin Injection",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800 545 8800",
    "Presentation": "Hydroxocobalamin Injection USP, Injection, 1000 ug/1 mL (NDC 0591-2888-30)",
    "Type of Update": "Revised",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/12/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Hydroxypropyl Cellulose (1600000 Wamw) Insert",
    "Company Name": "Bausch & Lomb Incorporated",
    "Contact Info": "800-553-5340",
    "Presentation": "Lacrisert, Insert, 5 mg (NDC 24208-800-60)",
    "Type of Update": "Revised",
    "Date of Update": "07/22/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Discontinuation of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Ophthalmology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/01/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Iloprost Solution",
    "Company Name": "Actelion Pharmaceuticals",
    "Contact Info": "800-526-7736",
    "Presentation": "Ventavis, Solution, 10 ug/1 mL (NDC 66215-302-30)",
    "Type of Update": "New",
    "Date of Update": "05/09/2024",
    "Availability Information": "",
    "Related Information": "Philips Respironics has decided to discontinue the I-neb AAD system and its associated supplies, including the medication discs required for administering VENTAVIS inhalation solution.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Pulmonary/Allergy",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "05/09/2024",
    "Initial Posting Date": "05/09/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Iloprost Solution",
    "Company Name": "Actelion Pharmaceuticals",
    "Contact Info": "800-526-7736",
    "Presentation": "Ventavis, Solution, 20 ug/1 mL (NDC 66215-303-30)",
    "Type of Update": "New",
    "Date of Update": "05/09/2024",
    "Availability Information": "",
    "Related Information": "Philips Respironics has decided to discontinue the I-neb AAD system and its associated supplies, including the medication discs required for administering VENTAVIS inhalation solution.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Pulmonary/Allergy",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "05/09/2024",
    "Initial Posting Date": "05/09/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Imipramine Hydrochloride Tablet",
    "Company Name": "Par Pharmaceutical, Inc.",
    "Contact Info": "800-828-9393",
    "Presentation": "Imipramine Hydrochloride, Tablet, 50 mg (NDC 49884-056-01)",
    "Type of Update": "Revised",
    "Date of Update": "09/15/2023",
    "Availability Information": "",
    "Related Information": "ANDA ownership transferred",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "09/14/2023",
    "Date Discontinued": "09/14/2023",
    "Initial Posting Date": "09/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Imipramine Hydrochloride Tablet",
    "Company Name": "Par Pharmaceutical, Inc.",
    "Contact Info": "800-828-9393",
    "Presentation": "Imipramine Hydrochloride, Tablet, 50 mg (NDC 49884-056-10)",
    "Type of Update": "Revised",
    "Date of Update": "09/15/2023",
    "Availability Information": "",
    "Related Information": "ANDA ownership transferred",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "09/14/2023",
    "Date Discontinued": "09/14/2023",
    "Initial Posting Date": "09/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Imipramine Hydrochloride Tablet",
    "Company Name": "Par Pharmaceutical, Inc.",
    "Contact Info": "800-828-9393",
    "Presentation": "Imipramine Hydrochloride, Tablet, 25 mg (NDC 49884-055-10)",
    "Type of Update": "Revised",
    "Date of Update": "09/15/2023",
    "Availability Information": "",
    "Related Information": "ANDA ownership transferred",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "09/14/2023",
    "Date Discontinued": "09/14/2023",
    "Initial Posting Date": "09/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Imipramine Hydrochloride Tablet",
    "Company Name": "Par Pharmaceutical, Inc.",
    "Contact Info": "800-828-9393",
    "Presentation": "Imipramine Hydrochloride, Tablet, 25 mg (NDC 49884-055-01)",
    "Type of Update": "Revised",
    "Date of Update": "09/15/2023",
    "Availability Information": "",
    "Related Information": "ANDA ownership transferred",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "09/14/2023",
    "Date Discontinued": "09/14/2023",
    "Initial Posting Date": "09/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Imipramine Hydrochloride Tablet",
    "Company Name": "Par Pharmaceutical, Inc.",
    "Contact Info": "800-828-9393",
    "Presentation": "Imipramine Hydrochloride, Tablet, 10 mg (NDC 49884-054-01)",
    "Type of Update": "Revised",
    "Date of Update": "09/15/2023",
    "Availability Information": "",
    "Related Information": "ANDA ownership transferred",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "09/14/2023",
    "Date Discontinued": "09/14/2023",
    "Initial Posting Date": "09/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Imipramine Hydrochloride Tablet",
    "Company Name": "Par Pharmaceutical, Inc.",
    "Contact Info": "800-828-9393",
    "Presentation": "Imipramine Hydrochloride, Tablet, 10 mg (NDC 49884-054-10)",
    "Type of Update": "Revised",
    "Date of Update": "09/15/2023",
    "Availability Information": "",
    "Related Information": "ANDA ownership transferred",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "09/14/2023",
    "Date Discontinued": "09/14/2023",
    "Initial Posting Date": "09/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Indigotindisulfonate Sodium Injection",
    "Company Name": "American Regent, Inc.",
    "Contact Info": "800-645-1706",
    "Presentation": "Indigo Carmine, Injection, 8 mg/1 mL (NDC 0517-0375-05)",
    "Type of Update": "Revised",
    "Date of Update": "11/01/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Medical Imaging",
    "Status": "To Be Discontinued",
    "Change Date": "11/01/2023",
    "Date Discontinued": "11/01/2023",
    "Initial Posting Date": "08/23/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Indigotindisulfonate Sodium Injection",
    "Company Name": "Provepharm SAS",
    "Contact Info": "610-601-8600",
    "Presentation": "Bludigo, Injection, 8 mg/1 mL (NDC 81284-315-05)",
    "Type of Update": "Revised",
    "Date of Update": "03/13/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Medical Imaging",
    "Status": "Resolved",
    "Change Date": "03/13/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "08/23/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Insulin (human) Injection",
    "Company Name": "Eli Lilly and Co.",
    "Contact Info": "800-545-5979",
    "Presentation": "Humulin-R, Injection, 100 [iU]/1 mL, 3mL vial (NDC 0002-0213-01)",
    "Type of Update": "New",
    "Date of Update": "03/01/2024",
    "Availability Information": "",
    "Related Information": "Humulin R U-100 will continue to be available in 10mL vials.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/01/2024",
    "Initial Posting Date": "03/01/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Insulin (human) Injection",
    "Company Name": "Eli Lilly and Co.",
    "Contact Info": "800-545-5979",
    "Presentation": "Humulin-R, Injection, 100 [iU]/1 mL, 3 mL vial (NDC 0002-8215-17)",
    "Type of Update": "New",
    "Date of Update": "03/01/2024",
    "Availability Information": "",
    "Related Information": "Humulin R U-100 will continue to be available in 10mL vials.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/01/2024",
    "Initial Posting Date": "03/01/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Insulin Detemir Injection",
    "Company Name": "Novo Nordisk",
    "Contact Info": "609-987-5800",
    "Presentation": "Levemir, Injection, 100 [iU]/1 mL (NDC 0169-6432-10)",
    "Type of Update": "New",
    "Date of Update": "11/08/2023",
    "Availability Information": "",
    "Related Information": "Limited supply of Levemir FlexPen through the end of 2024. Full brand discontinuation will occur on December 31, 2024.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Other",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "11/08/2023",
    "Initial Posting Date": "11/08/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Insulin Detemir Injection",
    "Company Name": "Novo Nordisk",
    "Contact Info": "609-987-5800",
    "Presentation": "Levemir, Injection, 100 [iU]/1 mL (NDC 0169-3687-12)",
    "Type of Update": "New",
    "Date of Update": "11/08/2023",
    "Availability Information": "",
    "Related Information": "Levemir vials will be available until the end of 2024. Full brand discontinuation will occur on December 31, 2024.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Other",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "11/08/2023",
    "Initial Posting Date": "11/08/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Insulin Glargine Injection",
    "Company Name": "Sanofi-Aventis U.S. LLC",
    "Contact Info": "800-633-1610 Option 7",
    "Presentation": "Insulin Glargine Solostar, Injection, 100 [iU]/mL (NDC 0955-1728-05)",
    "Type of Update": "New",
    "Date of Update": "05/24/2024",
    "Availability Information": "",
    "Related Information": "Sanofi has discontinued this product due to a business decision.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Other",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "05/24/2024",
    "Initial Posting Date": "05/24/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Insulin Glargine Injection",
    "Company Name": "Sanofi-Aventis U.S. LLC",
    "Contact Info": "800-633-1610 Option 7",
    "Presentation": "Insulin glargine, Injection, 100 [iU]/mL (NDC 0955-1729-01)",
    "Type of Update": "New",
    "Date of Update": "05/24/2024",
    "Availability Information": "",
    "Related Information": "Sanofi has discontinued this product due to a business decision.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Other",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "05/24/2024",
    "Initial Posting Date": "05/24/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Insulin Lispro Injection",
    "Company Name": "Eli Lilly and Co.",
    "Contact Info": "800-545-5979?",
    "Presentation": "Humalog, Injection, 3mL vial (NDC 0002-7510-17)",
    "Type of Update": "New",
    "Date of Update": "03/27/2024",
    "Availability Information": "",
    "Related Information": "Alternatives include 10 mL vial and KwikPen presentations of Humalog and Insulin Lispro Injection",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/27/2024",
    "Initial Posting Date": "03/27/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Insulin Lispro Injection",
    "Company Name": "Eli Lilly and Co.",
    "Contact Info": "800-545-5979?",
    "Presentation": "Humalog, Injection, 3mL vial (NDC 0002-7533-01)",
    "Type of Update": "New",
    "Date of Update": "03/27/2024",
    "Availability Information": "",
    "Related Information": "Alternatives include 10 mL vial and KwikPen presentations of Humalog and Insulin Lispro Injection",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/27/2024",
    "Initial Posting Date": "03/27/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Iobenguane I-131 Injection",
    "Company Name": "Progenics Pharmaceuticals Inc.",
    "Contact Info": "",
    "Presentation": "Azedra, Injection, 15 mCi/1 mL (NDC 71258-015-02)",
    "Type of Update": "New",
    "Date of Update": "08/23/2023",
    "Availability Information": "",
    "Related Information": "This product is being discontinued for lack of commercial demand.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "To Be Discontinued",
    "Change Date": "08/23/2023",
    "Date Discontinued": "08/23/2023",
    "Initial Posting Date": "08/23/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Iobenguane I-131 Injection",
    "Company Name": "Progenics Pharmaceuticals Inc.",
    "Contact Info": "",
    "Presentation": "Azedra, Injection, 15 mCi/1 mL (NDC 71258-015-22)",
    "Type of Update": "New",
    "Date of Update": "08/23/2023",
    "Availability Information": "",
    "Related Information": "This product is being discontinued for lack of commercial demand.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "To Be Discontinued",
    "Change Date": "08/23/2023",
    "Date Discontinued": "08/23/2023",
    "Initial Posting Date": "08/23/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Isoniazid Tablet",
    "Company Name": "Chartwell Molecular Holdings LLC",
    "Contact Info": "845-268-5000 Ext. 510",
    "Presentation": "Laniazid, Tablet, 300 mg (NDC 62135-709-90)",
    "Type of Update": "New",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/17/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Isoniazid Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Isoniazid Tablets, USP, Tablet, 100 mg (NDC 0555-0066-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "-",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/17/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Isoniazid Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Isoniazid Tablets, USP, Tablet, 300 mg (NDC 0555-0071-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/19/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Estimated recovery October 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/17/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Isoniazid Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Isoniazid Tablets, USP, Tablet, 300 mg (NDC 0555-0071-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "-",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/17/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Itraconazole Capsule",
    "Company Name": "Par Pharmaceutical, Inc.",
    "Contact Info": "800-828-9393",
    "Presentation": "Itraconazole, Capsule, 100 mg (NDC 49884-239-11)",
    "Type of Update": "New",
    "Date of Update": "09/14/2023",
    "Availability Information": "",
    "Related Information": "Business decision to discontinue manufacturing of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective; Other",
    "Status": "To Be Discontinued",
    "Change Date": "09/14/2023",
    "Date Discontinued": "09/14/2023",
    "Initial Posting Date": "09/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketamine Hydrochloride Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "866-625-1618",
    "Presentation": "Ketamine Hydrochloride, Injection, 10 mg/1 mL (NDC 25021-682-20)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Distributed by Sagent Pharmaceuticals: 1-866-625-1618",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/16/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketamine Hydrochloride Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "866-625-1618",
    "Presentation": "Ketamine Hydrochloride, Injection, 50 mg/1 mL (NDC 25021-683-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Distributed by Sagent Pharmaceuticals: 1-866-625-1618",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/16/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketamine Hydrochloride Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "866-625-1618",
    "Presentation": "Ketamine Hydrochloride, Injection, 100 mg/1 mL (NDC 25021-684-05)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Distributed by Sagent Pharmaceuticals: 1-866-625-1618",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/16/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketamine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 10 mg/1 mL (NDC 65219-184-20)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/16/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketamine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 50 mg/1 mL (NDC 65219-188-10)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/16/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketamine Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Ketamine HCl Injection, USP, Injection, 50 mg/1 mL (NDC 0143-9508-10)",
    "Type of Update": "Revised",
    "Date of Update": "05/17/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Additional lots will be available in the June - July 2024 timeframe. Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/28/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketamine Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Ketamine HCl Injection, USP, Injection, 100 mg/1 mL (NDC 0143-9509-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/28/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketamine Hydrochloride Injection",
    "Company Name": "Par Pharmaceutical, Inc.",
    "Contact Info": "800-828-9393",
    "Presentation": "Ketalar, Injection, 10 mg/1 mL (NDC 42023-113-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketamine Hydrochloride Injection",
    "Company Name": "Par Pharmaceutical, Inc.",
    "Contact Info": "800-828-9393",
    "Presentation": "Ketalar, Injection, 100 mg/1 mL (NDC 42023-115-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Recovery: TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketamine Hydrochloride Injection",
    "Company Name": "Par Pharmaceutical, Inc.",
    "Contact Info": "800-828-9393",
    "Presentation": "Ketalar, Injection, 50 mg/1 mL (NDC 42023-114-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Recovery: TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketamine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 10 mg/1 mL (NDC 55150-438-10)",
    "Type of Update": "Reverified",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/16/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketamine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 50 mg/1 mL (NDC 55150-439-10)",
    "Type of Update": "Reverified",
    "Date of Update": "08/05/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Intermittent availability expected",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/16/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketamine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 100 mg/1 mL (NDC 55150-440-10)",
    "Type of Update": "Reverified",
    "Date of Update": "08/05/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Intermittent availability expected",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/16/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketamine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 500 mg/5 mL (100 mg/mL) (NDC 0409-0040-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/16/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketamine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Ketamine Hydrochloride, Injection, 500 mg/10 mL (50 mg/mL) (NDC 0409-2053-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: January 2025; Estimated Recovery: March 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/16/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "855-273-0154",
    "Presentation": "Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 70860-700-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "855-273-0154",
    "Presentation": "Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 70860-701-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "855-273-0154",
    "Presentation": "Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 70860-701-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 15 mg/1 mL (NDC 25021-700-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/26/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 30 mg/1 mL (NDC 25021-701-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/26/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 30 mg/1 mL (NDC 25021-701-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/26/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 15 mg/1 mL (NDC 0409-3793-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/26/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 30 mg/1 mL (NDC 0409-3795-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/26/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/26/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Injection, 15 mg/1 mL (NDC 0641-6041-25)",
    "Type of Update": "Revised",
    "Date of Update": "05/17/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Shortage recovery: TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/06/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Injection, 30 mg/1 mL (NDC 0641-6042-25)",
    "Type of Update": "Revised",
    "Date of Update": "05/17/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Shortage recovery: TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/06/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Injection, 30 mg/1 mL (NDC 0641-6043-25)",
    "Type of Update": "Revised",
    "Date of Update": "05/17/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Shortage recovery: TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/06/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 15 mg/1 mL (NDC 63323-161-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 30 mg/1 mL (NDC 63323-162-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 30 mg/1 mL (NDC 63323-162-02)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "609-250-7990",
    "Presentation": "Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/06/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "609-250-7990",
    "Presentation": "Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/06/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "FOR INTRAVENOUS AND INTRAMUSCULAR USE. 30mg/mL (1 mL fill volume/ 2 mL container)",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/06/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 15 mg/1 mL (NDC 76045-107-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Not available at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 30 mg/1 mL (NDC 76045-104-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Not available at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 60 mg/2 mL (NDC 76045-105-20)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10)",
    "Type of Update": "Revised",
    "Date of Update": "05/13/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Recovery August 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/06/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "855-273-0154",
    "Presentation": "Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 70860-701-03)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "855-273-0154",
    "Presentation": "Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 70860-700-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "855-273-0154",
    "Presentation": "Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 70860-701-04)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Alembic Pharmaceuticals",
    "Contact Info": "908-393-9604",
    "Presentation": "Injection, 15 mg/1 mL (NDC 62332-599-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Alembic Pharmaceuticals",
    "Contact Info": "908-393-9604",
    "Presentation": "Injection, 30 mg/1 mL (NDC 62332-600-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ketorolac Tromethamine Injection",
    "Company Name": "Alembic Pharmaceuticals",
    "Contact Info": "908-393-9604",
    "Presentation": "Injection, 60 mg/2 mL (NDC 62332-601-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Labetalol Hydrochloride Tablet",
    "Company Name": "Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Tablet, 100 mg (NDC 0591-0605-01)",
    "Type of Update": "New",
    "Date of Update": "03/11/2024",
    "Availability Information": "",
    "Related Information": "Permanent discontinuation in the manufacturing of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/11/2024",
    "Initial Posting Date": "03/11/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Labetalol Hydrochloride Tablet",
    "Company Name": "Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Tablet, 100 mg (NDC 0591-0605-05)",
    "Type of Update": "New",
    "Date of Update": "03/11/2024",
    "Availability Information": "",
    "Related Information": "Permanent discontinuation in the manufacturing of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/11/2024",
    "Initial Posting Date": "03/11/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Labetalol Hydrochloride Tablet",
    "Company Name": "Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Tablet, 200 mg (NDC 0591-0606-01)",
    "Type of Update": "New",
    "Date of Update": "03/11/2024",
    "Availability Information": "",
    "Related Information": "Permanent discontinuation in the manufacturing of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/11/2024",
    "Initial Posting Date": "03/11/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Labetalol Hydrochloride Tablet",
    "Company Name": "Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Tablet, 200 mg (NDC 0591-0606-05)",
    "Type of Update": "New",
    "Date of Update": "03/11/2024",
    "Availability Information": "",
    "Related Information": "Permanent discontinuation in the manufacturing of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/11/2024",
    "Initial Posting Date": "03/11/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Labetalol Hydrochloride Tablet",
    "Company Name": "Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Tablet, 300 mg (NDC 0591-0607-01)",
    "Type of Update": "New",
    "Date of Update": "03/11/2024",
    "Availability Information": "",
    "Related Information": "Permanent discontinuation in the manufacturing of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/11/2024",
    "Initial Posting Date": "03/11/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lacosamide Tablet",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Tablet, 50 mg (NDC 65162-923-06)",
    "Type of Update": "New",
    "Date of Update": "04/15/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/15/2024",
    "Initial Posting Date": "04/15/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lacosamide Tablet",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Tablet, 100 mg (NDC 65162-924-06)",
    "Type of Update": "New",
    "Date of Update": "04/15/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/15/2024",
    "Initial Posting Date": "04/15/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lacosamide Tablet",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Tablet, 150 mg (NDC 65162-925-06)",
    "Type of Update": "New",
    "Date of Update": "04/15/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/15/2024",
    "Initial Posting Date": "04/15/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lacosamide Tablet",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Tablet, 200 mg (NDC 65162-926-06)",
    "Type of Update": "New",
    "Date of Update": "04/15/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/15/2024",
    "Initial Posting Date": "04/15/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lanthanum Carbonate Tablet, Chewable",
    "Company Name": "Takeda Pharmaceuticals USA Inc.",
    "Contact Info": "877-TAKEDA-7 (1-877-825-3327)",
    "Presentation": "Tablet, Chewable, 500 mg (NDC 66993-422-85)",
    "Type of Update": "New",
    "Date of Update": "02/06/2024",
    "Availability Information": "",
    "Related Information": "30 Apr 2024; Branded FOSRENOL will continue to be available",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Renal",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "02/06/2024",
    "Initial Posting Date": "02/06/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lanthanum Carbonate Tablet, Chewable",
    "Company Name": "Takeda Pharmaceuticals USA Inc.",
    "Contact Info": "877-TAKEDA-7 (1-877-825-3327)",
    "Presentation": "Tablet, Chewable, 750 mg (NDC 66993-423-85)",
    "Type of Update": "New",
    "Date of Update": "02/06/2024",
    "Availability Information": "",
    "Related Information": "30 Apr 2024; Branded FOSRENOL will continue to be available",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Renal",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "02/06/2024",
    "Initial Posting Date": "02/06/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lanthanum Carbonate Tablet, Chewable",
    "Company Name": "Takeda Pharmaceuticals USA Inc.",
    "Contact Info": "877-TAKEDA-7 (1-877-825-3327)",
    "Presentation": "Tablet, Chewable, 1000 mg (NDC 66993-424-85)",
    "Type of Update": "New",
    "Date of Update": "02/06/2024",
    "Availability Information": "",
    "Related Information": "30 Apr 2024; Branded FOSRENOL will continue to be available",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Renal",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "02/06/2024",
    "Initial Posting Date": "02/06/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 200 mg/20 mL (NDC 63323-710-50)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "LEUCOVORIN CALCIUM PRESERVATIVE FREE, Injection, 500 mg/50 mL (NDC 63323-711-00)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Backordered. Next release August 2024; Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Slate Run Pharmaceuticals",
    "Contact Info": "888-447-0095",
    "Presentation": "Injection, 50 mg (NDC 70436-116-82)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Slate Run Pharmaceuticals",
    "Contact Info": "888-447-0095",
    "Presentation": "Injection, 100 mg (NDC 70436-117-80)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Slate Run Pharmaceuticals",
    "Contact Info": "888-447-0095",
    "Presentation": "Injection, 200 mg (NDC 70436-118-80)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Slate Run Pharmaceuticals",
    "Contact Info": "888-447-0095",
    "Presentation": "Injection, 500 mg (NDC 70436-120-80)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 50 mg/5 mL (NDC 25021-813-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Limited availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 100 mg/10 mL (NDC 25021-814-30)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 200 mg/20 mL (NDC 25021-815-30)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 350 mg/17.5 mL (NDC 25021-816-30)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Kindos Pharmaceuticals Co. Ltd.",
    "Contact Info": "Meitheal Pharmaceuticals, Inc.: 844-824-8426",
    "Presentation": "Injection, 50 mg/5 mL (NDC 71288-160-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Meitheal Pharmaceuticals, Inc.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Kindos Pharmaceuticals Co. Ltd.",
    "Contact Info": "Meitheal Pharmaceuticals, Inc.: 844-824-8426",
    "Presentation": "Injection, 100 mg/10 mL (NDC 71288-161-20)",
    "Type of Update": "Revised",
    "Date of Update": "07/11/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Meitheal Pharmaceuticals, Inc.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Kindos Pharmaceuticals Co. Ltd.",
    "Contact Info": "Meitheal Pharmaceuticals, Inc.: 844-824-8426",
    "Presentation": "Injection, 200 mg/20 mL (NDC 71288-162-30)",
    "Type of Update": "Revised",
    "Date of Update": "07/11/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Meitheal Pharmaceuticals, Inc.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Kindos Pharmaceuticals Co. Ltd.",
    "Contact Info": "Meitheal Pharmaceuticals, Inc.: 844-824-8426",
    "Presentation": "Injection, 350 mg/17.5 mL (NDC 71288-163-30)",
    "Type of Update": "Revised",
    "Date of Update": "07/11/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Meitheal Pharmaceuticals, Inc.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Kindos Pharmaceuticals Co. Ltd.",
    "Contact Info": "Meitheal Pharmaceuticals, Inc.: 844-824-8426",
    "Presentation": "Injection, 500 mg/50 mL (NDC 71288-164-50)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "Estimated recovery October 2024; Marketed by Meitheal Pharmaceuticals, Inc.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Leucovorin Calcium Preservative Free, Injection, 500 mg/50 mL (NDC 25021-828-50)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Out of stock",
    "Related Information": "Estimated delivery August 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Leucovorin Calcium for Injection, USP, Injection, 50 mg/5 mL (NDC 0143-9555-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Leucovorin Calcium for Injection, USP, Injection, 100 mg/10 mL (NDC 0143-9554-01)",
    "Type of Update": "Revised",
    "Date of Update": "05/17/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Additional lots are scheduled for manufacturing and will be available in the May - June 2024 timeframe.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Injection, 200 mg/20 mL (NDC 0143-9553-01)",
    "Type of Update": "Revised",
    "Date of Update": "05/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Leucovorin Calcium for Injection, USP, Injection, 350 mg/17.5 mL (NDC 0143-9552-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Leucovorin Calcium, Injection, 10 mg/1 mL (NDC 63323-631-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Leucovorin Calcium, Injection, 10 mg/1 mL (NDC 63323-631-50)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Mylan Institutional, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Leucovorin Calcium Preservative Free, Injection, 100 mg/10 mL (NDC 67457-528-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Mylan Institutional, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Leucovorin Calcium Preservative Free, Injection, 200 mg/20 mL (NDC 67457-529-20)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Leucovorin Calcium Injection",
    "Company Name": "Mylan Institutional, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Leucovorin Calcium Preservative Free, Injection, 350 mg/17.5 mL (NDC 67457-530-35)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 20 mg/mL (NDC 55150-256-50)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/13/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-31)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next release not available at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, 5 mg/1 mL (NDC 63323-484-57)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next release not available at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, 5 mg/1 mL (NDC 63323-491-57)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Lidocaine Hydrochloride In Plastic Container, Injection, 10 mg/1 mL (NDC 63323-201-02)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-201-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-27)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-57)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-27)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-57)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-37)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 50 mg/5mL (1%, 10 mg/1 mL) Syringes (NDC 0409-9137-05)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride Preservative Free, Injection, 200 mg/2 mL (1%; 10 mg/mL) (NDC 0409-4713-32)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride In Plastic Container, Injection, 200 mg/20 mL (1%; 10 mg/mL) (NDC 0409-4276-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride, Injection, 300 mg/30 mL (1%; 10 mg/mL) (NDC 0409-4279-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride In Plastic Container, Injection, 500 mg/50 mL (1%; 10 mg/mL) (NDC 0409-4276-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride, Injection, 40 mg/2 mL (2%; 20 mg/mL) (NDC 0409-4282-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride, Injection, 200 mg/10 mL (2%; 20 mg/mL) (NDC 0409-4282-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride, Injection, 50 mg/5mL (1%,10 mg/1 mL) Syringes (NDC 0409-4904-34)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery and Estimated Recovery: December 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride, Injection, 100 mg/5mL (2%, 20 mg/1 mL) Syringes (NDC 0409-4903-34)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: October 2025; Estimated Recovery: December 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride, Injection, 100 mg/5 mL (2%; 20 mg/mL) (NDC 0409-2066-05)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride In Plastic Container, Injection, 400 mg/20 mL (2%; 20 mg/mL) (NDC 0409-4277-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride In Plastic Container, Injection, 1,000 mg/50 mL (2%; 20 mg/mL) (NDC 0409-4277-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride Preservative Free, Injection, 200 mg/5 mL (4%; 40 mg/mL) (NDC 0409-4283-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: July 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 100 mg/5mL (2%,20 mg/1 mL) Syringes (NDC 0409-1323-05)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Next Delivery and Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Amphastar Pharmaceuticals, Inc.",
    "Contact Info": "800-423-4136",
    "Presentation": "Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 76329-3390-1)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "old NDC 0548-3390-00",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-97)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next release not available at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-91)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next release not available at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 63323-202-02)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/1 mL (NDC 63323-208-05)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-17)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-27)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-57)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-27)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-07)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Xylocaine, Injection, 20 mg/1 mL (NDC 63323-496-97)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next release date not available at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride In Plastic Container, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4275-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery and Estimated Recovery: December 2026",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4278-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride Preservative Free, Injection, 50 mg/5 mL (1%; 10 mg/mL) (NDC 0409-4713-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Lidocaine Hydrochloride Preservative Free, Injection, 300 mg/20 mL (1.5%; 15 mg/mL) (NDC 0409-4776-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Lidocaine Hydrochloride And Dextrose, Injection, 4 mg/1 mL (NDC 0338-0409-03)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/25/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Lidocaine Hydrochloride And Dextrose, Injection, 8 mg/1 mL (NDC 0338-0411-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/25/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 10 mg/mL (NDC 55150-251-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Unavailable",
    "Related Information": "On backorder. Recovery: TBD. Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/13/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 10 mg/mL (NDC 55150-252-20)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/13/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 20 mg/mL (NDC 55150-254-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/13/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 20 mg/mL (NDC 55150-255-20)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/13/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Lidocaine HCl Injection, USP Preservative Free, Injection, 10 mg/1 mL (NDC 0143-9595-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots are scheduled to be manufactured.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/13/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Lidocaine HCl Injection, USP Preservative Free, Injection, 20 mg/1 mL (NDC 0143-9594-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots are scheduled to be manufactured.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/13/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Lidocaine HCl Injection, USP, Injection, 10 mg/1 mL (NDC 0143-9577-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Additional lots will be available in the July - August 2024 timeframe. Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/13/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Lidocaine HCl Injection, USP, Injection, 20 mg/1 mL (NDC 0143-9575-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Additional lots will be available in the July - August 2024 timeframe. Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/13/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Spectra Medical Devices, LLC",
    "Contact Info": "978-657-0889 ext. 5231",
    "Presentation": "Injection, 10 mg/1 mL (NDC 65282-1605-1)",
    "Type of Update": "Reverified",
    "Date of Update": "06/26/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/14/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Lidocaine Hydrochloride Preservative Free, Injection, 10 mg/mL (NDC 55150-158-72)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Intermittent availability expected",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Lidocaine Hydrochloride Preservative Free, Injection, 10 mg/1 mL (NDC 55150-159-74)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Intermittent availability expected",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/1 mL (NDC 55150-160-72)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Intermittent availability expected",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Lidocaine Hydrochloride Preservative Free, Injection, 10 mg/1 mL (NDC 55150-161-02)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Lidocaine Hydrochloride Preservative Free, Injection, 10 mg/1 mL (NDC 55150-162-05)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Lidocaine Hydrochloride Preservative Free, Injection, 10 mg/1 mL (NDC 55150-163-30)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/mL (NDC 55150-164-02)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/1 mL (NDC 55150-165-05)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/20/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Afaxys Pharma",
    "Contact Info": "713-724-0238",
    "Presentation": "Injection, 10 mg/1 mL (NDC 50102-400-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Inventory available through ANDA, ASD Healthcare, Henry Schein, McKesson Medical-Surgical and R&S",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Sintetica US",
    "Contact Info": "844-425-3131, SinteticaCS@eversana.com",
    "Presentation": "Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 83090-001-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Inventory available at Cardinal Health, McKesson, Cencora (FKA Amerisource Bergen). Product (LIDOCAINE HCL 1% 10X2ML) is Preservative free.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Sintetica US",
    "Contact Info": "844-425-3131, SinteticaCS@eversana.com",
    "Presentation": "Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 83090-002-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Inventory available at Cardinal Health, McKesson, Cencora (FKA Amerisource Bergen). Product (LIDOCAINE HCL 1% 10X5ML)  is Preservative free.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Sintetica US",
    "Contact Info": "844-425-3131, SinteticaCS@eversana.com",
    "Presentation": "Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 83090-003-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Inventory available at Cardinal Health, McKesson, Cencora (FKA Amerisource Bergen). Product (LIDOCAINE HCL 1% 10X10ML) is Preservative free.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Sintetica US",
    "Contact Info": "844-425-3131, SinteticaCS@eversana.com",
    "Presentation": "Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 83090-004-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Inventory available at Cardinal Health, McKesson, Cencora (FKA Amerisource Bergen). Product (LIDOCAINE HCL 2% 10X2ML)  is Preservative free.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Sintetica US",
    "Contact Info": "844-425-3131, SinteticaCS@eversana.com",
    "Presentation": "Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 83090-005-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Inventory available at Cardinal Health, McKesson, Cencora (FKA Amerisource Bergen). Product (LIDOCAINE HCL 2% 10X5ML)  is Preservative free.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Sintetica US",
    "Contact Info": "844-425-3131, SinteticaCS@eversana.com",
    "Presentation": "Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 83090-006-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Inventory available at Cardinal Health, McKesson, Cencora (FKA Amerisource Bergen). Product (LIDOCAINE HCL 2% 10X10ML) is Preservative free.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Sintetica US",
    "Contact Info": "844-425-3131, SinteticaCS@eversana.com",
    "Presentation": "Lidocaine Hydrochloride, Injection, 40 mg/1 mL (NDC 83090-007-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Inventory available at Cardinal Health, McKesson, Cencora (FKA Amerisource Bergen). Product (LIDOCAINE HCL 4% 10X5ML)  is Preservative free.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/22/2012",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Injection",
    "Company Name": "Huons Co., Ltd. (South Korea)",
    "Contact Info": "intbiz@huons.com",
    "Presentation": "Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 73293-0001-2)",
    "Type of Update": "Reverified",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Solution",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Lidocaine Viscous (Lidocaine Hydrochloride Oral Topical Solution, USP), Solution, 20 mg/1 mL (NDC 0054-3500-49)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Available to current customers.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/18/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Solution",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Lidocaine Viscous (Lidocaine Hydrochloride Oral Topical Solution, USP), Solution, 20 mg/1 mL (NDC 0054-0548-44)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Available to current customers.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/18/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Solution",
    "Company Name": "PAI Pharma",
    "Contact Info": "800-845-8210",
    "Presentation": "Lidocaine Hydrochloride Viscous, Solution, 20 mg/1 mL (NDC 0121-4950-40)",
    "Type of Update": "Revised",
    "Date of Update": "06/24/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/18/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Solution",
    "Company Name": "PAI Pharma",
    "Contact Info": "800-845-8210",
    "Presentation": "Lidocaine Hydrochloride Viscous, Solution, 20 mg/1 mL (NDC 0121-0950-03)",
    "Type of Update": "Revised",
    "Date of Update": "06/24/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/18/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Solution",
    "Company Name": "Rubicon Research Private Limited",
    "Contact Info": "Daliya.Bharati@advagenpharma.com",
    "Presentation": "Solution, 20 mg/1 mL (NDC 72888-125-26)",
    "Type of Update": "Revised",
    "Date of Update": "06/18/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Advagen Pharma Ltd.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/08/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lidocaine Hydrochloride Solution",
    "Company Name": "Chartwell Molecular Holdings LLC",
    "Contact Info": "845-268-5000 Ext. 510",
    "Presentation": "Lidocaine Hydrochloride Viscous, Solution, 20 mg/1 mL (NDC 62135-712-42)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/18/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Linezolid Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Zyvox, Tablet, 600 mg (NDC 0009-5138-03)",
    "Type of Update": "New",
    "Date of Update": "03/28/2024",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/28/2024",
    "Initial Posting Date": "03/28/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Liraglutide Injection",
    "Company Name": "Novo Nordisk, Inc.",
    "Contact Info": "833-493-4689",
    "Presentation": "Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15)",
    "Type of Update": "Revised",
    "Date of Update": "07/01/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Estimated shortage duration TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/18/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Liraglutide Injection",
    "Company Name": "Novo Nordisk, Inc.",
    "Contact Info": "833-493-4689",
    "Presentation": "Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12)",
    "Type of Update": "Revised",
    "Date of Update": "07/01/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Estimated shortage duration TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/18/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Liraglutide Injection",
    "Company Name": "Novo Nordisk, Inc.",
    "Contact Info": "833-493-4689",
    "Presentation": "Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13)",
    "Type of Update": "Revised",
    "Date of Update": "07/01/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Estimated shortage duration TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/18/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Rhodes Pharmaceuticals L.P.",
    "Contact Info": "888-827-0616",
    "Presentation": "Capsule, 10 mg (NDC 42858-161-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Rhodes Pharmaceuticals L.P.",
    "Contact Info": "888-827-0616",
    "Presentation": "Capsule, 20 mg (NDC 42858-162-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Rhodes Pharmaceuticals L.P.",
    "Contact Info": "888-827-0616",
    "Presentation": "Capsule, 30 mg (NDC 42858-163-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable, Unknown",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Rhodes Pharmaceuticals L.P.",
    "Contact Info": "888-827-0616",
    "Presentation": "Capsule, 40 mg (NDC 42858-164-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Rhodes Pharmaceuticals L.P.",
    "Contact Info": "888-827-0616",
    "Presentation": "Capsule, 60 mg (NDC 42858-166-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Rhodes Pharmaceuticals L.P.",
    "Contact Info": "888-827-0616",
    "Presentation": "Capsule, 50 mg (NDC 42858-165-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Rhodes Pharmaceuticals L.P.",
    "Contact Info": "888-827-0616",
    "Presentation": "Capsule, 70 mg (NDC 42858-167-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/11/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Alvogen",
    "Contact Info": "844-842-8672 and email: CustomerService-US@alvogen.com",
    "Presentation": "Capsule, 10 mg (NDC 47781-562-01)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Alvogen",
    "Contact Info": "844-842-8672 and email: CustomerService-US@alvogen.com",
    "Presentation": "Capsule, 20 mg (NDC 47781-563-01)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Resupply End of April2024",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Alvogen",
    "Contact Info": "844-842-8672 and email: CustomerService-US@alvogen.com",
    "Presentation": "Capsule, 30 mg (NDC 47781-564-01)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Alvogen",
    "Contact Info": "844-842-8672 and email: CustomerService-US@alvogen.com",
    "Presentation": "Capsule, 40 mg (NDC 47781-565-01)",
    "Type of Update": "Reverified",
    "Date of Update": "04/17/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Resupply End of April 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Alvogen",
    "Contact Info": "844-842-8672 and email: CustomerService-US@alvogen.com",
    "Presentation": "Capsule, 50 mg (NDC 47781-566-01)",
    "Type of Update": "Reverified",
    "Date of Update": "04/17/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Resupply End of April 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Alvogen",
    "Contact Info": "844-842-8672 and email: CustomerService-US@alvogen.com",
    "Presentation": "Capsule, 60 mg (NDC 47781-567-01)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Alvogen",
    "Contact Info": "844-842-8672 and email: CustomerService-US@alvogen.com",
    "Presentation": "Capsule, 70 mg (NDC 47781-568-01)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Apotex Corp.",
    "Contact Info": "800-706-5575",
    "Presentation": "Capsule, 10 mg (NDC 60505-4739-1)",
    "Type of Update": "Revised",
    "Date of Update": "07/16/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next resupply expected Aug 2024; limited inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/01/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Apotex Corp.",
    "Contact Info": "800-706-5575",
    "Presentation": "Capsule, 20 mg (NDC 60505-4740-1)",
    "Type of Update": "Revised",
    "Date of Update": "07/16/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next resupply expected Aug 2024; limited inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/01/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Apotex Corp.",
    "Contact Info": "800-706-5575",
    "Presentation": "Capsule, 30 mg (NDC 60505-4741-1)",
    "Type of Update": "Revised",
    "Date of Update": "07/16/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next resupply expected Aug 2024; limited inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/01/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Apotex Corp.",
    "Contact Info": "800-706-5575",
    "Presentation": "Capsule, 40 mg (NDC 60505-4742-1)",
    "Type of Update": "Revised",
    "Date of Update": "07/16/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next resupply expected Aug 2024; limited inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/01/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Apotex Corp.",
    "Contact Info": "800-706-5575",
    "Presentation": "Capsule, 50 mg (NDC 60505-4743-1)",
    "Type of Update": "Revised",
    "Date of Update": "07/16/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next resupply expected Aug 2024; limited inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/01/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Apotex Corp.",
    "Contact Info": "800-706-5575",
    "Presentation": "Capsule, 60 mg (NDC 60505-4744-1)",
    "Type of Update": "Revised",
    "Date of Update": "07/16/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next resupply expected Aug 2024; limited inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/01/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Apotex Corp.",
    "Contact Info": "800-706-5575",
    "Presentation": "Capsule, 70 mg (NDC 60505-4745-1)",
    "Type of Update": "Revised",
    "Date of Update": "07/16/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next resupply expected Aug 2024; limited inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/01/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Takeda Pharmaceuticals USA Inc.",
    "Contact Info": "877-TAKEDA-7 (1-877-825-3327)",
    "Presentation": "Vyvanse, Capsule, 10 mg (NDC 59417-101-10)",
    "Type of Update": "Reverified",
    "Date of Update": "06/24/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Takeda Pharmaceuticals USA Inc.",
    "Contact Info": "877-TAKEDA-7 (1-877-825-3327)",
    "Presentation": "Vyvanse, Capsule, 20 mg (NDC 59417-102-10)",
    "Type of Update": "Reverified",
    "Date of Update": "06/24/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Takeda Pharmaceuticals USA Inc.",
    "Contact Info": "877-TAKEDA-7 (1-877-825-3327)",
    "Presentation": "Vyvanse, Capsule, 30 mg (NDC 59417-103-10)",
    "Type of Update": "Reverified",
    "Date of Update": "06/24/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Takeda Pharmaceuticals USA Inc.",
    "Contact Info": "877-TAKEDA-7 (1-877-825-3327)",
    "Presentation": "Vyvanse, Capsule, 40 mg (NDC 59417-104-10)",
    "Type of Update": "Reverified",
    "Date of Update": "06/24/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Takeda Pharmaceuticals USA Inc.",
    "Contact Info": "877-TAKEDA-7 (1-877-825-3327)",
    "Presentation": "Vyvanse, Capsule, 50 mg (NDC 59417-105-10)",
    "Type of Update": "Reverified",
    "Date of Update": "06/24/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Takeda Pharmaceuticals USA Inc.",
    "Contact Info": "877-TAKEDA-7 (1-877-825-3327)",
    "Presentation": "Vyvanse, Capsule, 60 mg (NDC 59417-106-10)",
    "Type of Update": "Reverified",
    "Date of Update": "06/24/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Takeda Pharmaceuticals USA Inc.",
    "Contact Info": "877-TAKEDA-7 (1-877-825-3327)",
    "Presentation": "Vyvanse, Capsule, 70 mg (NDC 59417-107-10)",
    "Type of Update": "Reverified",
    "Date of Update": "06/24/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Mylan Pharmaceuticals Inc., a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Capsule, 10 mg (NDC 0378-6854-77)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Allocating limited inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Mylan Pharmaceuticals Inc., a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Capsule, 20 mg (NDC 0378-6855-77)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Allocating limited inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Mylan Pharmaceuticals Inc., a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Capsule, 30 mg (NDC 0378-6856-77)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Allocating limited inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Mylan Pharmaceuticals Inc., a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Capsule, 40 mg (NDC 0378-6857-77)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Allocating limited inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Mylan Pharmaceuticals Inc., a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Capsule, 50 mg (NDC 0378-6858-77)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Allocating limited inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Mylan Pharmaceuticals Inc., a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Capsule, 60 mg (NDC 0378-6859-77)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Allocating limited inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Mylan Pharmaceuticals Inc., a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Capsule, 70 mg (NDC 0378-6860-77)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Allocating limited inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Capsule, 10 mg (NDC 57664-046-88)",
    "Type of Update": "Reverified",
    "Date of Update": "07/08/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Capsule, 30 mg (NDC 57664-048-88)",
    "Type of Update": "Reverified",
    "Date of Update": "07/08/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Capsule, 30 mg (NDC 57664-048-88)",
    "Type of Update": "Reverified",
    "Date of Update": "07/08/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Capsule, 40 mg (NDC 57664-049-88)",
    "Type of Update": "Reverified",
    "Date of Update": "07/08/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Capsule, 50 mg (NDC 57664-050-88)",
    "Type of Update": "Reverified",
    "Date of Update": "07/08/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Capsule, 60 mg (NDC 57664-051-88)",
    "Type of Update": "Reverified",
    "Date of Update": "07/08/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Capsule, 70 mg (NDC 57664-052-88)",
    "Type of Update": "Reverified",
    "Date of Update": "07/08/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "SpecGx LLC",
    "Contact Info": "800-325-8888",
    "Presentation": "Capsule, 10 mg (NDC 0406-5111-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Allocations to all customers. Backorder projected in October",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "SpecGx LLC",
    "Contact Info": "800-325-8888",
    "Presentation": "Capsule, 20 mg (NDC 0406-5112-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Available to primary customers only. Intermittent backorder expected through Sept.",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "SpecGx LLC",
    "Contact Info": "800-325-8888",
    "Presentation": "Capsule, 30 mg (NDC 0406-5113-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Available to primary customers only. Backorder projected in mid August",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "SpecGx LLC",
    "Contact Info": "800-325-8888",
    "Presentation": "Capsule, 40 mg (NDC 0406-5114-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Backorder. Next release mid August. Backorder expected again in September",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "SpecGx LLC",
    "Contact Info": "800-325-8888",
    "Presentation": "Capsule, 50 mg (NDC 0406-5115-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Backorder. Next release mid August. Backorder expected again in October",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "SpecGx LLC",
    "Contact Info": "800-325-8888",
    "Presentation": "Capsule, 60 mg (NDC 0406-5116-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "On backorder",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "SpecGx LLC",
    "Contact Info": "800-325-8888",
    "Presentation": "Capsule, 70 mg (NDC 0406-5117-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "On backorder.",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Capsule, 20 mg (NDC 0054-0370-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Available on allocation",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Capsule, 30 mg (NDC 0054-0371-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Available on allocation",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Capsule, 40 mg (NDC 0054-0372-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Available on allocation",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Capsule, 50 mg (NDC 0054-0373-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Available on allocation",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Capsule, 60 mg (NDC 0054-0374-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Available on allocation",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Capsule, 70 mg (NDC 0054-0375-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Available on allocation",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Lannett Company, Inc.",
    "Contact Info": "844-834-0530",
    "Presentation": "Capsule, 10 mg (NDC 0527-4661-37)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Allocating limited inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Lannett Company, Inc.",
    "Contact Info": "844-834-0530",
    "Presentation": "Capsule, 20 mg (NDC 0527-4662-37)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Allocating limited inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Lannett Company, Inc.",
    "Contact Info": "844-834-0530",
    "Presentation": "Capsule, 30 mg (NDC 0527-4663-37)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Allocating limited inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Lannett Company, Inc.",
    "Contact Info": "844-834-0530",
    "Presentation": "Capsule, 40 mg (NDC 0527-4664-37)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Allocating limited inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Lannett Company, Inc.",
    "Contact Info": "844-834-0530",
    "Presentation": "Capsule, 50 mg (NDC 0527-4665-37)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Lannett Company, Inc.",
    "Contact Info": "844-834-0530",
    "Presentation": "Capsule, 60 mg (NDC 0527-4666-37)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "09/20/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Lannett Company, Inc.",
    "Contact Info": "844-834-0530",
    "Presentation": "Capsule, 70 mg (NDC 0527-4667-37)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Capsule, 20 mg (NDC 65162-023-09)",
    "Type of Update": "Reverified",
    "Date of Update": "07/09/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Capsule, 30 mg (NDC 65162-024-09)",
    "Type of Update": "Reverified",
    "Date of Update": "07/09/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Capsule, 40 mg (NDC 65162-025-09)",
    "Type of Update": "Reverified",
    "Date of Update": "07/09/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Capsule, 50 mg (NDC 65162-026-09)",
    "Type of Update": "Reverified",
    "Date of Update": "07/09/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Capsule, 60 mg (NDC 65162-027-09)",
    "Type of Update": "Reverified",
    "Date of Update": "07/09/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Capsule, 70 mg (NDC 65162-028-09)",
    "Type of Update": "Reverified",
    "Date of Update": "07/09/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Solco Healthcare US, LLC",
    "Contact Info": "866-931-9829",
    "Presentation": "Capsule, 10 mg (NDC 43547-602-10)",
    "Type of Update": "Reverified",
    "Date of Update": "06/17/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Solco Healthcare US, LLC",
    "Contact Info": "866-931-9829",
    "Presentation": "Capsule, 20 mg (NDC 43547-603-10)",
    "Type of Update": "Reverified",
    "Date of Update": "06/17/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Solco Healthcare US, LLC",
    "Contact Info": "866-931-9829",
    "Presentation": "Capsule, 30 mg (NDC 43547-604-10)",
    "Type of Update": "Reverified",
    "Date of Update": "06/17/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Solco Healthcare US, LLC",
    "Contact Info": "866-931-9829",
    "Presentation": "Capsule, 40 mg (NDC 43547-605-10)",
    "Type of Update": "Reverified",
    "Date of Update": "06/17/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Solco Healthcare US, LLC",
    "Contact Info": "866-931-9829",
    "Presentation": "Capsule, 50 mg (NDC 43547-606-10)",
    "Type of Update": "Reverified",
    "Date of Update": "06/17/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Solco Healthcare US, LLC",
    "Contact Info": "866-931-9829",
    "Presentation": "Capsule, 60 mg (NDC 43547-607-10)",
    "Type of Update": "Reverified",
    "Date of Update": "06/17/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Capsule",
    "Company Name": "Solco Healthcare US, LLC",
    "Contact Info": "866-931-9829",
    "Presentation": "Capsule, 70 mg (NDC 43547-608-10)",
    "Type of Update": "Reverified",
    "Date of Update": "06/17/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Tablet, Chewable, 10 mg (NDC 57664-083-88)",
    "Type of Update": "Reverified",
    "Date of Update": "07/08/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Tablet, Chewable, 20 mg (NDC 57664-084-88)",
    "Type of Update": "Reverified",
    "Date of Update": "07/08/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Tablet, Chewable, 30 mg (NDC 57664-085-88)",
    "Type of Update": "Reverified",
    "Date of Update": "07/08/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Tablet, Chewable, 50 mg (NDC 57664-087-88)",
    "Type of Update": "Reverified",
    "Date of Update": "07/08/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Tablet, Chewable, 60 mg (NDC 57664-088-88)",
    "Type of Update": "Reverified",
    "Date of Update": "07/08/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Tablet, Chewable, 40 mg (NDC 57664-086-88)",
    "Type of Update": "Reverified",
    "Date of Update": "07/08/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
    "Company Name": "Takeda Pharmaceuticals USA Inc.",
    "Contact Info": "877-TAKEDA-7 (1-877-825-3327)",
    "Presentation": "Vyvanse, Tablet, Chewable, 10 mg (NDC 59417-115-01)",
    "Type of Update": "Reverified",
    "Date of Update": "06/24/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
    "Company Name": "Takeda Pharmaceuticals USA Inc.",
    "Contact Info": "877-TAKEDA-7 (1-877-825-3327)",
    "Presentation": "Vyvanse, Tablet, Chewable, 20 mg (NDC 59417-116-01)",
    "Type of Update": "Reverified",
    "Date of Update": "06/24/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
    "Company Name": "Takeda Pharmaceuticals USA Inc.",
    "Contact Info": "877-TAKEDA-7 (1-877-825-3327)",
    "Presentation": "Vyvanse, Tablet, Chewable, 30 mg (NDC 59417-117-01)",
    "Type of Update": "Reverified",
    "Date of Update": "06/24/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
    "Company Name": "Takeda Pharmaceuticals USA Inc.",
    "Contact Info": "877-TAKEDA-7 (1-877-825-3327)",
    "Presentation": "Vyvanse, Tablet, Chewable, 40 mg (NDC 59417-118-01)",
    "Type of Update": "Reverified",
    "Date of Update": "06/24/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
    "Company Name": "Takeda Pharmaceuticals USA Inc.",
    "Contact Info": "877-TAKEDA-7 (1-877-825-3327)",
    "Presentation": "Vyvanse, Tablet, Chewable, 50 mg (NDC 59417-119-01)",
    "Type of Update": "Reverified",
    "Date of Update": "06/24/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
    "Company Name": "Takeda Pharmaceuticals USA Inc.",
    "Contact Info": "877-TAKEDA-7 (1-877-825-3327)",
    "Presentation": "Vyvanse, Tablet, Chewable, 60 mg (NDC 59417-120-01)",
    "Type of Update": "Reverified",
    "Date of Update": "06/24/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
    "Company Name": "Novadoz Pharmaceuticals LLC",
    "Contact Info": "(855) 668-2369; customerservice@novadozpharma.com",
    "Presentation": "Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 72205-132-91)",
    "Type of Update": "Revised",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
    "Company Name": "Novadoz Pharmaceuticals LLC",
    "Contact Info": "(855) 668-2369; customerservice@novadozpharma.com",
    "Presentation": "Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 72205-133-91)",
    "Type of Update": "Revised",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
    "Company Name": "Novadoz Pharmaceuticals LLC",
    "Contact Info": "(855) 668-2369; customerservice@novadozpharma.com",
    "Presentation": "Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 72205-134-91)",
    "Type of Update": "Revised",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
    "Company Name": "Novadoz Pharmaceuticals LLC",
    "Contact Info": "(855) 668-2369; customerservice@novadozpharma.com",
    "Presentation": "Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 72205-135-91)",
    "Type of Update": "Revised",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
    "Company Name": "Novadoz Pharmaceuticals LLC",
    "Contact Info": "(855) 668-2369; customerservice@novadozpharma.com",
    "Presentation": "Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 72205-136-91)",
    "Type of Update": "Revised",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
    "Company Name": "Novadoz Pharmaceuticals LLC",
    "Contact Info": "(855) 668-2369; customerservice@novadozpharma.com",
    "Presentation": "Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 72205-137-91)",
    "Type of Update": "Revised",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lithium Carbonate Tablet, Extended Release",
    "Company Name": "Mylan Pharmaceuticals Inc., a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Lithium Carbonate, Tablet, Extended Release, 300 mg (NDC 0378-1300-01)",
    "Type of Update": "New",
    "Date of Update": "10/04/2023",
    "Availability Information": "",
    "Related Information": "Discontinuance of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/04/2023",
    "Initial Posting Date": "10/04/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lithium Carbonate Tablet, Extended Release",
    "Company Name": "Mylan Pharmaceuticals Inc., a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Lithium Carbonate, Tablet, Extended Release, 300 mg (NDC 0378-1300-05)",
    "Type of Update": "New",
    "Date of Update": "10/04/2023",
    "Availability Information": "",
    "Related Information": "Discontinuance of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/04/2023",
    "Initial Posting Date": "10/04/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lithium Carbonate Tablet, Extended Release",
    "Company Name": "Mylan Pharmaceuticals Inc., a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Lithium Carbonate, Tablet, Extended Release, 450 mg (NDC 0378-1450-01)",
    "Type of Update": "New",
    "Date of Update": "10/04/2023",
    "Availability Information": "",
    "Related Information": "Discontinuance of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/04/2023",
    "Initial Posting Date": "10/04/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lorazepam Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 2 mg/1 mL Syringes (NDC 0409-1985-30)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: July 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/03/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lorazepam Injection",
    "Company Name": "Amphastar Pharmaceuticals, Inc.",
    "Contact Info": "800-423-4136",
    "Presentation": "Injection, 2 mg/1 mL (NDC 76329-8261-1)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/03/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lorazepam Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Ativan Injection (lorazepam injection, USP), Injection, 2 mg/1 mL (NDC 0641-6001-25)",
    "Type of Update": "Revised",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Additional lots are scheduled to be manufactured.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "09/05/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lorazepam Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Ativan Injection (lorazepam injection, USP), Injection, 2 mg/1 mL (NDC 0641-6000-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Additional lots are scheduled to be manufactured.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "09/05/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lorazepam Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Ativan Injection (lorazepam injection, USP), Injection, 4 mg/1 mL (NDC 0641-6003-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Additional lots are scheduled to be manufactured.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "09/05/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lorazepam Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Ativan Injection (lorazepam injection, USP), Injection, 4 mg/1 mL (NDC 0641-6002-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Additional lots are scheduled to be manufactured.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "09/05/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lorazepam Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Lorazepam injection, USP, Injection, 2 mg/1 mL (NDC 0641-6044-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "09/05/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lorazepam Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Lorazepam injection, USP, Injection, 2 mg/1 mL (NDC 0641-6046-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Additional lots are scheduled to be manufactured.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "09/05/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lorazepam Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Lorazepam injection, USP, Injection, 4 mg/1 mL (NDC 0641-6045-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Additional lots are scheduled to be manufactured.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "09/05/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Lorazepam Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Lorazepam injection, USP, Injection, 4 mg/1 mL (NDC 0641-6002-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Additional lots are scheduled to be manufactured.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "09/05/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Mafenide Acetate Solution",
    "Company Name": "Par Pharmaceutical, Inc.",
    "Contact Info": "800-828-9393",
    "Presentation": "Solution, 50 g (NDC 49884-902-78)",
    "Type of Update": "New",
    "Date of Update": "11/30/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Dermatology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "11/30/2023",
    "Initial Posting Date": "11/30/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Mannitol Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Osmitrol, Injection, 20 g/100 mL (NDC 0338-0357-02)",
    "Type of Update": "Revised",
    "Date of Update": "02/20/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Renal",
    "Status": "Resolved",
    "Change Date": "02/20/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "09/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Mannitol Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Mannitol 25%, Injection, 250 mg/1 mL (NDC 63323-024-25)",
    "Type of Update": "Revised",
    "Date of Update": "02/20/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Renal",
    "Status": "Resolved",
    "Change Date": "02/20/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "09/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Mannitol Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 12.5 g/50 mL (NDC 0409-4031-01)",
    "Type of Update": "Revised",
    "Date of Update": "02/20/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Renal",
    "Status": "Resolved",
    "Change Date": "02/20/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "09/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Mannitol Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Osmitrol, Injection, 0.1 (NDC 0338-0353-03)",
    "Type of Update": "Revised",
    "Date of Update": "02/20/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Renal",
    "Status": "Resolved",
    "Change Date": "02/20/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "09/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Mannitol Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Osmitrol, Injection, 20 g/100 mL (NDC 0338-0357-03)",
    "Type of Update": "Revised",
    "Date of Update": "02/20/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Renal",
    "Status": "Resolved",
    "Change Date": "02/20/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "09/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Mannitol Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Mannitol 20% In Plastic Container, Injection, 20 g/100 mL (NDC 0990-7715-03)",
    "Type of Update": "Revised",
    "Date of Update": "02/20/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Renal",
    "Status": "Resolved",
    "Change Date": "02/20/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "09/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Mannitol Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Mannitol 20% In Plastic Container, Injection, 20 g/100 mL (NDC 0990-7715-02)",
    "Type of Update": "Revised",
    "Date of Update": "02/20/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Renal",
    "Status": "Resolved",
    "Change Date": "02/20/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "09/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Mannitol Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Injection, 20 g/100 mL (NDC 0264-7578-20)",
    "Type of Update": "Revised",
    "Date of Update": "02/20/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Renal",
    "Status": "Resolved",
    "Change Date": "02/20/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "09/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Mefloquine Hydrochloride Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Mefloquine HCl Tablets USP, Tablet, 250 mg (NDC 0555-0171-78)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "-",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/14/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Melphalan Tablet",
    "Company Name": "Alvogen",
    "Contact Info": "844-842-8672",
    "Presentation": "Tablet, 2 mg (NDC 47781-200-50)",
    "Type of Update": "New",
    "Date of Update": "02/23/2024",
    "Availability Information": "",
    "Related Information": "Discontinuation due to low sales volume.   Supply currently available with April, 2024 expiry dating.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "02/23/2024",
    "Initial Posting Date": "02/23/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Memantine Hydrochloride Capsule, Extended Release",
    "Company Name": "AbbVie Inc.",
    "Contact Info": "Allergan, Inc.: 800-678-1605",
    "Presentation": "Namenda XR, Capsule, Extended Release, 7mg +14 mg+21 mg+28mg (NDC 0456-3400-29)",
    "Type of Update": "New",
    "Date of Update": "08/07/2024",
    "Availability Information": "",
    "Related Information": "Distributed by Allergan, Inc.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "08/07/2024",
    "Initial Posting Date": "08/07/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Memantine Hydrochloride Capsule, Extended Release",
    "Company Name": "AbbVie Inc.",
    "Contact Info": "Allergan, Inc.: 800-678-1605",
    "Presentation": "Namenda XR, Capsule, Extended Release, 14 mg (NDC 0456-3414-33)",
    "Type of Update": "New",
    "Date of Update": "08/07/2024",
    "Availability Information": "",
    "Related Information": "Distributed by Allergan, Inc.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "08/07/2024",
    "Initial Posting Date": "08/07/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Memantine Hydrochloride Capsule, Extended Release",
    "Company Name": "AbbVie Inc.",
    "Contact Info": "Allergan, Inc.: 800-678-1605",
    "Presentation": "Namenda XR, Capsule, Extended Release, 14mg (NDC 0456-3414-90)",
    "Type of Update": "New",
    "Date of Update": "08/07/2024",
    "Availability Information": "",
    "Related Information": "Distributed by Allergan, Inc.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "08/07/2024",
    "Initial Posting Date": "08/07/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Memantine Hydrochloride Capsule, Extended Release",
    "Company Name": "AbbVie Inc.",
    "Contact Info": "Allergan, Inc.: 800-678-1605",
    "Presentation": "Namenda XR, Capsule, Extended Release, 21 mg (NDC 0456-3421-33)",
    "Type of Update": "New",
    "Date of Update": "08/07/2024",
    "Availability Information": "",
    "Related Information": "Distributed by Allergan, Inc.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "08/07/2024",
    "Initial Posting Date": "08/07/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Memantine Hydrochloride Capsule, Extended Release",
    "Company Name": "AbbVie Inc.",
    "Contact Info": "Allergan, Inc.: 800-678-1605",
    "Presentation": "Namenda XR, Capsule, Extended Release, 28 mg (NDC 0456-3428-33)",
    "Type of Update": "New",
    "Date of Update": "08/07/2024",
    "Availability Information": "",
    "Related Information": "Distributed by Allergan, Inc.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "08/07/2024",
    "Initial Posting Date": "08/07/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Memantine Hydrochloride Capsule, Extended Release",
    "Company Name": "AbbVie Inc.",
    "Contact Info": "Allergan, Inc.: 800-678-1605",
    "Presentation": "Namenda XR, Capsule, Extended Release, 28 mg (NDC 0456-3428-90)",
    "Type of Update": "New",
    "Date of Update": "08/07/2024",
    "Availability Information": "",
    "Related Information": "Distributed by Allergan, Inc.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "08/07/2024",
    "Initial Posting Date": "08/07/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Mepivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Polocaine, Injection, 10 mg/1 mL (NDC 63323-283-57)",
    "Type of Update": "Revised",
    "Date of Update": "02/15/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Resolved",
    "Change Date": "02/15/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Mepivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Polocaine, Injection, 20 mg/1 mL (NDC 63323-296-57)",
    "Type of Update": "Revised",
    "Date of Update": "02/15/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Resolved",
    "Change Date": "02/15/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Mepivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Polocaine-mpf, Injection, 10 mg/1 mL (NDC 63323-260-37)",
    "Type of Update": "Revised",
    "Date of Update": "02/15/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Resolved",
    "Change Date": "02/15/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Mepivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Polocaine-mpf, Injection, 15 mg/1 mL (NDC 63323-293-37)",
    "Type of Update": "Revised",
    "Date of Update": "02/15/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Resolved",
    "Change Date": "02/15/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Mepivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Polocaine-mpf, Injection, 20 mg/1 mL (NDC 63323-294-27)",
    "Type of Update": "Revised",
    "Date of Update": "02/15/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Resolved",
    "Change Date": "02/15/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/14/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Mesalamine Capsule, Delayed Release",
    "Company Name": "AbbVie Inc.",
    "Contact Info": "800-633-9110",
    "Presentation": "Delzicol, Capsule, Delayed Release, 400 mg (NDC 0023-5853-18)",
    "Type of Update": "New",
    "Date of Update": "10/25/2023",
    "Availability Information": "",
    "Related Information": "Sales expected to last until June 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Gastroenterology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/25/2023",
    "Initial Posting Date": "10/25/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Mesalamine Capsule, Delayed Release",
    "Company Name": "AbbVie Inc.",
    "Contact Info": "800-633-9110",
    "Presentation": "Capsule, Delayed Release, 400 mg (NDC 59762-0117-1)",
    "Type of Update": "New",
    "Date of Update": "10/25/2023",
    "Availability Information": "",
    "Related Information": "Sales expected to last until June 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Gastroenterology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/25/2023",
    "Initial Posting Date": "10/25/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Mesalamine Tablet, Delayed Release",
    "Company Name": "Takeda Pharmaceuticals USA Inc.",
    "Contact Info": "866-861-1750",
    "Presentation": "Tablet, Delayed Release, 1.2 g (NDC 54092-100-01)",
    "Type of Update": "New",
    "Date of Update": "02/06/2024",
    "Availability Information": "",
    "Related Information": "The brand LIALDA will continue to be available",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "02/06/2024",
    "Initial Posting Date": "02/06/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methamphetamine Hydrochloride Tablet",
    "Company Name": "Dr. Reddy's Laboratories, Inc.",
    "Contact Info": "866-732-3952",
    "Presentation": "Tablet, 5 mg (NDC 68308-115-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/23/2024",
    "Availability Information": "Available",
    "Related Information": "Available to existing customers",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/17/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methamphetamine Hydrochloride Tablet",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Tablet, 5 mg (NDC 0054-0389-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/17/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Methotrexate Injection, USP Preservative Free, Injection, 1 g (NDC 0143-9830-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Currently available.  Additional product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/13/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Methotrexate Injection,USP Preservative Free, Injection, 25 mg/1 mL (NDC 0143-9519-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots are scheduled to be manufactured.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/13/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Injection",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3671-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Estimated recovery July 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Rheumatology; Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/13/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Injection",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3675-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/13/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Injection",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3678-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/13/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Methotrexate, Injection, 50 mg/2 mL (25 mg/mL) (NDC 61703-350-38)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: July 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Rheumatology; Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/13/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Methotrexate, Injection, 50 mg/2 mL  (25 mg/mL) (NDC 61703-350-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: July 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Rheumatology; Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/13/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Methotrexate, Injection, 1 g/40 mL (25 mg/mL)  (NDC 61703-408-41)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/13/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Methotrexate, Injection, 1 g/40 mL (25 mg/mL)   (NDC 61703-408-25)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/13/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Methotrexate, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-124-40)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/13/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Methotrexate Preservative Free, Injection, 1 g (NDC 63323-122-50)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/13/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 25 mg/1 mL (NDC 63323-123-10)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesaler for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/13/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Injection",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-30)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Unavailable, 30 Days",
    "Related Information": "Inventory on Hold pending further assessment",
    "Resolved Note": "",
    "Reason for Shortage": "Requirements related to complying with good manufacturing practices",
    "Therapeutic Category": "Rheumatology; Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/13/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Injection",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-03)",
    "Type of Update": "Revised",
    "Date of Update": "02/05/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Oncology",
    "Status": "To Be Discontinued",
    "Change Date": "02/05/2024",
    "Date Discontinued": "02/05/2024",
    "Initial Posting Date": "03/13/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Injection",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-35)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Requirements related to complying with good manufacturing practices",
    "Therapeutic Category": "Rheumatology; Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/13/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Tablet",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Tablet, 2.5 mg (NDC 59651-182-01)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Dermatology; Dental; Oncology",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Tablet",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Tablet, 2.5 mg (NDC 16729-486-01)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Dermatology; Dental; Oncology",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Tablet",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Methotrexate Sodium, Tablet, 2.5 mg (NDC 47335-235-83)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Dermatology; Dental; Oncology",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Tablet",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Methotrexate Sodium, Tablet, 2.5 mg (NDC 47335-235-96)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Dermatology; Dental; Oncology",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Tablet",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Tablet, 2.5 mg (NDC 0054-4550-25)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Dermatology; Dental; Oncology",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Tablet, 2.5 mg (NDC 0555-0572-02)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Dermatology; Dental; Oncology",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Tablet, 2.5 mg (NDC 0555-0572-35)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Dermatology; Dental; Oncology",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Trexall, Tablet, 5 mg (NDC 51285-366-01)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Dermatology; Dental; Oncology",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Trexall, Tablet, 7.5 mg (NDC 51285-367-01)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Dermatology; Dental; Oncology",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Trexall, Tablet, 10 mg (NDC 51285-368-01)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Dermatology; Dental; Oncology",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Trexall, Tablet, 15 mg (NDC 51285-369-01)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Dermatology; Dental; Oncology",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Tablet",
    "Company Name": "Mylan Pharmaceuticals Inc., a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Tablet, 2.5 mg (NDC 0378-0014-01)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Dermatology; Dental; Oncology",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Tablet",
    "Company Name": "Zydus Pharmaceuticals USA Inc.",
    "Contact Info": "877-993-8779",
    "Presentation": "Tablet, 2.5 mg (NDC 68382-775-01)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Dermatology; Dental; Oncology",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Tablet",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Tablet, 2.5 mg (NDC 69238-1423-6)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Dermatology; Dental; Oncology",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methotrexate Sodium Tablet",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Tablet, 2.5 mg (NDC 69238-1423-1)",
    "Type of Update": "Revised",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology; Dermatology; Dental; Oncology",
    "Status": "Resolved",
    "Change Date": "06/27/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "07/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methyldopa Tablet, Film Coated",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875",
    "Presentation": "Tablet, Film Coated, 250 mg (NDC 16729-030-01)",
    "Type of Update": "Revised",
    "Date of Update": "02/05/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "02/05/2024",
    "Date Discontinued": "02/05/2024",
    "Initial Posting Date": "08/30/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methyldopa Tablet, Film Coated",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875",
    "Presentation": "Tablet, Film Coated, 250 mg (NDC 16729-030-16)",
    "Type of Update": "Revised",
    "Date of Update": "02/05/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "02/05/2024",
    "Date Discontinued": "02/05/2024",
    "Initial Posting Date": "08/30/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methyldopa Tablet, Film Coated",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875",
    "Presentation": "Tablet, Film Coated, 500 mg (NDC 16729-031-01)",
    "Type of Update": "Revised",
    "Date of Update": "02/05/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "02/05/2024",
    "Date Discontinued": "02/05/2024",
    "Initial Posting Date": "08/30/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methyldopa Tablet, Film Coated",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875",
    "Presentation": "Tablet, Film Coated, 500 mg (NDC 16729-031-16)",
    "Type of Update": "Revised",
    "Date of Update": "02/05/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "02/05/2024",
    "Date Discontinued": "02/05/2024",
    "Initial Posting Date": "08/30/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Lannett Company, Inc.",
    "Contact Info": "844-834-0530",
    "Presentation": "Tablet, Extended Release, 18 mg (NDC 62175-310-37)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Allocating limited inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Lannett Company, Inc.",
    "Contact Info": "844-834-0530",
    "Presentation": "Tablet, Extended Release, 27 mg (NDC 62175-311-37)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Lannett Company, Inc.",
    "Contact Info": "844-834-0530",
    "Presentation": "Tablet, Extended Release, 36 mg (NDC 62175-312-37)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Lannett Company, Inc.",
    "Contact Info": "844-834-0530",
    "Presentation": "Tablet, Extended Release, 54 mg (NDC 62175-313-37)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Methylphenidate Hydrochloride Extended-Release Tablets, USP   CII, Tablet, Extended Release, 18 mg (NDC 62037-725-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Methylphenidate Hydrochloride Extended-Release Tablets, USP   CII, Tablet, Extended Release, 27 mg (NDC 62037-734-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Estimated recovery July 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Methylphenidate Hydrochloride Extended-Release Tablets, USP   CII, Tablet, Extended Release, 36 mg (NDC 62037-726-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Estimated recovery August 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Methylphenidate Hydrochloride Extended-Release Tablets, USP   CII, Tablet, Extended Release, 54 mg (NDC 62037-727-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Estimated recovery October 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Dr. Reddy's Laboratories, Inc.",
    "Contact Info": "866-732-3952",
    "Presentation": "Tablet, Extended Release, 18 mg (NDC 43598-438-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Estimated availability TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Dr. Reddy's Laboratories, Inc.",
    "Contact Info": "866-732-3952",
    "Presentation": "Tablet, Extended Release, 27 mg (NDC 43598-439-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Estimated availability TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Dr. Reddy's Laboratories, Inc.",
    "Contact Info": "866-732-3952",
    "Presentation": "Tablet, Extended Release, 36 mg (NDC 43598-440-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Unavailable. Estimated limited supplies from Aug 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Dr. Reddy's Laboratories, Inc.",
    "Contact Info": "866-732-3952",
    "Presentation": "Tablet, Extended Release, 54 mg (NDC 43598-441-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Estimated availability TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Trigen Laboratories, LLC",
    "Contact Info": "800-541-4802",
    "Presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 13811-706-10)",
    "Type of Update": "Revised",
    "Date of Update": "03/07/2024",
    "Availability Information": "Available",
    "Related Information": "Allocation to current contracted customers",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Trigen Laboratories, LLC",
    "Contact Info": "800-541-4802",
    "Presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 13811-707-10)",
    "Type of Update": "Revised",
    "Date of Update": "03/07/2024",
    "Availability Information": "Available",
    "Related Information": "Allocation to current contracted customers",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Trigen Laboratories, LLC",
    "Contact Info": "800-541-4802",
    "Presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 13811-708-10)",
    "Type of Update": "Revised",
    "Date of Update": "03/07/2024",
    "Availability Information": "Available",
    "Related Information": "Allocation to current contracted customers",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Trigen Laboratories, LLC",
    "Contact Info": "800-541-4802",
    "Presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 45 mg (NDC 13811-711-30)",
    "Type of Update": "Revised",
    "Date of Update": "03/07/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Trigen Laboratories, LLC",
    "Contact Info": "800-541-4802",
    "Presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 13811-709-10)",
    "Type of Update": "Revised",
    "Date of Update": "03/07/2024",
    "Availability Information": "Available",
    "Related Information": "Allocation to current contracted customers",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Trigen Laboratories, LLC",
    "Contact Info": "800-541-4802",
    "Presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 63 mg (NDC 13811-700-30)",
    "Type of Update": "Revised",
    "Date of Update": "03/07/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Trigen Laboratories, LLC",
    "Contact Info": "800-541-4802",
    "Presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 72 mg (NDC 13811-710-30)",
    "Type of Update": "Revised",
    "Date of Update": "03/07/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Janssen Pharmaceuticals",
    "Contact Info": "800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET",
    "Presentation": "Concerta, Tablet, Extended Release, 18 mg (NDC 50458-585-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Janssen Pharmaceuticals",
    "Contact Info": "800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET",
    "Presentation": "Concerta, Tablet, Extended Release, 27 mg (NDC 50458-588-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Janssen Pharmaceuticals",
    "Contact Info": "800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET",
    "Presentation": "Concerta, Tablet, Extended Release, 36 mg (NDC 50458-586-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Janssen Pharmaceuticals",
    "Contact Info": "800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET",
    "Presentation": "Concerta, Tablet, Extended Release, 54 mg (NDC 50458-587-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 57664-606-88)",
    "Type of Update": "Revised",
    "Date of Update": "07/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 57664-607-88)",
    "Type of Update": "Revised",
    "Date of Update": "07/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 57664-608-88)",
    "Type of Update": "Reverified",
    "Date of Update": "07/08/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Currently Not Marketed",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 57664-609-88)",
    "Type of Update": "Reverified",
    "Date of Update": "07/08/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Currently Not Marketed",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "SpecGx LLC",
    "Contact Info": "800-325-8888",
    "Presentation": "Methylin Er, Tablet, Extended Release, 10 mg (NDC 0406-1445-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Allocations to all customers. Backorder projected October.",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "SpecGx LLC",
    "Contact Info": "800-325-8888",
    "Presentation": "Methylin Er, Tablet, Extended Release, 20 mg (NDC 0406-1473-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Allocation to all customers; Expected backorder late Sept.",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "SpecGx LLC",
    "Contact Info": "800-325-8888",
    "Presentation": "Tablet, Extended Release, 27 mg (NDC 0406-0127-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Allocation to all customers.",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "SpecGx LLC",
    "Contact Info": "800-325-8888",
    "Presentation": "Tablet, Extended Release, 36 mg (NDC 0406-0136-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Backorder. Next release mid Sept. Intermittent backorder through November",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "SpecGx LLC",
    "Contact Info": "800-325-8888",
    "Presentation": "Tablet, Extended Release, 54 mg (NDC 0406-0154-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Backorder. Next release mid Sept. Intermittent backorder through November.",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Vertical Pharmaceuticals, LLC",
    "Contact Info": "800-541-4802",
    "Presentation": "Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Vertical Pharmaceuticals, LLC",
    "Contact Info": "800-541-4802",
    "Presentation": "Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Vertical Pharmaceuticals, LLC",
    "Contact Info": "800-541-4802",
    "Presentation": "Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Vertical Pharmaceuticals, LLC",
    "Contact Info": "800-541-4802",
    "Presentation": "Relexxii, Tablet, Extended Release, 45 mg (NDC 68025-088-30)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Vertical Pharmaceuticals, LLC",
    "Contact Info": "800-541-4802",
    "Presentation": "Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Vertical Pharmaceuticals, LLC",
    "Contact Info": "800-541-4802",
    "Presentation": "Relexxii, Tablet, Extended Release, 63 mg (NDC 68025-089-30)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylphenidate Hydrochloride Tablet, Extended Release",
    "Company Name": "Vertical Pharmaceuticals, LLC",
    "Contact Info": "800-541-4802",
    "Presentation": "Relexxii, Tablet, Extended Release, 72 mg (NDC 68025-084-30)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylprednisolone Acetate Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 40 mg/1 mL (NDC 55150-313-01)",
    "Type of Update": "Reverified",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylprednisolone Acetate Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 80 mg/1 mL (NDC 55150-314-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Unavailable",
    "Related Information": "On backorder. Recovery: TBD. Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylprednisolone Acetate Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 40 mg/1 mL (NDC 25021-820-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylprednisolone Acetate Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 40 mg/1 mL (NDC 25021-820-05)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylprednisolone Acetate Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 80 mg/1 mL (NDC 25021-821-05)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylprednisolone Acetate Injection",
    "Company Name": "Par Pharmaceutical, Inc.",
    "Contact Info": "800-828-9393",
    "Presentation": "Injection, 80 mg/1 mL (NDC 42023-240-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Recovery: July 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/16/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylprednisolone Acetate Injection",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Injection, 40 mg/1 mL (NDC 70121-1573-1)",
    "Type of Update": "Revised",
    "Date of Update": "07/09/2024",
    "Availability Information": "Available",
    "Related Information": "Sufficient Inventory available (02 to 04 Wk) as per current demand.\nNext Supply from wk. of 14th July-24",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylprednisolone Acetate Injection",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Injection, 40 mg/1 mL (NDC 70121-1573-5)",
    "Type of Update": "Revised",
    "Date of Update": "07/09/2024",
    "Availability Information": "Available",
    "Related Information": "Sufficient Inventory available (02 to 04 Wk) as per current demand.\nNext Supply from wk. of 7th July-24",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylprednisolone Acetate Injection",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Injection, 80 mg/1 mL (NDC 70121-1574-1)",
    "Type of Update": "Revised",
    "Date of Update": "07/09/2024",
    "Availability Information": "Available",
    "Related Information": "Sufficient Inventory available (02 to 04 Wk) as per current demand.\nNext Supply from wk. of 7th July-24",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylprednisolone Acetate Injection",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Injection, 80 mg/1 mL (NDC 70121-1574-5)",
    "Type of Update": "Revised",
    "Date of Update": "07/09/2024",
    "Availability Information": "Available",
    "Related Information": "Available Inventory for 1 week as per current demand.\nNext Supply from wk. of 14th July-24",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylprednisolone Acetate Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Depo-medrol, Injection, 20 mg/1 mL (NDC 0009-0274-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylprednisolone Acetate Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylprednisolone Acetate Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-03)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylprednisolone Acetate Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-51)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylprednisolone Acetate Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-52)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylprednisolone Acetate Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylprednisolone Acetate Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-12)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylprednisolone Acetate Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: July 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylprednisolone Acetate Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-03)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylprednisolone Acetate Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-22)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: July 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylprednisolone Acetate Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-23)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: July 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylprednisolone Acetate Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Methylprednisolone Acetate Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-03)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: July 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Metronidazole Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Metro I.v. In Plastic Container, Injection, 500 mg/100 mL (NDC 0264-5535-32)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/13/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Metronidazole Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Flagyl I.v. Rtu In Plastic Container, Injection, 500 mg/100 mL (NDC 0338-1055-48)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/13/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Metronidazole Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "TBD",
    "Presentation": "Metronidazole In Plastic Container, Injection, 500 mg/100 mL (NDC 47335-993-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/13/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "WG Critical Care",
    "Contact Info": "888-493-0861",
    "Presentation": "Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-610-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Available",
    "Related Information": "Please check wholesalers and distributors for inventory.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "WG Critical Care",
    "Contact Info": "888-493-0861",
    "Presentation": "Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-611-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Available",
    "Related Information": "Please check wholesalers and distributors for inventory.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 1 mg/1 mL (NDC 63323-411-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "5 & 8 mos dating available for wholesalers. Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2 mL (NDC 76045-001-20)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 1 mg/1 mL (NDC 63323-411-12)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 1 mg/1 mL (NDC 63323-411-25)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 5 mg/1 mL (NDC 63323-412-25)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 5 mg/1 mL (NDC 63323-412-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 5 mg/1 mL (NDC 63323-412-02)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Midazolam Injection, USP, Injection, 1 mg/1 mL (NDC 0641-6056-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Midazolam Injection, USP, Injection, 1 mg/1 mL (NDC 0641-6057-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Midazolam Injection, USP, Injection, 1 mg/1 mL (NDC 0641-6059-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Additional lots will be available in the August 2024 timeframe. Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Midazolam Injection, USP, Injection, 5 mg/1 mL (NDC 0641-6061-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots are scheduled to be manufactured.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Midazolam Injection, USP, Injection, 5 mg/1 mL (NDC 0641-6060-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots are scheduled to be manufactured.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-2305-17)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) (NDC 0409-2305-05)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL (5 mg/mL) (NDC 0409-2308-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-2596-05)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: July 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Midazolam Hydrochloride Preservative Free, Injection, 10 mg/2 mL (5 mg/mL)   (NDC 0409-2308-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 25 mg/5 mL (5 mg/mL)  (NDC 0409-2596-03)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 10 mg/10 mL (1 mg/mL)  (NDC 0409-2587-05)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery and Estimated Recovery: December 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Avet Pharmaceuticals, Inc.",
    "Contact Info": "855-228-9470",
    "Presentation": "Injection, 5 mg/1 mL (NDC 23155-601-42)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Unavailable, 4-6 weeks",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Avet Pharmaceuticals, Inc.",
    "Contact Info": "855-228-9470",
    "Presentation": "Injection, 5 mg/1 mL (NDC 23155-601-41)",
    "Type of Update": "Revised",
    "Date of Update": "07/17/2024",
    "Availability Information": "Unavailable, 2-4 weeks",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Avet Pharmaceuticals, Inc.",
    "Contact Info": "855-228-9470",
    "Presentation": "Injection, 1 mg/1 mL (NDC 23155-600-41)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "Athenex: 855-273-0154; Alvogen: 973-532-7840",
    "Presentation": "Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 70860-601-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "Athenex: 855-273-0154; Alvogen: 973-532-7840",
    "Presentation": "Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 70860-601-05)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "Athenex: 855-273-0154; Alvogen: 973-532-7840",
    "Presentation": "Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 47781-589-17)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "Athenex: 855-273-0154; Alvogen: 973-532-7840",
    "Presentation": "Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 47781-589-91)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "Athenex: 855-273-0154; Alvogen: 973-532-7840",
    "Presentation": "Midazolam Hydrochloride, Injection, 2 mg/2 mL (NDC 70860-600-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Midazolam Hydrochloride Injection",
    "Company Name": "Gland Pharma Limited",
    "Contact Info": "Athenex: 855-273-0154; Alvogen: 973-532-7840",
    "Presentation": "Midazolam Hydrochloride, Injection, 2 mg/2 mL (NDC 47781-588-68)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia; Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/02/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Minocycline Extended Release Tablet",
    "Company Name": "EPI Health",
    "Contact Info": "(800) 499-4468",
    "Presentation": "Minolira, Extended Release Tablet, 135 mg (NDC 71403-102-30)",
    "Type of Update": "New",
    "Date of Update": "11/02/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Anti-Infective",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "11/02/2023",
    "Initial Posting Date": "11/02/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Minocycline Extended Release Tablets",
    "Company Name": "EPI Health",
    "Contact Info": "(800) 499-4468",
    "Presentation": "Minolira, Extended Release Tablets, 105mg (NDC 71403-101-30)",
    "Type of Update": "New",
    "Date of Update": "11/02/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Anti-Infective",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "11/02/2023",
    "Initial Posting Date": "11/02/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "MINOCYCLINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE",
    "Company Name": "Journey Medical Corporation",
    "Contact Info": "480-434-6670",
    "Presentation": "XIMINO, CAPSULE, EXTENDED RELEASE, 45 mg (NDC 69489-121-30)",
    "Type of Update": "New",
    "Date of Update": "09/29/2023",
    "Availability Information": "",
    "Related Information": "Discontinuation due to business reasons.",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Antibiotic",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "09/29/2023",
    "Initial Posting Date": "09/29/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Injection",
    "Company Name": "Piramal Critical Care Inc.",
    "Contact Info": "800-414-1901",
    "Presentation": "Mitigo (Morphine Sulfate Injection, USP), Injection, 200 mg/20 mL (NDC 66794-160-02)",
    "Type of Update": "Revised",
    "Date of Update": "06/26/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Injection",
    "Company Name": "Piramal Critical Care Inc.",
    "Contact Info": "800-414-1901",
    "Presentation": "Mitigo (Morphine Sulfate Injection, USP), Injection, 500 mg/20 mL (NDC 66794-162-02)",
    "Type of Update": "Revised",
    "Date of Update": "06/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Injection",
    "Company Name": "Amphastar Pharmaceuticals, Inc.",
    "Contact Info": "800-423-4136",
    "Presentation": "Injection, 1 mg/1 mL (NDC 76329-1912-1)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/06/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Duramorph (Morphine Sulfate Injection, USP), Injection, 1 mg/1 mL (NDC 0641-6019-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots are scheduled to be manufactured.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/03/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Duramorph (Morphine Sulfate Injection, USP), Injection, .5 mg/1 mL (NDC 0641-6020-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/03/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Infumorph 200 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 10 mg/1 mL (NDC 0641-6039-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/03/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Infumorph 500 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 25 mg/1 mL (NDC 0641-6040-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/03/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 2 mg/1 mL (NDC 76045-004-11)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 4 mg/1 mL (NDC 76045-005-11)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 2 mg/1 mL (NDC 63323-452-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 4 mg/1 mL (NDC 63323-454-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 5 mg/1 mL (NDC 63323-455-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 10 mg/1 mL (NDC 63323-451-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Morphine Sulfate, Injection, 2 mg/1 mL Syringes (NDC 0409-1890-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/179002/download",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Morphine Sulfate, Injection, 4 mg/1 mL Syringes (NDC 0409-1891-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/179002/download",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Morphine Sulfate, Injection, 8 mg/1 mL Syringes (NDC 0409-1892-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/179002/download",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Morphine Sulfate, Injection, 10 mg/1 mL Syringes (NDC 0409-1893-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/179002/download",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Morphine Sulfate, Injection, 5 mg/10 mL (0.5 mg/mL) (NDC 0409-3814-12)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: July 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/179002/download",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Morphine Sulfate, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-3815-12)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: July 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/179002/download",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-1896-20)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: December 2024; Estimated Recovery: March 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/179002/download",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-1134-05)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery and Estimated Recovery: December 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Morphine Sulfate Injection, USP, Injection, 4 mg/1 mL (NDC 0641-6125-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/03/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Morphine Sulfate Injection, USP, Injection, 8 mg/1 mL (NDC 0641-6126-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Currently available.  Additional product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/03/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Morphine Sulfate Injection, USP, Injection, 10 mg/1 mL (NDC 0641-6127-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/03/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Tablet, Extended Release",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "(973) 658-1839",
    "Presentation": "Tablet, Extended Release, 15 mg (NDC 0228-4270-11)",
    "Type of Update": "New",
    "Date of Update": "04/03/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/03/2024",
    "Initial Posting Date": "04/03/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Tablet, Extended Release",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "(973) 658-1839",
    "Presentation": "Tablet, Extended Release, 30 mg (NDC 0228-4271-11)",
    "Type of Update": "New",
    "Date of Update": "04/03/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/03/2024",
    "Initial Posting Date": "04/03/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Tablet, Extended Release",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "(973) 658-1839",
    "Presentation": "Tablet, Extended Release, 60 mg (NDC 0228-4311-11)",
    "Type of Update": "New",
    "Date of Update": "04/03/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/03/2024",
    "Initial Posting Date": "04/03/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Tablet, Extended Release",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "(973) 658-1839",
    "Presentation": "Tablet, Extended Release, 100 mg (NDC 0228-4323-11)",
    "Type of Update": "New",
    "Date of Update": "04/03/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/03/2024",
    "Initial Posting Date": "04/03/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Tablet, Extended Release",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "(973) 658-1839",
    "Presentation": "Tablet, Extended Release, 200 mg (NDC 0228-4347-11)",
    "Type of Update": "New",
    "Date of Update": "04/03/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/03/2024",
    "Initial Posting Date": "04/03/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Tablet, Extended Release",
    "Company Name": "Actavis Pharma, Inc.",
    "Contact Info": "(973) 658-1839",
    "Presentation": "Tablet, Extended Release, 15 mg (NDC 0228-4270-11)",
    "Type of Update": "New",
    "Date of Update": "03/05/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/05/2024",
    "Initial Posting Date": "03/05/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Tablet, Extended Release",
    "Company Name": "Actavis Pharma, Inc.",
    "Contact Info": "(973) 658-1839",
    "Presentation": "Tablet, Extended Release, 30 mg (NDC 0228-4271-11)",
    "Type of Update": "New",
    "Date of Update": "03/05/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/05/2024",
    "Initial Posting Date": "03/05/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Tablet, Extended Release",
    "Company Name": "Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "(973) 658-1839",
    "Presentation": "Tablet, Extended Release, 60 mg (NDC 0228-4311-11)",
    "Type of Update": "New",
    "Date of Update": "03/05/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/05/2024",
    "Initial Posting Date": "03/05/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Tablet, Extended Release",
    "Company Name": "Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "(973) 658-1839",
    "Presentation": "Tablet, Extended Release, 100 mg (NDC 0228-4323-11)",
    "Type of Update": "New",
    "Date of Update": "03/05/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/05/2024",
    "Initial Posting Date": "03/05/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Morphine Sulfate Tablet, Extended Release",
    "Company Name": "Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "(973) 658-1839",
    "Presentation": "Tablet, Extended Release, 200 mg (NDC 0228-4347-11)",
    "Type of Update": "New",
    "Date of Update": "03/05/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/05/2024",
    "Initial Posting Date": "03/05/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Moxifloxacin Hydrochloride Tablet",
    "Company Name": "Dr. Reddy's Laboratories, Inc.",
    "Contact Info": "866-732-3952",
    "Presentation": "Tablet, 400 mg (NDC 55111-112-66)",
    "Type of Update": "New",
    "Date of Update": "10/04/2023",
    "Availability Information": "",
    "Related Information": "Discontinuance of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Anti-Infective",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/04/2023",
    "Initial Posting Date": "10/04/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Moxifloxacin Hydrochloride Tablet",
    "Company Name": "Dr. Reddy's Laboratories, Inc.",
    "Contact Info": "866-732-3952",
    "Presentation": "Tablet, 400 mg (NDC 55111-112-01)",
    "Type of Update": "New",
    "Date of Update": "10/04/2023",
    "Availability Information": "",
    "Related Information": "Discontinuance of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Anti-Infective",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/04/2023",
    "Initial Posting Date": "10/04/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Moxifloxacin Hydrochloride Tablet",
    "Company Name": "Dr. Reddy's Laboratories, Inc.",
    "Contact Info": "866-732-3952",
    "Presentation": "Tablet, 400 mg (NDC 55111-112-05)",
    "Type of Update": "New",
    "Date of Update": "10/04/2023",
    "Availability Information": "",
    "Related Information": "Discontinuance of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Anti-Infective",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/04/2023",
    "Initial Posting Date": "10/04/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Moxifloxacin Hydrochloride Tablet",
    "Company Name": "Dr. Reddy's Laboratories, Inc.",
    "Contact Info": "866-732-3952",
    "Presentation": "Tablet, 400 mg (NDC 55111-112-66)",
    "Type of Update": "New",
    "Date of Update": "10/04/2023",
    "Availability Information": "",
    "Related Information": "Discontinuance of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Anti-Infective",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/04/2023",
    "Initial Posting Date": "10/04/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Multi-Vitamin Infusion (Adult and Pediatric) Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "M.v.i. Adult, Injection, 10 Kit In 1 Package (61703-434-82) (NDC 61703-434-82)",
    "Type of Update": "Revised",
    "Date of Update": "10/30/2023",
    "Availability Information": "Discontinued",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "To Be Discontinued",
    "Change Date": "10/30/2023",
    "Date Discontinued": "10/30/2023",
    "Initial Posting Date": "10/30/2013",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Multi-Vitamin Infusion (Adult and Pediatric) Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "M.v.i. Adult, Injection, 2 Box In 1 Case (61703-422-83)  (NDC 61703-422-83)",
    "Type of Update": "Revised",
    "Date of Update": "10/30/2023",
    "Availability Information": "Discontinued",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "To Be Discontinued",
    "Change Date": "10/30/2023",
    "Date Discontinued": "10/30/2023",
    "Initial Posting Date": "10/30/2013",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Multi-Vitamin Infusion (Adult and Pediatric) Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "M.v.i. Pediatric, Injection, 7 mg/5 mL; 80 mg/5 mL; 20 ug/5 mL; 1 ug/5 mL; 5 mg/5 mL; 10 ug/5 mL; 140 ug/5 mL; 17 mg/5 mL; 200 ug/5 mL; 1 mg/5 mL; .7 mg/5 mL; 1.4 mg/5 mL; 1.2 mg/5 mL (NDC 61703-421-53)",
    "Type of Update": "Revised",
    "Date of Update": "10/30/2023",
    "Availability Information": "Discontinued",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "To Be Discontinued",
    "Change Date": "10/30/2023",
    "Date Discontinued": "10/30/2023",
    "Initial Posting Date": "10/30/2013",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Naltrexone Hydrochloride Tablet",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7875, option 2",
    "Presentation": "Tablet, 50 mg (NDC 16729-081-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/29/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Naltrexone Hydrochloride Tablet",
    "Company Name": "Accord Healthcare Inc.",
    "Contact Info": "866-941-7857, option 2",
    "Presentation": "Tablet, 50 mg (NDC 16729-081-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/23/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/29/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Naltrexone Hydrochloride Tablet",
    "Company Name": "Elite Laboratories, Inc.",
    "Contact Info": "800-397-9228",
    "Presentation": "Tablet, 50 mg (NDC 51224-206-50)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Tagi Pharma",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/29/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Naltrexone Hydrochloride Tablet",
    "Company Name": "Elite Laboratories, Inc.",
    "Contact Info": "800-397-9228",
    "Presentation": "Tablet, 50 mg (NDC 51224-206-30)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Tagi Pharma",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/29/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Naltrexone Hydrochloride Tablet",
    "Company Name": "Elite Laboratories, Inc.",
    "Contact Info": "800-397-9228",
    "Presentation": "Tablet, 50 mg (NDC 68094-909-50)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Precision Dose",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/29/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Naltrexone Hydrochloride Tablet",
    "Company Name": "Elite Laboratories, Inc.",
    "Contact Info": "800-397-9228",
    "Presentation": "Tablet, 50 mg (NDC 68094-909-30)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Precision Dose",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/29/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Naltrexone Hydrochloride Tablet",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Tablet, 50 mg (NDC 47335-326-88)",
    "Type of Update": "Reverified",
    "Date of Update": "07/08/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/29/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Naltrexone Hydrochloride Tablet",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Tablet, 50 mg (NDC 47335-326-83)",
    "Type of Update": "Reverified",
    "Date of Update": "07/08/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/29/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Naltrexone Hydrochloride Tablet",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Tablet, 50 mg (NDC 47335-326-08)",
    "Type of Update": "Reverified",
    "Date of Update": "07/08/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Currently Not Marketed",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/29/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Naltrexone Hydrochloride Tablet",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Tablet, 50 mg (NDC 47335-326-18)",
    "Type of Update": "Reverified",
    "Date of Update": "07/08/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Currently Not Marketed",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/29/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Naltrexone Hydrochloride Tablet",
    "Company Name": "SpecGx LLC",
    "Contact Info": "800-325-8888",
    "Presentation": "Tablet, 50 mg (NDC 0406-1170-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Long term allocations to primary customers with intermittent backorder expected through mid 2025.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/29/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Naltrexone Hydrochloride Tablet",
    "Company Name": "SpecGx LLC",
    "Contact Info": "800-325-8888",
    "Presentation": "Tablet, 50 mg (NDC 0406-1170-03)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Long term allocations to primary customers with intermittent backorder expected through mid 2025.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/29/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Naltrexone Hydrochloride Tablet",
    "Company Name": "Chartwell Molecular Holdings LLC",
    "Contact Info": "845-268-5000 Ext. 510",
    "Presentation": "Tablet, 50 mg (NDC 62135-242-60)",
    "Type of Update": "New",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/29/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Neomycin Sulfate Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Neomycin Sulfate Tablets, USP, Tablet, 500 mg (NDC 0093-1177-01)",
    "Type of Update": "Revised",
    "Date of Update": "05/17/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Resolved",
    "Change Date": "05/17/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/16/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Neomycin Sulfate Tablet",
    "Company Name": "XGen Pharmaceuticals DJB, Inc.",
    "Contact Info": "866-390-4411",
    "Presentation": "Tablet, 500 mg (NDC 39822-0310-5)",
    "Type of Update": "Revised",
    "Date of Update": "05/17/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Resolved",
    "Change Date": "05/17/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/16/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Nifedipine Capsule",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Capsule, 10 mg (NDC 59762-1004-1)",
    "Type of Update": "New",
    "Date of Update": "10/26/2023",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug. Supply expected to exhaust November 2023.",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/26/2023",
    "Initial Posting Date": "10/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "NIFEDIPINE CAPSULE",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "PROCARDIA, CAPSULE, 10 mg (NDC 59762-1004-1)",
    "Type of Update": "New",
    "Date of Update": "12/27/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "11/26/2023",
    "Initial Posting Date": "12/27/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Nitroglycerin Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "Baxter Healthcare 888-229-0001",
    "Presentation": "Nitroglycerin in Dextrose 5%, Injection, 20 mg/100 mL (NDC 0338-1049-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Nitroglycerin Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "Baxter Healthcare 888-229-0001",
    "Presentation": "Nitroglycerin in Dextrose 5%, Injection, 40 mg/100 mL (NDC 0338-1051-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Nitroglycerin Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "Baxter Healthcare 888-229-0001",
    "Presentation": "Nitroglycerin in Dextrose 5%, Injection, 10 mg/100 mL (NDC 0338-1047-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Nitroglycerin Injection",
    "Company Name": "American Regent, Inc.",
    "Contact Info": "American Regent 800-645-1706",
    "Presentation": "Injection, 5 mg/1 mL (NDC 0517-4810-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Estimated availability: Q3 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Nizatidine Capsule",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Capsule, 300 mg (NDC 0591-3138-30)",
    "Type of Update": "Revised",
    "Date of Update": "03/11/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "03/11/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "03/27/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Nizatidine Capsule",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Capsule, 150 mg (NDC 0591-3137-60)",
    "Type of Update": "Revised",
    "Date of Update": "03/11/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "03/11/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "03/27/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ofatumumab Injection",
    "Company Name": "Novartis Pharmaceuticals Corporation",
    "Contact Info": "888-669-6682",
    "Presentation": "Arzerra, Injection, 20 mg/1 mL (NDC 0078-0669-13)",
    "Type of Update": "New",
    "Date of Update": "11/03/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Oncology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "11/03/2023",
    "Initial Posting Date": "11/03/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ofatumumab Injection",
    "Company Name": "Novartis Pharmaceuticals Corporation",
    "Contact Info": "888-669-6682",
    "Presentation": "Arzerra, Injection, 20 mg/1 mL (NDC 0078-0690-61)",
    "Type of Update": "New",
    "Date of Update": "11/03/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Oncology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "11/03/2023",
    "Initial Posting Date": "11/03/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Omeprazole; Sodium Bicarbonate\t For Suspension",
    "Company Name": "Par Pharmaceutical, Inc.",
    "Contact Info": "800-828-9393",
    "Presentation": "For Suspension, 20 mg; 1680 mg (NDC 49884-268-11)",
    "Type of Update": "New",
    "Date of Update": "12/07/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Gastroenterology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "12/07/2023",
    "Initial Posting Date": "12/07/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Omeprazole; Sodium Bicarbonate Suspension",
    "Company Name": "Par Pharmaceutical, Inc.",
    "Contact Info": "800-828-9393",
    "Presentation": "Suspension, 40 mg; 1680 mg (NDC 49884-269-11)",
    "Type of Update": "New",
    "Date of Update": "12/07/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Gastroenterology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "12/07/2023",
    "Initial Posting Date": "12/07/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Oxaliplatin Injection",
    "Company Name": "Actavis Pharma, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Injection, 5 mg/1 mL (NDC 45963-611-53)",
    "Type of Update": "New",
    "Date of Update": "03/25/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/25/2024",
    "Initial Posting Date": "03/25/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Oxaliplatin Injection",
    "Company Name": "Actavis Pharma, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Injection, 5 mg/1 mL (NDC 45963-611-59)",
    "Type of Update": "New",
    "Date of Update": "03/25/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/25/2024",
    "Initial Posting Date": "03/25/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Oxybutynin Chloride Syrup",
    "Company Name": "Chartwell Molecular Holdings LLC",
    "Contact Info": "845-268-5000 Ext. 510",
    "Presentation": "Oxybutynin Chloride, Syrup, 5 mg/5 mL (NDC 62135-520-47)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Urology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Oxybutynin Chloride Syrup",
    "Company Name": "Lannett Company, Inc.",
    "Contact Info": "215-333-9000 ext: 4",
    "Presentation": "Syrup, 5 mg/5 mL (NDC 54838-510-80)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Urology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/13/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Parathyroid Hormone Injection",
    "Company Name": "Takeda Pharmaceuticals USA Inc.",
    "Contact Info": "866-888-0660",
    "Presentation": "Natpara, Injection, 50 ug/.08 mL, Injection, Powder, Lyophilized, For Solution (NDC 68875-0203-2)",
    "Type of Update": "Reverified",
    "Date of Update": "06/24/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Takeda will be ceasing manufacturing of Natpara at the end of 2024 with a priority to maintain treatment continuity for patients enrolled in the U.S. Special Use Program until inventory is depleted or expired. Please refer to the following link for more details  https://www.takeda.com/en-us/newsroom/statements/2022/takeda-to-discontinue-manufacturing-of-natpar-natpara/",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "09/11/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Parathyroid Hormone Injection",
    "Company Name": "Takeda Pharmaceuticals USA Inc.",
    "Contact Info": "866-888-0660",
    "Presentation": "Natpara, Injection, 75 ug/.08 mL, Injection, Powder, Lyophilized, For Solution (NDC 68875-0204-2)",
    "Type of Update": "Reverified",
    "Date of Update": "06/24/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Takeda will be ceasing manufacturing of Natpara at the end of 2024 with a priority to maintain treatment continuity for patients enrolled in the U.S. Special Use Program until inventory is depleted or expired. Please refer to the following link for more details  https://www.takeda.com/en-us/newsroom/statements/2022/takeda-to-discontinue-manufacturing-of-natpar-natpara/",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "09/11/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Parathyroid Hormone Injection",
    "Company Name": "Takeda Pharmaceuticals USA Inc.",
    "Contact Info": "866-888-0660",
    "Presentation": "Natpara, Injection, 100 ug/.08 mL, Injection, Powder, Lyophilized, For Solution (NDC 68875-0205-2)",
    "Type of Update": "Reverified",
    "Date of Update": "06/24/2024",
    "Availability Information": "Unavailable",
    "Related Information": "The 100 mcg cartridge is no longer available and Takeda is unable to resupply prior to ceasing of manufacturing of Natpara at the end of 2024. Please refer to the following link for more details  https://www.takeda.com/en-us/newsroom/statements/2022/takeda-to-discontinue-manufacturing-of-natpar-natpara/",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "09/11/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Parathyroid Hormone Injection",
    "Company Name": "Takeda Pharmaceuticals USA Inc.",
    "Contact Info": "866-888-0660",
    "Presentation": "Natpara, Injection, 25 ug/.08 mL, Injection, Powder, Lyophilized, For Solution (NDC 68875-0202-2)",
    "Type of Update": "Reverified",
    "Date of Update": "06/24/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Takeda will be ceasing manufacturing of Natpara at the end of 2024 with a priority to maintain treatment continuity for patients enrolled in the U.S. Special Use Program until inventory is depleted or expired. Please refer to the following link for more details  https://www.takeda.com/en-us/newsroom/statements/2022/takeda-to-discontinue-manufacturing-of-natpar-natpara/",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "09/11/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Penicillin G Benzathine Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Bicillin L-A, Injection, 600000 [iU]/1 mL (NDC 60793-700-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: February 2025; Estimated Recovery: March 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Penicillin G Benzathine Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Bicillin L-A, Injection, 1200000 [iU]/2 mL (NDC 60793-701-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: August 2024; Estimated Recovery: December 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Penicillin G Benzathine Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Bicillin L-A, Injection, 2400000 [iU]/4 mL (NDC 60793-702-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Penicillin G Benzathine Injection",
    "Company Name": "Laboratoires Delbert",
    "Contact Info": "Provepharm: 833-727-6556",
    "Presentation": "Extencilline, Injection, 1,200,000 units (NDC 81284-521-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/24/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/180283/download?attachment",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Penicillin G Benzathine Injection",
    "Company Name": "Laboratoires Delbert",
    "Contact Info": "Provepharm: 833-727-6556",
    "Presentation": "Extencilline, Injection, 2,400,000 units (NDC 81284-522-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/24/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/180283/download?attachment",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Penicillin G Benzathine Injection",
    "Company Name": "Laboratorios Atral",
    "Contact Info": "Mark Cuban Cost Plus Drug Company: 682-428-8081",
    "Presentation": "Lentocilin, Injection, 1200000 U/4 mL (NDC 84383-110-01)",
    "Type of Update": "New",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/26/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/179787/download?attachment",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Phenytoin Oral Suspension",
    "Company Name": "VistaPharm",
    "Contact Info": "(877) 530-1633",
    "Presentation": "Oral Suspension, 125 mg/5 mL (NDC 66689-036-50)",
    "Type of Update": "New",
    "Date of Update": "02/28/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "02/28/2024",
    "Initial Posting Date": "02/28/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Phenytoin Oral Suspension",
    "Company Name": "VistaPharm",
    "Contact Info": "(877) 530-1633",
    "Presentation": "Oral Suspension, 125 mg/5 mL (NDC 66689-775-08)",
    "Type of Update": "New",
    "Date of Update": "02/28/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "02/28/2024",
    "Initial Posting Date": "02/28/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Phenytoin Sodium Extended-Release Capsule",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Extended-Release Capsule, 100 mg (NDC 65162-212-10)",
    "Type of Update": "New",
    "Date of Update": "03/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/21/2024",
    "Initial Posting Date": "03/21/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Phenytoin Sodium Extended-Release Capsule",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Extended-Release Capsule, 100 mg (NDC 65162-212-11)",
    "Type of Update": "New",
    "Date of Update": "03/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/21/2024",
    "Initial Posting Date": "03/21/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Phenytoin Sodium Extended-Release Capsule",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Extended-Release Capsule, 100 mg (NDC 65162-212-50)",
    "Type of Update": "New",
    "Date of Update": "03/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/21/2024",
    "Initial Posting Date": "03/21/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Piroxicam Capsule",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Feldene, Capsule, 20 mg (NDC 0069-3230-66)",
    "Type of Update": "New",
    "Date of Update": "08/24/2023",
    "Availability Information": "",
    "Related Information": "Supply expected to exhaust late October 2023; Discontinuation of the manufacture of the drug",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "To Be Discontinued",
    "Change Date": "08/24/2023",
    "Date Discontinued": "08/24/2023",
    "Initial Posting Date": "08/24/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Posaconazole Oral Suspension",
    "Company Name": "Merck Sharp & Dohme LLC",
    "Contact Info": "800-672-6372",
    "Presentation": "Noxafil, Oral Suspension, 40MG/ML (NDC 0085-1328-01)",
    "Type of Update": "New",
    "Date of Update": "11/15/2023",
    "Availability Information": "",
    "Related Information": "To be discontinued \non December 18th, 2023.",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Anti-Infective",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "11/15/2023",
    "Initial Posting Date": "11/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Posaconazole Tablet, Delayed Release",
    "Company Name": "Merck Sharp & Dohme Corp., a subsidiary of Merck and Co., Inc.",
    "Contact Info": "800-672-6372",
    "Presentation": "Noxafil, Tablet, Delayed Release, 100 mg (NDC 0085-4324-02)",
    "Type of Update": "New",
    "Date of Update": "07/22/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "07/22/2024",
    "Initial Posting Date": "07/22/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Acetate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Potassium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3294-51)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: November 2024; Estimated Recovery: December 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/10/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Acetate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Potassium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-8183-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: August 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/10/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Acetate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Potassium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3294-25)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: November 2024; Estimated Recovery: December 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/10/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Acetate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Potassium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-8183-25)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/10/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Acetate Injection",
    "Company Name": "Exela Pharma Sciences, LLC",
    "Contact Info": "828-758-5474",
    "Presentation": "Injection, 3.93 g/20 mL (NDC 51754-2001-4)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Pending a batch release that will restock channel.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/10/2019",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Chloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 149 mg/1 mL (NDC 0409-6635-01)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "05/07/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/02/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Chloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 149 mg/1 mL (NDC 0409-6651-06)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "05/07/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/02/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Chloride Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 149 mg/1 mL (NDC 0409-6653-05)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "05/07/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/02/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Chloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Potassium Chloride In Plastic Container, Injection, 2 meq/1 mL (NDC 63323-967-30)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "05/07/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/02/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Chloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Potassium Chloride In Plastic Container, Injection, 2 meq/1 mL (NDC 63323-965-05)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "05/07/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/02/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Chloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Potassium Chloride In Plastic Container, Injection, 2 meq/1 mL (NDC 63323-965-10)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "05/07/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/02/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Chloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Potassium Chloride In Plastic Container, Injection, 2 meq/1 mL (NDC 63323-965-20)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "05/07/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/02/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Chloride Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Injection, 14.9 g/100 mL (NDC 0264-1940-20)",
    "Type of Update": "Revised",
    "Date of Update": "02/02/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "To Be Discontinued",
    "Change Date": "02/06/2024",
    "Date Discontinued": "02/02/2024",
    "Initial Posting Date": "11/02/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Chloride Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Injection, 14.9 g/100 mL (NDC 0264-1944-20)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "05/07/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/02/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Chloride Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Potassium Chloride, Injection, 7.46 g/1000 mL (NDC 0338-0709-48)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "05/07/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/02/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Chloride Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Potassium Chloride, Injection, 14.9 g/1000 mL (NDC 0338-0705-41)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "05/07/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/02/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Chloride Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Potassium Chloride, Injection, 14.9 g/1000 mL (NDC 0338-0705-48)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "05/07/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/02/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Chloride Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Potassium Chloride, Injection, 29.8 g/1000 mL (NDC 0338-0703-41)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "05/07/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/02/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Chloride Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Potassium Chloride, Injection, 29.8 g/1000 mL (NDC 0338-0703-48)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "05/07/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/02/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Chloride Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Potassium Chloride 20mEq In Plastic Container, Injection, 400 meq/1000 mL (NDC 0990-7077-14)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "05/07/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/02/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Chloride Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Potassium Chloride 10mEq In Plastic Container, Injection, 10 meq/100 mL (NDC 0990-7074-26)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "05/07/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/02/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Chloride Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Potassium Chloride 10mEq In Plastic Container, Injection, 200 meq/1000 mL (NDC 0990-7075-14)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "05/07/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/02/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Chloride Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Potassium Chloride 20mEq In Plastic Container, Injection, 200 meq/1000 mL (NDC 0990-7075-26)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "05/07/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/02/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Chloride Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Potassium Chloride 40mEq In Plastic Container, Injection, 400 meq/1000 mL (NDC 0990-7077-26)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "05/07/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/02/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Chloride Injection",
    "Company Name": "Nexus Pharmaceuticals, LLC",
    "Contact Info": "888-806-4606",
    "Presentation": "Injection, 20 mEq (NDC 14789-107-08)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "05/07/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/02/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Chloride Injection",
    "Company Name": "Nexus Pharmaceuticals, LLC",
    "Contact Info": "888-806-4606",
    "Presentation": "Injection, 40 mEq (NDC 14789-107-16)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "05/07/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/02/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Chloride Injection",
    "Company Name": "Nexus Pharmaceuticals, LLC",
    "Contact Info": "888-806-4606",
    "Presentation": "Injection, 20 mEq (NDC 14789-108-16)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "05/07/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/02/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Chloride Injection",
    "Company Name": "Nexus Pharmaceuticals, LLC",
    "Contact Info": "888-806-4606",
    "Presentation": "Injection, 10 mEq (NDC 14789-108-08)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "05/07/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/02/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Potassium Chloride Injection",
    "Company Name": "Nexus Pharmaceuticals, LLC",
    "Contact Info": "888-806-4606",
    "Presentation": "Injection, 10 mEq (NDC 14789-109-16)",
    "Type of Update": "Revised",
    "Date of Update": "05/07/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "05/07/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "11/02/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Pralatrexate Solution",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Folotyn, Solution, 20 mg/1 mL (NDC 65219-550-01)",
    "Type of Update": "New",
    "Date of Update": "03/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Hematology; Oncology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/21/2024",
    "Initial Posting Date": "03/21/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Pralatrexate Solution",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Folotyn, Solution, 40 mg/2 mL (NDC 65219-552-02)",
    "Type of Update": "New",
    "Date of Update": "03/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Hematology; Oncology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/21/2024",
    "Initial Posting Date": "03/21/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Praziquantel Tablet",
    "Company Name": "Bayer HealthCare Pharmaceuticals Inc.",
    "Contact Info": "888-842-2937",
    "Presentation": "Biltricide, Tablet, 600 mg (NDC 50419-747-01)",
    "Type of Update": "New",
    "Date of Update": "03/05/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/05/2024",
    "Initial Posting Date": "03/05/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Prazosin Hydrochloride Capsule",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Minipress, Capsule, 1 mg (NDC 0069-4310-71)",
    "Type of Update": "New",
    "Date of Update": "04/28/2023",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug. Supply expected to exhaust in August 2023",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "04/28/2023",
    "Date Discontinued": "04/28/2023",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Prazosin Hydrochloride Capsule",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Minipress, Capsule, 2 mg (NDC 0069-4370-71)",
    "Type of Update": "New",
    "Date of Update": "04/28/2023",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug. Supply expected to exhaust in September 2023",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "04/28/2023",
    "Date Discontinued": "04/28/2023",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Prazosin Hydrochloride Capsule",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Minipress, Capsule, 5 mg (NDC 0069-4380-71)",
    "Type of Update": "New",
    "Date of Update": "04/28/2023",
    "Availability Information": "",
    "Related Information": "Discontinuation of the manufacture of the drug. Supply expected to exhaust in September 2023",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "To Be Discontinued",
    "Change Date": "04/28/2023",
    "Date Discontinued": "04/28/2023",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Promethazine Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Promethazine HCl Injection, USP, Injection, 25 mg/1 mL (NDC 0641-0928-25)",
    "Type of Update": "Revised",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction; Gastroenterology; Pediatric; Pulmonary/Allergy",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Promethazine Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Promethazine HCl Injection, USP, Injection, 50 mg/1 mL (NDC 0641-0929-25)",
    "Type of Update": "Revised",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction; Gastroenterology; Pediatric; Pulmonary/Allergy",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Promethazine Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Promethazine HCl Injection, USP, Injection, 25 mg/1 mL (NDC 0641-1495-35)",
    "Type of Update": "Revised",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction; Gastroenterology; Pediatric; Pulmonary/Allergy",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Promethazine Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Promethazine HCl Injection, USP, Injection, 50 mg/1 mL (NDC 0641-1496-35)",
    "Type of Update": "Revised",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction; Gastroenterology; Pediatric; Pulmonary/Allergy",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Promethazine Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Phenergan Injection (Promethazine HCl Injection,USP, Injection, 25 mg/1 mL (NDC 0641-6084-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction; Gastroenterology; Pediatric; Pulmonary/Allergy",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Promethazine Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Phenergan Injection (Promethazine HCl Injection,USP, Injection, 50 mg/1 mL (NDC 0641-6085-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction; Gastroenterology; Pediatric; Pulmonary/Allergy",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Promethazine Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Phenergan Injection (Promethazine HCl Injection,USP, Injection, 25 mg/1 mL (NDC 0641-6082-25)",
    "Type of Update": "Revised",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Additional lots will be available in the September 2024 timeframe. Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction; Gastroenterology; Pediatric; Pulmonary/Allergy",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Promethazine Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Phenergan Injection (Promethazine HCl Injection,USP, Injection, 50 mg/1 mL (NDC 0641-6083-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction; Gastroenterology; Pediatric; Pulmonary/Allergy",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Promethazine Hydrochloride Injection",
    "Company Name": "XGen Pharmaceuticals DJB, Inc.",
    "Contact Info": "866-390-4411",
    "Presentation": "Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 39822-5525-3)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction; Gastroenterology; Other; Pulmonary/Allergy",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Promethazine Hydrochloride Injection",
    "Company Name": "XGen Pharmaceuticals DJB, Inc.",
    "Contact Info": "866-390-4411",
    "Presentation": "Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 39822-5550-6)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction; Gastroenterology; Other; Pulmonary/Allergy",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/21/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Propranolol Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 1 mg/1 mL (NDC 63323-604-01)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Backordered. Next release not available at this time; Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Propranolol Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Injection, 1 mg/1 mL (NDC 0143-9872-10)",
    "Type of Update": "Reverified",
    "Date of Update": "05/17/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Propranolol Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Injection, 1 mg/1 mL (NDC 0143-9872-10)",
    "Type of Update": "Reverified",
    "Date of Update": "05/17/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "10/31/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril Hydrochloride Tablet",
    "Company Name": "Chartwell Molecular Holdings LLC",
    "Contact Info": "845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com",
    "Presentation": "Quinapril Hydrochloride, Tablet, 5 mg (NDC 62135-484-60)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril Hydrochloride Tablet",
    "Company Name": "Chartwell Molecular Holdings LLC",
    "Contact Info": "845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com",
    "Presentation": "Quinapril Hydrochloride, Tablet, 10 mg (NDC 62135-485-90)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril Hydrochloride Tablet",
    "Company Name": "Chartwell Molecular Holdings LLC",
    "Contact Info": "845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com",
    "Presentation": "Quinapril Hydrochloride, Tablet, 20 mg (NDC 62135-486-90)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril Hydrochloride Tablet",
    "Company Name": "Chartwell Molecular Holdings LLC",
    "Contact Info": "845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com",
    "Presentation": "Quinapril Hydrochloride, Tablet, 40 mg (NDC 62135-487-90)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril Hydrochloride Tablet",
    "Company Name": "Solco Healthcare US, LLC",
    "Contact Info": "866-931-9829",
    "Presentation": "Tablet, 5 mg (NDC 43547-410-09)",
    "Type of Update": "Reverified",
    "Date of Update": "06/17/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Not available. Long-term backorder for all NDCs. No estimated release date at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril Hydrochloride Tablet",
    "Company Name": "Solco Healthcare US, LLC",
    "Contact Info": "866-931-9829",
    "Presentation": "Tablet, 10 mg (NDC 43547-411-09)",
    "Type of Update": "Reverified",
    "Date of Update": "06/17/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Not available. Long-term backorder for all NDCs. No estimated release date at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril Hydrochloride Tablet",
    "Company Name": "Solco Healthcare US, LLC",
    "Contact Info": "866-931-9829",
    "Presentation": "Tablet, 20 mg (NDC 43547-412-09)",
    "Type of Update": "Reverified",
    "Date of Update": "06/17/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Not available. Long-term backorder for all NDCs. No estimated release date at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril Hydrochloride Tablet",
    "Company Name": "Solco Healthcare US, LLC",
    "Contact Info": "866-931-9829",
    "Presentation": "Tablet, 40 mg (NDC 43547-413-09)",
    "Type of Update": "Reverified",
    "Date of Update": "06/17/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Not available. Long-term backorder for all NDCs. No estimated release date at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril Hydrochloride Tablet",
    "Company Name": "Lupin Pharmaceuticals, Inc.",
    "Contact Info": "866-587-4617",
    "Presentation": "Quinapril Hydrochloride, Tablet, 5 mg (NDC 68180-556-09)",
    "Type of Update": "Reverified",
    "Date of Update": "05/18/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Requirements related to complying with good manufacturing practices",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril Hydrochloride Tablet",
    "Company Name": "Lupin Pharmaceuticals, Inc.",
    "Contact Info": "Lupin Pharmaceuticals, Inc.",
    "Presentation": "Quinapril Hydrochloride, Tablet, 10 mg (NDC 68180-557-09)",
    "Type of Update": "Reverified",
    "Date of Update": "05/18/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Requirements related to complying with good manufacturing practices",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril Hydrochloride Tablet",
    "Company Name": "Lupin Pharmaceuticals, Inc.",
    "Contact Info": "866-587-4617",
    "Presentation": "Quinapril Hydrochloride, Tablet, 20 mg (NDC 68180-558-09)",
    "Type of Update": "Reverified",
    "Date of Update": "05/18/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Requirements related to complying with good manufacturing practices",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril Hydrochloride Tablet",
    "Company Name": "Lupin Pharmaceuticals, Inc.",
    "Contact Info": "866-587-4617",
    "Presentation": "Quinapril Hydrochloride, Tablet, 40 mg (NDC 68180-554-09)",
    "Type of Update": "Reverified",
    "Date of Update": "05/18/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Requirements related to complying with good manufacturing practices",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril Hydrochloride Tablet",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2876",
    "Presentation": "Quinapril Hydrochloride, Tablet, 5 mg (NDC 65862-617-90)",
    "Type of Update": "Reverified",
    "Date of Update": "07/02/2024",
    "Availability Information": "Discontinued",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril Hydrochloride Tablet",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2876",
    "Presentation": "Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90)",
    "Type of Update": "Reverified",
    "Date of Update": "07/02/2024",
    "Availability Information": "Discontinued",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril Hydrochloride Tablet",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2876",
    "Presentation": "Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90)",
    "Type of Update": "Reverified",
    "Date of Update": "07/02/2024",
    "Availability Information": "Discontinued",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril Hydrochloride Tablet",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2876",
    "Presentation": "Quinapril Hydrochloride, Tablet, 40 mg (NDC 65862-620-90)",
    "Type of Update": "Reverified",
    "Date of Update": "07/02/2024",
    "Availability Information": "Discontinued",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril Hydrochloride Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Accupril, Tablet, 40 mg (NDC 0071-0535-23)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery and Estimated Recovery: TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril Hydrochloride Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Accupril, Tablet, 10 mg (NDC 0071-0530-23)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery and Estimated Recovery: TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril Hydrochloride Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Accupril, Tablet, 20 mg (NDC 0071-0532-23)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery and Estimated Recovery: TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril Hydrochloride Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Accupril, Tablet, 5 mg (NDC 0071-0527-23)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery and Estimated Recovery: TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril/Hydrochlorothiazide Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Accuretic, Tablet, 10 mg/12.5 mg (NDC 0071-0222-23)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery and Estimated Recovery: TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril/Hydrochlorothiazide Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Accuretic, Tablet, 20 mg/12.5 mg (NDC 0071-0220-23)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery and Estimated Recovery: TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril/Hydrochlorothiazide Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Accuretic, Tablet, 25 mg/20 mg (NDC 0071-0223-23)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery and Estimated Recovery: TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril/Hydrochlorothiazide Tablet",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2876",
    "Presentation": "Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 65862-161-90)",
    "Type of Update": "Reverified",
    "Date of Update": "07/02/2024",
    "Availability Information": "Discontinued",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril/Hydrochlorothiazide Tablet",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2876",
    "Presentation": "Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 65862-162-90)",
    "Type of Update": "Reverified",
    "Date of Update": "07/02/2024",
    "Availability Information": "Discontinued",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril/Hydrochlorothiazide Tablet",
    "Company Name": "Aurobindo Pharma USA",
    "Contact Info": "866-850-2876",
    "Presentation": "Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 65862-163-90)",
    "Type of Update": "Reverified",
    "Date of Update": "07/02/2024",
    "Availability Information": "Discontinued",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril/Hydrochlorothiazide Tablet",
    "Company Name": "Chartwell Molecular Holdings LLC",
    "Contact Info": "845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com",
    "Presentation": "Quinapril/Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 62135-669-90)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril/Hydrochlorothiazide Tablet",
    "Company Name": "Chartwell Molecular Holdings LLC",
    "Contact Info": "845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com",
    "Presentation": "Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 62135-668-90)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Quinapril/Hydrochlorothiazide Tablet",
    "Company Name": "Chartwell Molecular Holdings LLC",
    "Contact Info": "845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com",
    "Presentation": "Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 62135-667-90)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Cardiovascular",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/19/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Remifentanil Hydrochloride Injection",
    "Company Name": "Mylan Institutional, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Ultiva, Injection, 1 mg/1 mL (NDC 72078-034-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next supply in August 2024.",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Remifentanil Hydrochloride Injection",
    "Company Name": "Mylan Institutional, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Ultiva, Injection, 2 mg (NDC 72078-035-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next supply in September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Remifentanil Hydrochloride Injection",
    "Company Name": "Mylan Institutional, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Ultiva, Injection, 5 mg (NDC 67457-198-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available (expires 11/30/24)",
    "Related Information": "Next supply in Q4-2024.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Remifentanil Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Remifentanil HCl for Injection, Injection, 1 mg per vial (NDC 0143-9391-10)",
    "Type of Update": "Reverified",
    "Date of Update": "05/23/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Additional lots will be available in the June 2024 timeframe. Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Remifentanil Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Injection, 2 mg per vial (NDC 0143-9392-10)",
    "Type of Update": "Revised",
    "Date of Update": "05/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Remifentanil Hydrochloride Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Injection, 5 mg per vial (NDC 0143-9393-10)",
    "Type of Update": "Revised",
    "Date of Update": "05/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Remifentanil Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 1 mg/1 mL (NDC 63323-723-03)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Backordered. Next release September 2024. Check wholesalers for inventory.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Remifentanil Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 1 mg/1 mL (NDC 63323-724-05)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Remifentanil Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 1 mg/1 mL (NDC 63323-725-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Backordered. Next release not available at this time; Check wholesalers for inventory.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/28/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rifampin Capsule",
    "Company Name": "Epic Pharma, LLC",
    "Contact Info": "(718) 276-8600 ext. 3",
    "Presentation": "Capsule, 150 mg (NDC 42806-801-30)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/22/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rifampin Capsule",
    "Company Name": "Epic Pharma, LLC",
    "Contact Info": "(718) 276-8600 ext. 3",
    "Presentation": "Capsule, 150 mg (NDC 42806-801-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/22/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rifampin Capsule",
    "Company Name": "Epic Pharma, LLC",
    "Contact Info": "(718) 276-8600 ext. 3",
    "Presentation": "Capsule, 300 mg (NDC 42806-799-30)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/22/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rifampin Capsule",
    "Company Name": "Epic Pharma, LLC",
    "Contact Info": "(718) 276-8600 ext. 3",
    "Presentation": "Capsule, 300 mg (NDC 42806-799-60)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/22/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rifampin Capsule",
    "Company Name": "Epic Pharma, LLC",
    "Contact Info": "(718) 276-8600 ext. 3",
    "Presentation": "Capsule, 300 mg (NDC 42806-799-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/22/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rifampin Capsule",
    "Company Name": "Epic Pharma, LLC",
    "Contact Info": "(718) 276-8600 ext. 3",
    "Presentation": "Capsule, 300 mg (NDC 42806-799-05)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/22/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rifampin Capsule",
    "Company Name": "Lupin Pharmaceuticals, Inc.",
    "Contact Info": "866-587-4617",
    "Presentation": "Rifampin, Capsule, 150 mg (NDC 68180-658-06)",
    "Type of Update": "Reverified",
    "Date of Update": "05/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/22/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rifampin Capsule",
    "Company Name": "Lupin Pharmaceuticals, Inc.",
    "Contact Info": "866-587-4617",
    "Presentation": "Rifampin, Capsule, 300 mg (NDC 68180-659-06)",
    "Type of Update": "Reverified",
    "Date of Update": "05/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/22/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rifampin Capsule",
    "Company Name": "Lupin Pharmaceuticals, Inc.",
    "Contact Info": "866-587-4617",
    "Presentation": "Rifampin, Capsule, 300 mg (NDC 68180-659-07)",
    "Type of Update": "Reverified",
    "Date of Update": "05/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/22/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rifampin Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 600 mg (NDC 63323-351-20)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/17/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rifampin Injection",
    "Company Name": "Sanofi-Aventis U.S. LLC",
    "Contact Info": "800-633-1610",
    "Presentation": "Rifadin, Injection, 600 mg/10 mL (NDC 0068-0597-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/17/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rifampin Injection",
    "Company Name": "Mylan Institutional, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Injection, 600 mg/10 mL (NDC 67457-445-60)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next supply in July 2024.",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/17/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rifapentine Tablet, Film Coated",
    "Company Name": "Sanofi-Aventis U.S. LLC",
    "Contact Info": "800-633-1610 Option 7",
    "Presentation": "Priftin, Tablet, Film Coated, 150 mg (NDC 0088-2102-24)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anti-Infective",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/25/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Riluzole Oral Suspension",
    "Company Name": "EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)",
    "Contact Info": "610-937-6172",
    "Presentation": "Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0306-1)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/26/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Riluzole Oral Suspension",
    "Company Name": "EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)",
    "Contact Info": "610-937-6172",
    "Presentation": "Tiglutik, Oral Suspension, 50 mg/10 mL (NDC 70726-0303-2)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next release not available at this time; Shortage per Manufacturer: Product manufacturing interrupted due to viscosity testing",
    "Resolved Note": "",
    "Reason for Shortage": "Requirements related to complying with good manufacturing practices",
    "Therapeutic Category": "Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/26/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Riluzole Oral Suspension",
    "Company Name": "EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)",
    "Contact Info": "610-937-6172",
    "Presentation": "Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0304-1)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/26/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Riluzole Oral Suspension",
    "Company Name": "EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)",
    "Contact Info": "610-937-6172",
    "Presentation": "Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0305-1)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/26/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rocuronium Bromide Injection",
    "Company Name": "Piramal Critical Care Inc.",
    "Contact Info": "800-414-1901",
    "Presentation": "Injection, 50 mg/5 mL (NDC 66794-228-41)",
    "Type of Update": "Revised",
    "Date of Update": "06/26/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rocuronium Bromide Injection",
    "Company Name": "Piramal Critical Care Inc.",
    "Contact Info": "800-414-1901",
    "Presentation": "Injection, 100 mg/10 mL (NDC 66794-229-41)",
    "Type of Update": "Revised",
    "Date of Update": "06/26/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rocuronium Bromide Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 10 mg/1 mL (NDC 65219-065-05)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "7 month expiry available upon request; Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rocuronium Bromide Injection",
    "Company Name": "Meitheal Pharmaceuticals, Inc.",
    "Contact Info": "844-824-8426",
    "Presentation": "Injection, 10 mg/1 mL (NDC 71288-700-06)",
    "Type of Update": "Reverified",
    "Date of Update": "07/03/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rocuronium Bromide Injection",
    "Company Name": "Meitheal Pharmaceuticals, Inc.",
    "Contact Info": "844-824-8426",
    "Presentation": "Injection, 10 mg/1 mL (NDC 71288-718-11)",
    "Type of Update": "Reverified",
    "Date of Update": "07/03/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rocuronium Bromide Injection",
    "Company Name": "Mylan Institutional, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rocuronium Bromide Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 10 mg/1 mL (NDC 63323-426-05)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rocuronium Bromide Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 10 mg/1 mL (NDC 63323-426-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rocuronium Bromide Injection",
    "Company Name": "XGen Pharmaceuticals DJB, Inc.",
    "Contact Info": "866-390-4411",
    "Presentation": "Injection, 50 mg/5 mL (NDC 39822-4200-2)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "Tamarang is the application holder and X-Gen is the distributor/labeler",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rocuronium Bromide Injection",
    "Company Name": "XGen Pharmaceuticals DJB, Inc.",
    "Contact Info": "866-390-4411",
    "Presentation": "Injection, 100 mg/10 mL (NDC 39822-4200-6)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "Tamarang is the application holder and X-Gen is the distributor/labeler",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rocuronium Bromide Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 10 mg/1 mL (NDC 25021-687-05)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rocuronium Bromide Injection",
    "Company Name": "Mylan Institutional, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rocuronium Bromide Injection",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Injection, 10 mg/1 mL (NDC 0781-3220-95)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rocuronium Bromide Injection",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Injection, 10 mg/1 mL (NDC 0781-3220-92)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rocuronium Bromide Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-3189-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rocuronium Bromide Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-1403-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rocuronium Bromide Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-7037-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rocuronium Bromide Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-5160-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rocuronium Bromide Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 100 mg/10 mL (NDC 55150-226-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Unavailable",
    "Related Information": "On backorder. Recovery: TBD. Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rocuronium Bromide Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 50 mg/5 mL (NDC 55150-225-05)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Unavailable",
    "Related Information": "On backorder. Recovery: TBD. Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rocuronium Bromide Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 43066-007-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "Tamarang is the application holder and Baxter is the distributor/labeler",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rocuronium Bromide Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 43066-013-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "Tamarang is the application holder and Baxter is the distributor/labeler",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rocuronium Bromide Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Rocuronium Bromide Injection, Injection, 10 mg/1 mL (NDC 0143-9250-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots will be available.  Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Rocuronium Bromide Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Rocuronium Bromide Injection, Injection, 10 mg/1 mL (NDC 0143-9251-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/15/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Somerset Therapeutics, LLC",
    "Contact Info": "732-554-1019",
    "Presentation": "Injection, 2 mg/1 mL (NDC 70069-061-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/29/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Somerset Therapeutics, LLC",
    "Contact Info": "732-554-1019",
    "Presentation": "Injection, 2 mg/1 mL (NDC 70069-061-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/29/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Somerset Therapeutics, LLC",
    "Contact Info": "732-554-1019",
    "Presentation": "Injection, 2 mg/1 mL (NDC 70069-062-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/29/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Somerset Therapeutics, LLC",
    "Contact Info": "732-554-1019",
    "Presentation": "Injection, 2 mg/1 mL (NDC 70069-062-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/29/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Somerset Therapeutics, LLC",
    "Contact Info": "732-554-1019",
    "Presentation": "Injection, 5 mg/1 mL (NDC 70069-064-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/29/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Somerset Therapeutics, LLC",
    "Contact Info": "732-554-1019",
    "Presentation": "Injection, 5 mg/1 mL (NDC 70069-064-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/29/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Somerset Therapeutics, LLC",
    "Contact Info": "732-554-1019",
    "Presentation": "Injection, 5 mg/1 mL (NDC 70069-064-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/29/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "InfoRLife SA",
    "Contact Info": "Sagent: 866-625-1618",
    "Presentation": "Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-66)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Sagent Pharmaceuticals",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/27/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "InfoRLife SA",
    "Contact Info": "Sagent: 866-625-1618",
    "Presentation": "Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-67)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Sagent Pharmaceuticals",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/27/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "InfoRLife SA",
    "Contact Info": "Sagent: 866-625-1618",
    "Presentation": "Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-82)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Sagent Pharmaceuticals",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/27/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "InfoRLife SA",
    "Contact Info": "Sagent: 866-625-1618",
    "Presentation": "Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-87)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Sagent Pharmaceuticals",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/27/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "InfoRLife SA",
    "Contact Info": "Sagent: 866-625-1618",
    "Presentation": "Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-82)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Sagent Pharmaceuticals",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/27/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "InfoRLife SA",
    "Contact Info": "Sagent: 866-625-1618",
    "Presentation": "Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-87)",
    "Type of Update": "Reverified",
    "Date of Update": "07/01/2024",
    "Availability Information": "Available",
    "Related Information": "Marketed by Sagent Pharmaceuticals",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/27/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Caplin Steriles, Ltd.",
    "Contact Info": "888-229-0001",
    "Presentation": "Injection, 2 mg/1 mL (NDC 43066-015-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Check wholesalers for inventory; Marketed by Baxter",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/22/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Caplin Steriles, Ltd.",
    "Contact Info": "888-229-0001",
    "Presentation": "Injection, 5 mg/1 mL (NDC 43066-019-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory; Marketed by Baxter",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/22/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Caplin Steriles, Ltd.",
    "Contact Info": "888-229-0001",
    "Presentation": "Injection, 5 mg/1 mL (NDC 43066-023-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited supply; Check wholesalers for inventory; Marketed by Baxter",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/22/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Caplin Steriles, Ltd.",
    "Contact Info": "888-229-0001",
    "Presentation": "Injection, 10 mg/1 mL (NDC 43066-027-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory; Marketed by Baxter",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/22/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 2 mg/1 mL (NDC 55150-195-20)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 2 mg/1 mL (NDC 55150-196-99)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 5 mg/1 mL (NDC 55150-197-20)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 5 mg/1 mL (NDC 55150-198-30)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 7.5 mg/1 mL (NDC 55150-199-20)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 10 mg/1 mL (NDC 55150-200-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 10 mg/1 mL (NDC 55150-201-20)",
    "Type of Update": "Revised",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Naropin, Injection, 2 mg/1 mL (NDC 63323-285-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next release not available at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Naropin, Injection, 2 mg/1 mL (NDC 63323-285-20)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next release not available at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Naropin, Injection, 5 mg/1 mL (NDC 63323-286-20)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next release not available at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-20)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Naropin, Injection, 10 mg/1 mL (NDC 63323-288-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next release not available at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Naropin, Injection, 10 mg/1 mL (NDC 63323-288-20)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next release not available at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Naropin, Injection, 2 mg/1 mL (NDC 63323-285-61)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next release not available at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Naropin, Injection, 2 mg/1 mL (NDC 63323-285-63)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next release not available at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Naropin, Injection, 2 mg/1 mL (NDC 63323-285-65)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Naropin, Injection, 2 mg/1 mL (NDC 63323-285-64)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Naropin, Injection, 5 mg/1 mL (NDC 63323-286-00)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Naropin, Injection, 5 mg/1 mL (NDC 63323-286-63)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Naropin, Injection, 2 mg/1 mL (NDC 63323-285-23)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Naropin, Injection, 5 mg/1 mL (NDC 63323-286-35)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Naropin, Injection, 5 mg/1 mL (NDC 63323-286-23)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-21)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Naropin, Injection, 10 mg/1 mL (NDC 63323-288-11)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Naropin, Injection, 10 mg/1 mL (NDC 63323-288-21)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Ropivacaine Hydrochloride Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Naropin, Injection, 5 mg/1 mL (NDC 63323-286-31)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next release not available at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Semaglutide Injection",
    "Company Name": "Novo Nordisk, Inc.",
    "Contact Info": "833-493-4689",
    "Presentation": "Wegovy, Injection, .25 mg/.5 mL (NDC 0169-4525-14)",
    "Type of Update": "Revised",
    "Date of Update": "08/06/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Estimated shortage duration TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "08/23/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Semaglutide Injection",
    "Company Name": "Novo Nordisk, Inc.",
    "Contact Info": "833-493-4689",
    "Presentation": "Wegovy, Injection, .5 mg/.5 mL (NDC 0169-4505-14)",
    "Type of Update": "Revised",
    "Date of Update": "08/06/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/31/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Semaglutide Injection",
    "Company Name": "Novo Nordisk, Inc.",
    "Contact Info": "833-496-4689",
    "Presentation": "Wegovy, Injection, 1 mg/.5 mL (NDC 0169-4501-14)",
    "Type of Update": "Revised",
    "Date of Update": "08/06/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/31/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Semaglutide Injection",
    "Company Name": "Novo Nordisk, Inc.",
    "Contact Info": "833-496-4689",
    "Presentation": "Wegovy, Injection, 1.7 mg/.75 mL (NDC 0169-4517-14)",
    "Type of Update": "Revised",
    "Date of Update": "08/06/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/31/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Semaglutide Injection",
    "Company Name": "Novo Nordisk, Inc.",
    "Contact Info": "833-496-4689",
    "Presentation": "Wegovy, Injection, 2.4 mg/.75 mL (NDC 0169-4524-14)",
    "Type of Update": "Revised",
    "Date of Update": "08/06/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/31/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Semaglutide Injection",
    "Company Name": "Novo Nordisk, Inc.",
    "Contact Info": "866-696-4090 and press 0",
    "Presentation": "Ozempic, Injection, 1.34 mg/1 mL (NDC 0169-4130-13)",
    "Type of Update": "Revised",
    "Date of Update": "08/06/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "08/23/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Semaglutide Injection",
    "Company Name": "Novo Nordisk, Inc.",
    "Contact Info": "866-696-4090 and press 0",
    "Presentation": "Ozempic, Injection, 2.68 mg/1 mL (NDC 0169-4772-12)",
    "Type of Update": "Revised",
    "Date of Update": "08/06/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "08/23/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Semaglutide Injection",
    "Company Name": "Novo Nordisk, Inc.",
    "Contact Info": "866-696-4090 and press 0",
    "Presentation": "Ozempic, Injection, .68 mg/1 mL (NDC 0169-4181-13)",
    "Type of Update": "Revised",
    "Date of Update": "08/06/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "08/23/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Acetate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 200 mEq/100 mL (2 mEq/mL)  (NDC 0409-3299-25)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: December 2024; Estimated Recovery: March 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/03/2016",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Acetate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 100 mEq/50 mL (2 mEq/mL)   (NDC 0409-3299-26)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery and Estimated Recovery: December 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/03/2016",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Acetate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-25)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: July 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/03/2016",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Acetate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 4 meq/100 mL (NDC 63323-032-00)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Total Parenteral Nutrition",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2016",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Acetate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: August 2024; Estimated Recovery: December 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/03/2016",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Acetate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-06)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: July 2024; Estimated Recovery: December 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/03/2016",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Acetate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-73)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: August 2024; Estimated Recovery: December 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/03/2016",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Acetate Injection",
    "Company Name": "Milla Pharmaceuticals",
    "Contact Info": "833-251-8463",
    "Presentation": "Injection, 100 mEq/50mL (2 mEq/mL) (NDC 69784-230-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Total Parenteral Nutrition",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2016",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Acetate Injection",
    "Company Name": "Milla Pharmaceuticals",
    "Contact Info": "833-251-8463",
    "Presentation": "Injection, 200 mEq/100mL (2 mEq/mL) (NDC 69784-231-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Total Parenteral Nutrition",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/23/2016",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Acetate Injection",
    "Company Name": "Milla Pharmaceuticals",
    "Contact Info": "833-251-8463",
    "Presentation": "Injection, 400 mEq/100mL (4 mEq/mL) (NDC 69784-232-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/03/2016",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Acetate Injection",
    "Company Name": "Milla Pharmaceuticals",
    "Contact Info": "833-251-8463",
    "Presentation": "Injection, 40 mEq/20mL (2 mEq/mL) (NDC 69784-229-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/03/2016",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Benzoate; Sodium Phenylacetate Injection",
    "Company Name": "Bausch Health Americas, Inc.",
    "Contact Info": "908-927-1400",
    "Presentation": "Ammonul, Injection, 100 mg/1 mL; 100 mg/1 mL (NDC 0187-0010-50)",
    "Type of Update": "New",
    "Date of Update": "07/03/2024",
    "Availability Information": "",
    "Related Information": "Discontinuation due to business decision",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Inborn Errors; Other",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "07/03/2024",
    "Initial Posting Date": "07/03/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Benzoate; Sodium Phenylacetate Injection",
    "Company Name": "Bausch Health Americas, Inc.",
    "Contact Info": "908-927-1400",
    "Presentation": "Ammonul, Injection, 100 mg/1 mL; 100 mg/1 mL (NDC 68682-001-50)",
    "Type of Update": "New",
    "Date of Update": "07/03/2024",
    "Availability Information": "",
    "Related Information": "Discontinuation due to business decision",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Inborn Errors; Other",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "07/03/2024",
    "Initial Posting Date": "07/03/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Bicarbonate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection,  2.5 mEq/5 mL (4.2%, 0.5 mEq/mL)  (NDC 0409-5555-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: August 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Bicarbonate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection,  2.5 mEq/5 mL (4.2%, 0.5 mEq/mL)  (NDC 0409-5555-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: April 2025; Estimated Recovery: June 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Bicarbonate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 44.6 mEq/50 mL (7.5%, 0.9 mEq/mL) Syringes (NDC 0409-4916-14)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: November 2024; Estimated Recovery: December 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Bicarbonate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection,  50 mEq/50 mL (8.4%, 1 mEq/mL)  (NDC 0409-6625-14)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: July 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Bicarbonate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection,  50 mEq/50 mL (8.4%, 1 mEq/mL)  (NDC 0409-6625-35)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: April 2025; Estimated Recovery: June 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Bicarbonate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 10 mEq/10 mL (8.4%, 1 mEq/mL) Syringes (NDC 0409-4900-14)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: October 2024; Estimated Recovery: December 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Bicarbonate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Sodium Bicarbonate, Injection, 5 mEq/10 mL (4.2%, 0.5 mEq/mL) Syringes (NDC 0409-5534-14)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Limited Supply Available. Next Delivery: October 2024; Estimated Recovery: December 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Bicarbonate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Sodium Bicarbonate, Injection,  50 mEq/50 mL (8.4%, 1 mEq/mL) Syringes (NDC 0409-6637-14)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: October 2024; Estimated Recovery: March 2025",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Bicarbonate Injection",
    "Company Name": "Amphastar Pharmaceuticals, Inc.",
    "Contact Info": "800-423-4136",
    "Presentation": "Injection, 84 mg/1 mL (NDC 76329-3352-1)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "03/01/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Bicarbonate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 42 mg/1 mL (NDC 63323-083-05)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Backordered. Next release September 2024. Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/24/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Bicarbonate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 84 mg/1 mL (NDC 63323-089-50)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/24/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Bicarbonate Injection",
    "Company Name": "Exela Pharma Sciences, LLC",
    "Contact Info": "828-758-5474 ext. 154",
    "Presentation": "Injection, 84 mg/1 mL (NDC 51754-5001-5)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "Available in NDC 51754-5001-4 which is carton of 25 vials. The 521754-5001-05 was discontinued over a year ago.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/24/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Bicarbonate Injection",
    "Company Name": "Exela Pharma Sciences, LLC",
    "Contact Info": "828-758-5474 ext. 154",
    "Presentation": "Injection, 84 mg/1 mL (NDC 51754-5011-4)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/24/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Bicarbonate Injection",
    "Company Name": "Exela Pharma Sciences, LLC",
    "Contact Info": "828-758-5474 ext. 154",
    "Presentation": "Injection, 42 mg/1 mL (NDC 51754-5012-4)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/24/2017",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 900 mg/100 mL (NDC 0990-7984-13)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7984-13",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 900 mg/100 mL (NDC 0990-7984-36)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7984-36",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 900 mg/100 mL (NDC 0990-7984-37)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7984-37",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 900 mg/100 mL (NDC 0990-7984-23)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7984-23",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 900 mg/100 mL (NDC 0990-7984-20)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7984-20",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Guerbet LLC",
    "Contact Info": "877-729-6679",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, .9 mg/1 mL (NDC 0019-1188-81)",
    "Type of Update": "Revised",
    "Date of Update": "05/31/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/21/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Guerbet LLC",
    "Contact Info": "877-729-6679",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, .9 mg/1 mL (NDC 0019-1188-27)",
    "Type of Update": "Reverified",
    "Date of Update": "05/31/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Sodium Chloride Injection in RFID presentation is not available and the plan is to discontinue this presentation from sales",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/21/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Sodium Chloride, Injection, .9 g/100 mL (NDC 0264-7800-00)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Sodium Chloride, Injection, .9 g/100 mL (NDC 0264-7800-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Sodium Chloride, Injection, .9 g/100 mL (NDC 0264-7800-20)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Sodium Chloride, Injection, .9 g/100 mL (NDC 0264-7800-09)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 mg/1 mL (NDC 0264-1800-32)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 mg/1 mL (NDC 0264-1800-31)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 mg/1 mL (NDC 0264-1800-36)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 900 mg/100 mL (9%, 9mg/mL) (NDC 0409-7101-66)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 900 mg/100 mL (9%, 9mg/mL) (NDC 0409-7101-67)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 900 mg/100 mL (9%, 9mg/mL) (NDC 0409-7101-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Laboratorios Grifols, S.A.",
    "Contact Info": "800-848-0462",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 g/1000 mL (NDC 76297-001-21)",
    "Type of Update": "Reverified",
    "Date of Update": "05/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Laboratorios Grifols, S.A.",
    "Contact Info": "800-848-0462",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 g/1000 mL (NDC 76297-001-31)",
    "Type of Update": "Reverified",
    "Date of Update": "05/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Laboratorios Grifols, S.A.",
    "Contact Info": "800-848-0462",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 g/1000 mL (NDC 76297-001-01)",
    "Type of Update": "Reverified",
    "Date of Update": "05/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Laboratorios Grifols, S.A.",
    "Contact Info": "800-848-0462",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 g/1000 mL (NDC 76297-001-41)",
    "Type of Update": "Reverified",
    "Date of Update": "05/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Laboratorios Grifols, S.A.",
    "Contact Info": "800-848-0462",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 g/1000 mL (NDC 76297-001-11)",
    "Type of Update": "Reverified",
    "Date of Update": "05/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 mg/1 mL (NDC 63323-623-53)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 mg/1 mL (NDC 63323-623-61)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 mg/1 mL (NDC 65219-472-20)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 mg/1 mL (NDC 65219-474-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 g/1000 mL (NDC 0338-0049-18)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 g/1000 mL (NDC 0338-0049-41)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 g/1000 mL (NDC 0338-0049-48)",
    "Type of Update": "Revised",
    "Date of Update": "06/21/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Recovery Late July 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 g/1000 mL (NDC 0338-0049-31)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 g/1000 mL (NDC 0338-0049-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 g/1000 mL (NDC 0338-0049-03)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 g/1000 mL (NDC 0338-0049-04)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 g/1000 mL (NDC 0338-0049-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 g/1000 mL (NDC 0338-0049-11)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 g/1000 mL (NDC 0338-0049-38)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 g/1000 mL (NDC 0338-9543-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 g/1000 mL (NDC 0338-9543-06)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 g/1000 mL (NDC 0338-9543-04)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 900 mg/100 mL (NDC 0338-0553-11)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 450 mg/100 mL (NDC 0338-9151-30)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 900 mg/100 mL (NDC 0338-9159-30)",
    "Type of Update": "Reverified",
    "Date of Update": "06/21/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "On allocation; Recovery Q3",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 900 mg/100 mL (NDC 0338-0553-18)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 g/1000 mL (NDC 0338-9543-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 g/1000 mL (NDC 0338-9543-04)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 g/1000 mL (NDC 0338-9543-06)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Spectra Medical Devices, LLC",
    "Contact Info": "978-657-0889",
    "Presentation": "Sodium Chloride 0.9%, Injection, 9 mg/1 mL (NDC 65282-1510-1)",
    "Type of Update": "Reverified",
    "Date of Update": "06/26/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/21/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Spectra Medical Devices, LLC",
    "Contact Info": "978-657-0889",
    "Presentation": "Sodium Chloride 0.9%, Injection, 9 mg/1 mL (NDC 65282-1505-1)",
    "Type of Update": "Reverified",
    "Date of Update": "06/26/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/21/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Bacteriostatic Sodium Chloride 0.9% In Plastic Container, Injection, 9 mg/1 mL (NDC 63323-924-30)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/08/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Bacteriostatic Sodium Chloride 0.9% In Plastic Container, Injection, 9 mg/1 mL (NDC 63323-924-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/08/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Bacteriostatic Sodium Chloride 0.9% In Plastic Container, Injection, 9% (9 mg/1 mL) (NDC 0409-1966-12)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: July Next Delivery: July 2024; Estimated Recovery: September 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/08/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Bacteriostatic Sodium Chloride 0.9% In Plastic Container, Injection, 9% (9 mg/1 mL) (NDC 0409-1966-05)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/08/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Bacteriostatic Sodium Chloride 0.9% In Plastic Container, Injection, 9% (9 mg/1 mL) (NDC 0409-1966-07)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/08/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 900 mg/100 mL (NDC 0990-7983-61)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7983-61",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 900 mg/100 mL (NDC 0990-7983-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7983-02",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 900 mg/100 mL (NDC 0990-7983-55)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7983-55",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Laboratorios Grifols, S.A.",
    "Contact Info": "800-848-0462",
    "Presentation": "Sodium Chloride 0.9%, 50 mL Fleboflex Plastic Container, Injection, 0.9% (NDC 79672-613-01)",
    "Type of Update": "Revised",
    "Date of Update": "05/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Laboratorios Grifols, S.A.",
    "Contact Info": "800-848-0462",
    "Presentation": "Sodium Chloride 0.9%, 100 mL Fleboflex Plastic Container, Injection, 0.9% (NDC 79672-613-02)",
    "Type of Update": "Reverified",
    "Date of Update": "05/18/2024",
    "Availability Information": "Available",
    "Related Information": "Product available for contracted customers.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Laboratorios Grifols, S.A.",
    "Contact Info": "800-848-0462",
    "Presentation": "Sodium Chloride 0.9%, 250 mL Fleboflex Plastic Container, Injection, 0.9% (NDC 79672-613-03)",
    "Type of Update": "Reverified",
    "Date of Update": "05/18/2024",
    "Availability Information": "Available",
    "Related Information": "Product available for contracted customers.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Laboratorios Grifols, S.A.",
    "Contact Info": "800-848-0462",
    "Presentation": "Sodium Chloride 0.9%, 500 mL Fleboflex Plastic Container, Injection, 0.9% (NDC 79672-613-04)",
    "Type of Update": "Reverified",
    "Date of Update": "05/18/2024",
    "Availability Information": "Available",
    "Related Information": "Product available for contracted customers.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Laboratorios Grifols, S.A.",
    "Contact Info": "800-848-0462",
    "Presentation": "Sodium Chloride 0.9%, 1000 mL Fleboflex Plastic Container, Injection, 0.9% (NDC 79672-613-05)",
    "Type of Update": "Reverified",
    "Date of Update": "05/18/2024",
    "Availability Information": "Available",
    "Related Information": "Product available for contracted customers.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 900 mg/100 mL (NDC 0990-7983-03)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7983-03",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 900 mg/100 mL (NDC 0990-7983-09)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7983-09",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 mg/1 mL (NDC 63323-186-02)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "3, 4, 5 & 8 month expiry available upon request; Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/21/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 mg/1 mL (NDC 63323-186-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/21/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9 mg/1 mL (NDC 63323-186-20)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/21/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sodium Chloride, Injection, 9 mg/1 mL (NDC 63323-186-00)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next release not available at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/21/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9% (9 mg/1 mL) (NDC 0409-4888-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/21/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9% (9 mg/1 mL) (NDC 0409-4888-12)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: November 2024; Estimated Recovery: December 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/21/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9% (9 mg/1 mL) (NDC 0409-4888-20)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/21/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Injection, 9% (9 mg/1 mL) (NDC 0409-4888-50)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/21/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Medefil, Inc.",
    "Contact Info": "630-682-4600",
    "Presentation": "Sodium Chloride 0.9%, Injection, 9 mg/1 mL (NDC 64253-202-30)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "08/02/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sodium Chloride, Injection, 4 meq/1 mL (NDC 63323-095-61)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Backordered. Next release August 2024; Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Gastroenterology; Endocrinology/Metabolism; Total Parenteral Nutrition; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "09/18/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Sodium Chloride Injection USP, 0.9%, Injection, 9 mg/1 mL (NDC 0641-0497-25)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "This presentation is temporarily on backorder.  Recovery is TBD at this time.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/21/2018",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Sodium Chloride, Injection, .45 g/100 mL (NDC 0264-7802-00)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Injection",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Sodium Chloride, Injection, .45 g/100 mL (NDC 0264-7802-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/10/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Irrigation",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Irrigation, .9 g/100mL (NDC 0264-7388-60)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Irrigation",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Irrigation, .9 g/100mL (NDC 0264-7388-50)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Irrigation",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Irrigation, .9 g/100mL (NDC 0264-2201-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Irrigation",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Irrigation, .9 g/100mL (NDC 0264-2201-00)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Irrigation",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Irrigation, 900 mg/100 mL (NDC 0338-0048-02)",
    "Type of Update": "Reverified",
    "Date of Update": "06/21/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "On allocation; Recovery Q3",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Irrigation",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Irrigation, 900 mg/100 mL (NDC 0338-0048-03)",
    "Type of Update": "Reverified",
    "Date of Update": "06/21/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "On allocation; Recovery Q3",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Irrigation",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Irrigation, 900 mg/100 mL (NDC 0338-0048-04)",
    "Type of Update": "Reverified",
    "Date of Update": "06/21/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "On allocation; Recovery Q3",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Irrigation",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Irrigation, 900 mg/100 mL (NDC 0990-6138-22)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Allocated to Contracted Customers Only. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-6139-22",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Irrigation",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Irrigation, 900 mg/100 mL (NDC 0990-6138-03)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Allocated to Contracted Customers Only. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-6139-22",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Irrigation",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Irrigation, 900 mg/100 mL (NDC 0990-7138-09)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Allocated to Contracted Customers Only. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-6139-22",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 0.9% Irrigation",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Sodium Chloride 0.9% In Plastic Container, Irrigation, 900 mg/100 mL (NDC 0990-7138-36)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Unavailable",
    "Related Information": "ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7138-36",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 14.6% Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sodium Chloride 14.6%, Injection, 2.5 meq/1 mL (NDC 63323-090-20)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/05/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 14.6% Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sodium Chloride 14.6%, Injection, 2.5 meq/1 mL (NDC 63323-090-40)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/05/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 14.6% Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Sodium Chloride, Injection, 14.6% 100 mEq/40 mL (2.5 mEq/mL) (NDC 0409-6660-75)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/05/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 23.4% Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Sodium Chloride, Injection, 400 mEq/100 mL (4 mEq/mL) (NDC 0409-1141-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Limited Supply Available. Next Delivery: July 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 23.4% Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sodium Chloride 23.4%, Injection, 4 meq/1 mL (NDC 63323-099-63)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Endocrinology/Metabolism; Total Parenteral Nutrition; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/01/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Chloride 23.4% Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sodium Chloride 23.4%, Injection, 4 meq/1 mL (NDC 63323-093-30)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Endocrinology/Metabolism; Total Parenteral Nutrition; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "09/18/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Phosphate, Dibasic, Anhydrous, Sodium Phosphate, Monobasic, Monohydrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 15 mL vial (NDC 0409-7391-72)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "08/02/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "09/01/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Phosphate, Dibasic, Anhydrous, Sodium Phosphate, Monobasic, Monohydrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 5 mL vial (NDC 63323-884-06)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "08/02/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "09/01/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Phosphate, Dibasic, Anhydrous, Sodium Phosphate, Monobasic, Monohydrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 15 mL vial (NDC 63323-881-16)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "08/02/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "09/01/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Phosphate, Dibasic, Anhydrous, Sodium Phosphate, Monobasic, Monohydrate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 50 mL vial (NDC 63323-886-56)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "08/02/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "09/01/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Phosphate, Dibasic, Anhydrous, Sodium Phosphate, Monobasic, Monohydrate Injection",
    "Company Name": "American Regent, Inc.",
    "Contact Info": "800-645-1706",
    "Presentation": "Injection, 15 mL vial (NDC 0517-7315-25)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "08/02/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "09/01/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Phosphate, Dibasic, Anhydrous, Sodium Phosphate, Monobasic, Monohydrate Injection",
    "Company Name": "American Regent, Inc.",
    "Contact Info": "800-645-1706",
    "Presentation": "Injection, 5 mL vial (NDC 0517-7305-25)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "08/02/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "09/01/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sodium Phosphate, Dibasic, Anhydrous, Sodium Phosphate, Monobasic, Monohydrate Injection",
    "Company Name": "American Regent, Inc.",
    "Contact Info": "800-645-1706",
    "Presentation": "Injection, 50 mL vial (NDC 0517-7350-25)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition",
    "Status": "Resolved",
    "Change Date": "08/02/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "09/01/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Genentech, Inc",
    "Contact Info": "800-551-2231",
    "Presentation": "Nutropin AQ, Injection, 10 mg/2 mL (NDC 50242-074-01)",
    "Type of Update": "New",
    "Date of Update": "03/22/2024",
    "Availability Information": "",
    "Related Information": "The decision to discontinue commercial distribution of Nutropin AQ in the United States is a business decision, taken in view of the availability of generic and alternative treatments for patients, and is not related to any quality, safety or efficacy concerns with the product.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/22/2024",
    "Initial Posting Date": "03/22/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Genentech, Inc",
    "Contact Info": "800-551-2231",
    "Presentation": "Nutropin AQ, Injection, 5 mg/2 mL (NDC 50242-075-01)",
    "Type of Update": "New",
    "Date of Update": "03/22/2024",
    "Availability Information": "",
    "Related Information": "The decision to discontinue commercial distribution of Nutropin AQ in the United States is a business decision, taken in view of the availability of generic and alternative treatments for patients, and is not related to any quality, safety or efficacy concerns with the product.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/22/2024",
    "Initial Posting Date": "03/22/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Genentech, Inc",
    "Contact Info": "800-551-2231",
    "Presentation": "Nutropin AQ, Injection, 20 mg/2 mL (NDC 50242-076-01)",
    "Type of Update": "New",
    "Date of Update": "03/22/2024",
    "Availability Information": "",
    "Related Information": "The decision to discontinue commercial distribution of Nutropin AQ in the United States is a business decision, taken in view of the availability of generic and alternative treatments for patients, and is not related to any quality, safety or efficacy concerns with the product.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "03/22/2024",
    "Initial Posting Date": "03/22/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Novo Nordisk, Inc.",
    "Contact Info": "609-987-5800",
    "Presentation": "Norditropin, Injection, 5 mg/1.5 mL (NDC 0169-7704-21)",
    "Type of Update": "Revised",
    "Date of Update": "07/31/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Intermittent Supply until end of Q2 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Novo Nordisk, Inc.",
    "Contact Info": "609-987-5800",
    "Presentation": "Norditropin, Injection, 10 mg/1.5 mL (NDC 0169-7705-21)",
    "Type of Update": "Revised",
    "Date of Update": "07/31/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Novo Nordisk, Inc.",
    "Contact Info": "609-987-5800",
    "Presentation": "Norditropin, Injection, 15 mg/1.5 mL (NDC 0169-7708-21)",
    "Type of Update": "Revised",
    "Date of Update": "07/31/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Novo Nordisk, Inc.",
    "Contact Info": "609-987-5800",
    "Presentation": "Norditropin, Injection, 30 mg/3 mL (NDC 0169-7703-21)",
    "Type of Update": "Revised",
    "Date of Update": "07/31/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Unavailable until end of 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Omnitrope, Injection, 5 mg/1.5 mL (NDC 0781-3001-07)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Omnitrope, Injection, 10 mg/1.5 mL (NDC 0781-3004-07)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Eli Lilly and Co.",
    "Contact Info": "800-545-5979",
    "Presentation": "Humatrope, Injection, 12 mg/vial (NDC 0002-8148-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Eli Lilly and Co.",
    "Contact Info": "800-545-5979",
    "Presentation": "Humatrope, Injection, 24 mg/vial (NDC 0002-8149-01)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Genotropin, Injection, 5 mg/mL, w/ preservative (NDC 0013-2626-81)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Genotropin, Injection, 12 mg/mL, w/ preservative (NDC 0013-2646-81)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Genotropin, Injection, 0.2 mg preservative free (NDC 0013-2649-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Genotropin, Injection, 0.4 mg preservative free (NDC 0013-2650-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery: September 2024; Estimated Recovery: December 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Genotropin, Injection, 0.6 mg preservative free (NDC 0013-2651-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Genotropin, Injection, 0.8 mg preservative free (NDC 0013-2652-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Genotropin, Injection, 1.0 mg preservative free (NDC 0013-2653-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Genotropin, Injection, 1.2 mg preservative free (NDC 0013-2654-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Genotropin, Injection, 1.4 mg preservative free (NDC 0013-2655-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Genotropin, Injection, 1.6 mg preservative free (NDC 0013-2656-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Genotropin, Injection, 1.8 mg preservative free (NDC 0013-2657-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Genotropin, Injection, 2.0 mg preservative free (NDC 0013-2658-02)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Genentech, Inc",
    "Contact Info": "800-551-2231",
    "Presentation": "Nutropin Aq, Injection, 10 mg/2 mL (NDC 50242-074-01)",
    "Type of Update": "Revised",
    "Date of Update": "03/22/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Somatropin%20Injection&st=d",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Genentech, Inc",
    "Contact Info": "800-551-2231",
    "Presentation": "Nutropin Aq, Injection, 5 mg/2 mL (NDC 50242-075-01)",
    "Type of Update": "Revised",
    "Date of Update": "03/22/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Somatropin%20Injection&st=d",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Somatropin Injection",
    "Company Name": "Genentech, Inc",
    "Contact Info": "800-551-2231",
    "Presentation": "Nutropin Aq, Injection, 20 mg/2 mL (NDC 50242-076-01)",
    "Type of Update": "Revised",
    "Date of Update": "03/22/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "01/06/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Somatropin%20Injection&st=d",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sterile Water Injection",
    "Company Name": "Nephron Pharmaceuticals Corporation",
    "Contact Info": "800-443-4313",
    "Presentation": "Injection, 1 mL/1 mL (NDC 0487-6105-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/17/2024",
    "Availability Information": "Product will be made available as it is released, TBD",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Requirements related to complying with good manufacturing practices",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sterile Water Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Sterile Water For Injection, Injection, 1 mL/1 mL (NDC 0641-6147-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sterile Water Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 1 mL/1 mL (NDC 0409-4887-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sterile Water Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 1 mL/1 mL (NDC 0409-4887-20)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sterile Water Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 1 mL/1 mL (NDC 0409-4887-50)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sterile Water Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 1 mL/1 mL (NDC 0409-4887-99)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sterile Water Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-10)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sterile Water Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-20)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sterile Water Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-50)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sterile Water Injection",
    "Company Name": "Medefil, Inc.",
    "Contact Info": "630-682-4600",
    "Presentation": "Injection, 10 mL/10 mL (NDC 64253-020-30)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sterile Water Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Bacteriostatic Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 0409-3977-03)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/03/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sterile Water Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 1000 mL/1000 mL (NDC 63323-178-76)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Other",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "11/23/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sterile Water Irrigant",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0264-2101-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sterile Water Irrigant",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0264-2101-00)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sterile Water Irrigant",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-6139-22)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Allocated to Contracted Customers Only. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-6139-22",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sterile Water Irrigant",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-6139-03)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Allocated to Contracted Customers Only. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-6139-22",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sterile Water Irrigant",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-7139-09)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Allocated to Contracted Customers Only. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-6139-22",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sterile Water Irrigant",
    "Company Name": "ICU Medical, Inc.",
    "Contact Info": "1-866-829-9025 or ProductAvailability@icumed.com",
    "Presentation": "Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-7139-36)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Allocated to Contracted Customers Only. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-6139-22",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sterile Water Irrigant",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-02)",
    "Type of Update": "Reverified",
    "Date of Update": "06/21/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "On allocation; Recovery Q3 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sterile Water Irrigant",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-03)",
    "Type of Update": "Reverified",
    "Date of Update": "06/21/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "On allocation; Recovery Q3 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sterile Water Irrigant",
    "Company Name": "Baxter Healthcare",
    "Contact Info": "888-229-0001",
    "Presentation": "Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-04)",
    "Type of Update": "Reverified",
    "Date of Update": "06/21/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "On allocation; Recovery Q3 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sterile Water Irrigant",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0264-2101-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sterile Water Irrigant",
    "Company Name": "B. Braun Medical Inc.",
    "Contact Info": "800-227-2862",
    "Presentation": "Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0264-2101-00)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Available",
    "Related Information": "On allocation",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology; Other; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "04/28/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Streptozocin Powder, For Solution",
    "Company Name": "ESTEVE PHARMACEUTICALS, S.A.",
    "Contact Info": "mcomasl@esteve.com",
    "Presentation": "Zanosar, Powder, For Solution, 1 g/10 mL (NDC 68118-100-01)",
    "Type of Update": "Reverified",
    "Date of Update": "01/15/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/166810/download",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Streptozocin Powder, For Solution",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Zanosar, Powder, For Solution, 100 mg/1 mL (NDC 0703-4636-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/19/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Estimated Recovery TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Other",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "07/12/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sucralfate Tablet",
    "Company Name": "Nostrum Laboratories, Inc.",
    "Contact Info": "816-841-4636",
    "Presentation": "Tablet, 1 g (NDC 29033-003-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "07/15/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "01/04/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sucralfate Tablet",
    "Company Name": "Nostrum Laboratories, Inc.",
    "Contact Info": "816-841-4636",
    "Presentation": "Tablet, 1 g (NDC 29033-003-05)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "07/15/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "01/04/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sucralfate Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Sucralfate Tablets, USP, Tablet, 1 g (NDC 0093-2210-01)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "07/15/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "01/04/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sucralfate Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Sucralfate Tablets, USP, Tablet, 1 g (NDC 0093-2210-05)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "07/15/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "01/04/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sucralfate Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Sucralfate Tablets, USP, Tablet, 1 g (NDC 0093-2210-98)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "07/15/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "01/04/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sucralfate Tablet",
    "Company Name": "Allergan, Inc.",
    "Contact Info": "800-678-1605",
    "Presentation": "Carafate, Tablet, 1 g (NDC 58914-171-10)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "07/15/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "01/04/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sucralfate Tablet",
    "Company Name": "Allergan, Inc.",
    "Contact Info": "800-678-1605",
    "Presentation": "Tablet, 1 g (NDC 59762-040-11)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "07/15/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "01/04/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sucralfate Tablet",
    "Company Name": "Allergan, Inc.",
    "Contact Info": "800-678-1605",
    "Presentation": "Tablet, 1 g (NDC 59762-040-15)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "07/15/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "01/04/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sucralfate Tablet",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Tablet, 1 g (NDC 69238-1656-1)",
    "Type of Update": "Revised",
    "Date of Update": "07/15/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "07/15/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "01/04/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sufentanil Citrate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Sufentanil Citrate Injection, USP, Injection, 50 mcg/1 mL (NDC 17478-050-02)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Not currently manufactured",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/03/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sufentanil Citrate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Sufentanil Citrate Injection, USP, Injection, 50 mcg/1 mL (NDC 17478-050-05)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Not currently manufactured",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/03/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sufentanil Citrate Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Injection, 50 ug/1 mL (NDC 0409-3382-21)",
    "Type of Update": "Revised",
    "Date of Update": "07/30/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "Limited Supply Available. Next Delivery: July 2024; Estimated Recovery: September 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/03/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/179002/download",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sufentanil Citrate Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Sufentanil Citrate Injection, USP, Injection, 50 mcg/1 mL (NDC 17478-050-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Not currently manufactured",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Analgesia/Addiction; Pediatric",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/03/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sulfasalazine Tablet",
    "Company Name": "Chartwell Molecular Holdings LLC",
    "Contact Info": "845-268-5000 Ext. 510",
    "Presentation": "Sulfasalazine, Tablet, 500 mg (NDC 62135-960-01)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "04/24/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sulfasalazine Tablet",
    "Company Name": "Chartwell Molecular Holdings LLC",
    "Contact Info": "845-268-5000 Ext. 510",
    "Presentation": "Sulfasalazine, Tablet, 500 mg (NDC 62135-960-05)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "04/24/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sulfasalazine Tablet",
    "Company Name": "Chartwell Molecular Holdings LLC",
    "Contact Info": "845-268-5000 Ext. 510",
    "Presentation": "Sulfasalazine, Tablet, 500 mg (NDC 62135-960-10)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "04/24/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sulfasalazine Tablet",
    "Company Name": "Chartwell Molecular Holdings LLC",
    "Contact Info": "845-268-5000 Ext. 510",
    "Presentation": "Sulfasalazine, Tablet, 500 mg (NDC 62135-960-31)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "04/24/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sulfasalazine Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Azulfidine, Tablet, 500 mg (NDC 0013-0101-30)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "04/24/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sulfasalazine Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Azulfidine, Tablet, 500 mg (NDC 0013-0102-60)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "06/13/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sulfasalazine Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Tablet, 500 mg (NDC 59762-0104-5)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "04/27/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sulfasalazine Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Tablet, 500 mg (NDC 59762-5000-5)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "04/27/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sulfasalazine Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Azulfidine, Tablet, 500 mg (NDC 0013-0101-10)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "04/24/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sulfasalazine Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Azulfidine, Tablet, 500 mg (NDC 0013-0101-20)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "04/24/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sulfasalazine Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Azulfidine, Tablet, 500 mg (NDC 0013-0102-50)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "04/24/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sulfasalazine Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Azulfidine, Tablet, 500 mg (NDC 0013-0102-20)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "04/24/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sulfasalazine Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Tablet, 500 mg (NDC 59762-0104-1)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "04/24/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sulfasalazine Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Tablet, 500 mg (NDC 59762-0104-6)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "04/24/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sulfasalazine Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Tablet, 500 mg (NDC 59762-5000-1)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "04/24/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sulfasalazine Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "800-533-4535",
    "Presentation": "Tablet, 500 mg (NDC 59762-5000-6)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "04/24/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sulfasalazine Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Sulfasalazine Tablets, USP, Tablet, 500 mg (NDC 0093-3234-01)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "04/24/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sulfasalazine Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Sulfasalazine Tablets, USP, Tablet, 500 mg (NDC 0093-3234-10)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "04/24/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Sulfasalazine Tablet",
    "Company Name": "Teva Pharmaceuticals USA, Inc.",
    "Contact Info": "800-545-8800",
    "Presentation": "Sulfasalazine Tablets, USP, Tablet, 500 mg (NDC 0093-3234-05)",
    "Type of Update": "Revised",
    "Date of Update": "05/21/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "05/21/2024",
    "Date Discontinued": "",
    "Initial Posting Date": "04/24/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Technetium TC-99M Pyrophosphate Kit Injection",
    "Company Name": "Curium US LLC",
    "Contact Info": "888-744-1414",
    "Presentation": "Technescan PYP, Injection, 11.9 mg/10 mL; 3.2 mg/10 mL (NDC 69945-094-20)",
    "Type of Update": "Reverified",
    "Date of Update": "07/16/2024",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Medical Imaging",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/27/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Technetium TC-99M Pyrophosphate Kit Injection",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "CIS-PYRO, Injection, 12 mg/10 mL (NDC 45567-0060-1)",
    "Type of Update": "Reverified",
    "Date of Update": "07/08/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Estimated return of supply: TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Medical Imaging",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/27/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Technetium TC-99M Pyrophosphate Kit Injection",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "CIS-PYRO, Injection, 12 mg/10 mL (NDC 45567-0060-2)",
    "Type of Update": "Reverified",
    "Date of Update": "07/08/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Estimated return of supply: TBD",
    "Resolved Note": "",
    "Reason for Shortage": "Shortage of an active ingredient",
    "Therapeutic Category": "Medical Imaging",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/27/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Technetium Tc-99m Sodium Pertechnetate Generator",
    "Company Name": "NorthStar Medical Radioisotopes, LLC",
    "Contact Info": "(844) 438-6659",
    "Presentation": "RadioGenix System, Generator, 7.5 Ci/7.5 Ci (NDC 71612-075-02)",
    "Type of Update": "New",
    "Date of Update": "10/17/2023",
    "Availability Information": "",
    "Related Information": "The RadioGenix System is a technetium Tc 99m generator that produces Sodium Pertechnetate Tc 99m Injection, USP from a non-uranium potassium molybdate Mo-99 source solution, which is shielded within a source container that completely encases a vial containing 22-30 mL of solution; The company has made a business decision to discontinue production and distribution. The production date for the last batch of Mo-99 source vessels is October 30, 2023 with an expiration date of November 20, 2023.",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Medical Imaging",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/17/2023",
    "Initial Posting Date": "10/17/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Technetium Tc-99m Sodium Pertechnetate Generator",
    "Company Name": "NorthStar Medical Radioisotopes, LLC",
    "Contact Info": "(844) 438-6659",
    "Presentation": "RadioGenix System, Generator, 12 Ci/12 Ci (NDC 71612-120-02)",
    "Type of Update": "New",
    "Date of Update": "10/17/2023",
    "Availability Information": "",
    "Related Information": "The RadioGenix System is a technetium Tc 99m generator that produces Sodium Pertechnetate Tc 99m Injection, USP from a non-uranium potassium molybdate Mo-99 source solution, which is shielded within a source container that completely encases a vial containing 22-30 mL of solution. The company has made a business decision to discontinue production and distribution. The production date for the last batch of Mo-99 source vessels is October 30, 2023 with an expiration date of November 20, 2023.",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Medical Imaging",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/17/2023",
    "Initial Posting Date": "10/17/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Technetium Tc-99m Sodium Pertechnetate Generator",
    "Company Name": "NorthStar Medical Radioisotopes, LLC",
    "Contact Info": "(844) 438-6659",
    "Presentation": "RadioGenix System, Generator, 19 Ci/19 Ci (NDC 71612-190-02)",
    "Type of Update": "New",
    "Date of Update": "10/17/2023",
    "Availability Information": "",
    "Related Information": "The RadioGenix System is a technetium Tc 99m generator that produces Sodium Pertechnetate Tc 99m Injection, USP from a non-uranium potassium molybdate Mo-99 source solution, which is shielded within a source container that completely encases a vial containing 22-30 mL of solution. The company has made a business decision to discontinue production and distribution. The production date for the last batch of Mo-99 source vessels is October 30, 2023 with an expiration date of November 20, 2023.",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Medical Imaging",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/17/2023",
    "Initial Posting Date": "10/17/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Technetium Tc-99m Sodium Pertechnetate Generator",
    "Company Name": "NorthStar Medical Radioisotopes, LLC",
    "Contact Info": "(844) 438-6659",
    "Presentation": "RadioGenix System, Generator, 15 Ci/15 Ci (NDC 71612-150-02)",
    "Type of Update": "New",
    "Date of Update": "10/17/2023",
    "Availability Information": "",
    "Related Information": "The RadioGenix System is a technetium Tc 99m generator that produces Sodium Pertechnetate Tc 99m Injection, USP from a non-uranium potassium molybdate Mo-99 source solution, which is shielded within a source container that completely encases a vial containing 22-30 mL of solution; The company has made a business decision to discontinue production and distribution. The production date for the last batch of Mo-99 source vessels is October 30, 2023 with an expiration date of November 20, 2023.",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Medical Imaging",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "10/17/2023",
    "Initial Posting Date": "10/17/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Temazepam Capsule",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Capsule, 15 mg (NDC 65162-556-10)",
    "Type of Update": "New",
    "Date of Update": "04/30/2024",
    "Availability Information": "",
    "Related Information": "Business-related decision to discontinue the product.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/30/2024",
    "Initial Posting Date": "04/30/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Temazepam Capsule",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Capsule, 15 mg (NDC 65162-556-50)",
    "Type of Update": "New",
    "Date of Update": "04/30/2024",
    "Availability Information": "",
    "Related Information": "Business-related decision to discontinue the product.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/30/2024",
    "Initial Posting Date": "04/30/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Temazepam Capsule",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Capsule, 30 mg (NDC 65162-557-10)",
    "Type of Update": "New",
    "Date of Update": "04/30/2024",
    "Availability Information": "",
    "Related Information": "Business-related decision to discontinue the product.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/30/2024",
    "Initial Posting Date": "04/30/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Temazepam Capsule",
    "Company Name": "Amneal Pharmaceuticals",
    "Contact Info": "866-525-7270",
    "Presentation": "Capsule, 30 mg (NDC 65162-557-50)",
    "Type of Update": "New",
    "Date of Update": "04/30/2024",
    "Availability Information": "",
    "Related Information": "Business-related decision to discontinue the product.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "04/30/2024",
    "Initial Posting Date": "04/30/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Testosterone Gel, Metered",
    "Company Name": "Endo Pharmaceuticals. Inc.",
    "Contact Info": "800-462-3636",
    "Presentation": "Fortesta, Gel, Metered, 10 mg/.5 g (NDC 63481-183-18)",
    "Type of Update": "New",
    "Date of Update": "12/07/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Urology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "12/07/2023",
    "Initial Posting Date": "12/07/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Testosterone Gel, Metered",
    "Company Name": "Endo Pharmaceuticals. Inc.",
    "Contact Info": "800-462-3636",
    "Presentation": "Fortesta, Gel, Metered, 10 mg/.5 g (NDC 63481-183-17)",
    "Type of Update": "New",
    "Date of Update": "12/07/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Urology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "12/07/2023",
    "Initial Posting Date": "12/07/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Testosterone Gel, Metered",
    "Company Name": "Endo Pharmaceuticals. Inc.",
    "Contact Info": "800-462-3636",
    "Presentation": "Fortesta, Gel, Metered, 10 mg/.5 g (NDC 63481-183-16)",
    "Type of Update": "New",
    "Date of Update": "12/07/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Urology",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "12/07/2023",
    "Initial Posting Date": "12/07/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Testosterone Gel, Metered",
    "Company Name": "Endo Pharmaceuticals. Inc.",
    "Contact Info": "800-828-9393, option 5, then option 2",
    "Presentation": "Fortesta, Gel, Metered, 10 mg/.5 g (NDC 0603-7831-88)",
    "Type of Update": "New",
    "Date of Update": "08/25/2023",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Urology",
    "Status": "To Be Discontinued",
    "Change Date": "08/25/2023",
    "Date Discontinued": "08/25/2023",
    "Initial Posting Date": "08/25/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Tirzepatide Injection",
    "Company Name": "Eli Lilly and Co.",
    "Contact Info": "800-545-5979",
    "Presentation": "Zepbound, Injection, 5 mg/.5 mL (NDC 0002-2495-80)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Tirzepatide Injection",
    "Company Name": "Eli Lilly and Co.",
    "Contact Info": "800-545-5979",
    "Presentation": "Zepbound, Injection, 12.5 mg/.5 mL (NDC 0002-2460-80)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Tirzepatide Injection",
    "Company Name": "Eli Lilly and Co.",
    "Contact Info": "800-545-5979",
    "Presentation": "Zepbound, Injection, 2.5 mg/.5 mL (NDC 0002-2506-80)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Tirzepatide Injection",
    "Company Name": "Eli Lilly and Co.",
    "Contact Info": "800-545-5979",
    "Presentation": "Zepbound, Injection, 7.5 mg/.5 mL (NDC 0002-2484-80)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Tirzepatide Injection",
    "Company Name": "Eli Lilly and Co.",
    "Contact Info": "800-545-5979",
    "Presentation": "Zepbound, Injection, 10 mg/.5 mL (NDC 0002-2471-80)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Tirzepatide Injection",
    "Company Name": "Eli Lilly and Co.",
    "Contact Info": "800-545-5979",
    "Presentation": "Zepbound, Injection, 15 mg/.5 mL (NDC 0002-2457-80)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Tirzepatide Injection",
    "Company Name": "Eli Lilly and Co.",
    "Contact Info": "800-545-5979",
    "Presentation": "Mounjaro, Injection, 10 mg/.5 mL (NDC 0002-1471-80)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Tirzepatide Injection",
    "Company Name": "Eli Lilly and Co.",
    "Contact Info": "800-545-5979",
    "Presentation": "Mounjaro, Injection, 2.5 mg/.5 mL (NDC 0002-1506-80)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Tirzepatide Injection",
    "Company Name": "Eli Lilly and Co.",
    "Contact Info": "800-545-5979",
    "Presentation": "Mounjaro, Injection, 7.5 mg/.5 mL (NDC 0002-1484-80)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Tirzepatide Injection",
    "Company Name": "Eli Lilly and Co.",
    "Contact Info": "800-545-5979",
    "Presentation": "Mounjaro, Injection, 12.5 mg/.5 mL (NDC 0002-1460-80)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Tirzepatide Injection",
    "Company Name": "Eli Lilly and Co.",
    "Contact Info": "800-545-5979",
    "Presentation": "Mounjaro, Injection, 15 mg/.5 mL (NDC 0002-1457-80)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Tirzepatide Injection",
    "Company Name": "Eli Lilly and Co.",
    "Contact Info": "800-545-5979",
    "Presentation": "Mounjaro, Injection, 5 mg/.5 mL (NDC 0002-1495-80)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Endocrinology/Metabolism",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/15/2022",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Triamcinolone Acetonide Injection",
    "Company Name": "Harrow Eye, LLC",
    "Contact Info": "(615) 733-4734",
    "Presentation": "Triesence, Injection, 40 mg/1 mL (NDC 0065-0543-01)",
    "Type of Update": "Reverified",
    "Date of Update": "07/15/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Estimated shortage duration: 3-18 months. There are no therapeutic equivalents.",
    "Resolved Note": "",
    "Reason for Shortage": "Requirements related to complying with good manufacturing practices",
    "Therapeutic Category": "Ophthalmology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "09/27/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Triamcinolone Hexacetonide Injection",
    "Company Name": "Medexus",
    "Contact Info": "1-855-336-3322 Option 9",
    "Presentation": "Hexatrione, Injection, 40 mg/2 mL (NDC 59137-570-01)",
    "Type of Update": "Reverified",
    "Date of Update": "12/19/2023",
    "Availability Information": "Unavailable",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Rheumatology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/04/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "https://www.fda.gov/media/154709/download",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Triazolam Tablet",
    "Company Name": "Pfizer Inc.",
    "Contact Info": "844-646-4398",
    "Presentation": "Halcion, Tablet, .25 mg (NDC 0009-0017-55)",
    "Type of Update": "New",
    "Date of Update": "06/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "06/27/2024",
    "Initial Posting Date": "06/27/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Triazolam Tablet",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Tablet, .125 mg (NDC 0054-4858-25)",
    "Type of Update": "New",
    "Date of Update": "01/30/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "01/30/2024",
    "Initial Posting Date": "01/30/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Triazolam Tablet",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Tablet, .25 mg (NDC 0054-4859-25)",
    "Type of Update": "New",
    "Date of Update": "01/30/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "01/30/2024",
    "Initial Posting Date": "01/30/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Triazolam Tablet",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Tablet, .25 mg (NDC 0054-4859-29)",
    "Type of Update": "New",
    "Date of Update": "01/30/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "01/30/2024",
    "Initial Posting Date": "01/30/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Trimethobenzamide Hydrochloride Capsule",
    "Company Name": "Avet Pharmaceuticals, Inc.",
    "Contact Info": "855-228-9470",
    "Presentation": "Capsule, 300 mg (NDC 62135-773-30)",
    "Type of Update": "Revised",
    "Date of Update": "02/27/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "Available. Marketed by Chartwell Pharmaceuticals. To order call, 845-268-5000 Ext. 510.",
    "Reason for Shortage": "",
    "Therapeutic Category": "Gastroenterology",
    "Status": "Resolved",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "02/16/2021",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Valproate Sodium Injection",
    "Company Name": "Hikma Pharmaceuticals USA, Inc.",
    "Contact Info": "800-631-2174",
    "Presentation": "Valproate Sodium Injection, USP, Injection, 500 mg/5 mL (NDC 0143-9785-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/25/2024",
    "Availability Information": "Available",
    "Related Information": "Additional lots will be scheduled for manufacturing. Product will be made available as it is released.",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/30/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Valproate Sodium Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 100 mg/1 mL (NDC 63323-494-05)",
    "Type of Update": "Reverified",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Neurology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "12/30/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Valproate Sodium Injection",
    "Company Name": "Sagent Pharmaceuticals",
    "Contact Info": "866-625-1618",
    "Presentation": "Injection, 100 mg/mL, 5 mL (NDC 70860-784-41)",
    "Type of Update": "Revised",
    "Date of Update": "01/09/2024",
    "Availability Information": "",
    "Related Information": "No longer ordering APD NDC",
    "Resolved Note": "",
    "Reason for Shortage": "Discontinuation of the manufacture of the drug",
    "Therapeutic Category": "Neurology",
    "Status": "To Be Discontinued",
    "Change Date": "01/09/2024",
    "Date Discontinued": "01/09/2024",
    "Initial Posting Date": "12/30/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Vecuronium Bromide Injection",
    "Company Name": "Hospira, Inc., a Pfizer Company",
    "Contact Info": "844-646-4398",
    "Presentation": "Vecuronium Bromide, Injection, 1 mg/1 mL (NDC 0409-1632-01)",
    "Type of Update": "Revised",
    "Date of Update": "03/22/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "To Be Discontinued",
    "Change Date": "03/22/2024",
    "Date Discontinued": "03/22/2024",
    "Initial Posting Date": "05/06/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Vecuronium Bromide Injection",
    "Company Name": "Mylan Institutional, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Injection, 1 mg/1 mL (NDC 67457-438-10)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Re-supply in July 2024.",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/06/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Vecuronium Bromide Injection",
    "Company Name": "Mylan Institutional, a Viatris Company",
    "Contact Info": "800-796-9526",
    "Presentation": "Injection, 1 mg/1 mL (NDC 67457-475-20)",
    "Type of Update": "Reverified",
    "Date of Update": "07/18/2024",
    "Availability Information": "Available",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/06/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Vecuronium Bromide Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 1 mg/1 mL (NDC 63323-781-10)",
    "Type of Update": "Revised",
    "Date of Update": "03/22/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "To Be Discontinued",
    "Change Date": "03/22/2024",
    "Date Discontinued": "03/22/2024",
    "Initial Posting Date": "05/06/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Vecuronium Bromide Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 1 mg/1 mL (NDC 63323-782-20)",
    "Type of Update": "Revised",
    "Date of Update": "03/22/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "To Be Discontinued",
    "Change Date": "03/22/2024",
    "Date Discontinued": "03/22/2024",
    "Initial Posting Date": "05/06/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Vecuronium Bromide Injection",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Vecuronium Bromide, Injection, 1 mg/1 mL (NDC 47335-931-44)",
    "Type of Update": "Reverified",
    "Date of Update": "07/08/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/06/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Vecuronium Bromide Injection",
    "Company Name": "Sun Pharmaceutical Industries, Inc.",
    "Contact Info": "800-818-4555",
    "Presentation": "Vecuronium Bromide, Injection, 1 mg/1 mL (NDC 47335-932-44)",
    "Type of Update": "Reverified",
    "Date of Update": "07/08/2024",
    "Availability Information": "Limited Availability",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/06/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Vecuronium Bromide Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 10 mg (NDC 55150-235-10)",
    "Type of Update": "Reverified",
    "Date of Update": "08/05/2024",
    "Availability Information": "Unavailable",
    "Related Information": "On backorder. Recovery: TBD. Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "Demand increase for the drug",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/06/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Vecuronium Bromide Injection",
    "Company Name": "Eugia US LLC",
    "Contact Info": "888-238-7880",
    "Presentation": "Injection, 20 mg (NDC 55150-236-20)",
    "Type of Update": "Reverified",
    "Date of Update": "08/05/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Anesthesia",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "05/06/2020",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Vinblastine Sulfate Injection",
    "Company Name": "Fresenius Kabi USA, LLC",
    "Contact Info": "888-386-1300",
    "Presentation": "Injection, 1 mg/1 mL (NDC 63323-278-10)",
    "Type of Update": "Revised",
    "Date of Update": "08/02/2024",
    "Availability Information": "Available",
    "Related Information": "Check wholesalers for inventory",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Oncology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "09/14/2023",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Vitamin A Palmitate Injection",
    "Company Name": "Casper Pharma, LLC",
    "Contact Info": "844-522-7737",
    "Presentation": "Aquasol A, Injection, 15 mg/1 mL (NDC 70199-026-11)",
    "Type of Update": "New",
    "Date of Update": "06/10/2024",
    "Availability Information": "Unavailable",
    "Related Information": "Next Delivery and Estimated Recovery: August 2024",
    "Resolved Note": "",
    "Reason for Shortage": "Delay in shipping of the drug",
    "Therapeutic Category": "Endocrinology/Metabolism; Ophthalmology",
    "Status": "Current",
    "Change Date": "",
    "Date Discontinued": "",
    "Initial Posting Date": "06/10/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Zolpidem Tartrate Tablet, Extended Release",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Tablet, Extended Release, 6.25 mg (NDC 0781-5315-01)",
    "Type of Update": "New",
    "Date of Update": "01/26/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "01/26/2024",
    "Initial Posting Date": "01/26/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  },
  {
    "Generic Name": "Zolpidem Tartrate Tablet, Extended Release",
    "Company Name": "Sandoz Inc.",
    "Contact Info": "800-525-8747",
    "Presentation": "Tablet, Extended Release, 12.5 mg (NDC 0781-5316-01)",
    "Type of Update": "New",
    "Date of Update": "01/26/2024",
    "Availability Information": "",
    "Related Information": "",
    "Resolved Note": "",
    "Reason for Shortage": "",
    "Therapeutic Category": "Psychiatry",
    "Status": "To Be Discontinued",
    "Change Date": "",
    "Date Discontinued": "01/26/2024",
    "Initial Posting Date": "01/26/2024",
    "Generic Name Note": "",
    "Generic Name Link": "",
    "Company Info Link": "",
    "Availability Link": "",
    "Related Info Link": "",
    "Resolved Note Link": "",
    "Discontinued Note Link": ""
  }
]